PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 32608183-4 2021 Coating the PCL fibers with polydopamine resulted in the binding of the largest BMP-2 quantity per surface area. polydopamine 28-40 bone morphogenetic protein 2 Homo sapiens 80-85 33985511-5 2021 RESULTS: Human epidermal growth factor receptor 2 (Her2)-specific dimeric affibody (ZHer2) mediated cisplatin-loaded mesoporous polydopamine/MnO2/polydopamine nanoparticles (Pt@mPDA/MnO2/PDA-ZHer2 NPs) for MRI and enhanced chemo-radiotherapy of Her2-positive ovarian tumors is reported. polydopamine 128-140 erb-b2 receptor tyrosine kinase 2 Homo sapiens 9-49 33985511-5 2021 RESULTS: Human epidermal growth factor receptor 2 (Her2)-specific dimeric affibody (ZHer2) mediated cisplatin-loaded mesoporous polydopamine/MnO2/polydopamine nanoparticles (Pt@mPDA/MnO2/PDA-ZHer2 NPs) for MRI and enhanced chemo-radiotherapy of Her2-positive ovarian tumors is reported. polydopamine 128-140 erb-b2 receptor tyrosine kinase 2 Homo sapiens 51-55 33985511-5 2021 RESULTS: Human epidermal growth factor receptor 2 (Her2)-specific dimeric affibody (ZHer2) mediated cisplatin-loaded mesoporous polydopamine/MnO2/polydopamine nanoparticles (Pt@mPDA/MnO2/PDA-ZHer2 NPs) for MRI and enhanced chemo-radiotherapy of Her2-positive ovarian tumors is reported. polydopamine 128-140 erb-b2 receptor tyrosine kinase 2 Homo sapiens 85-89 34013303-2 2021 Redox species (anthraquinone (AQ), methylene blue (MB), and polydopamine (PDA)) are used as redox indicators for anchoring capture miRNA probes, which hybridize with the complementary targets, miRNA-21, miRNA-155, and miRNA-210, respectively. polydopamine 60-72 microRNA 21 Homo sapiens 193-201 34013303-2 2021 Redox species (anthraquinone (AQ), methylene blue (MB), and polydopamine (PDA)) are used as redox indicators for anchoring capture miRNA probes, which hybridize with the complementary targets, miRNA-21, miRNA-155, and miRNA-210, respectively. polydopamine 74-77 microRNA 21 Homo sapiens 193-201 34013303-2 2021 Redox species (anthraquinone (AQ), methylene blue (MB), and polydopamine (PDA)) are used as redox indicators for anchoring capture miRNA probes, which hybridize with the complementary targets, miRNA-21, miRNA-155, and miRNA-210, respectively. polydopamine 74-77 microRNA 155 Homo sapiens 203-212 32608183-7 2021 With polydopamine and plasma modifications as well as with unmodified PCL, high amounts of BMP-2 could also be attached directly to the surface. polydopamine 5-17 bone morphogenetic protein 2 Homo sapiens 91-96 33908524-2 2021 This work highlights the application of small- and ultra-small-angle neutron scattering (SANS and USANS, respectively), in combination with contrast variation techniques, in observing the in situ phase transition of polydopamine-stabilised perfluorohexane (PDA/PFH) emulsion droplets into microbubbles during heating. polydopamine 216-228 USH1 protein network component sans Homo sapiens 89-93 33909747-0 2021 Correction: A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy. polydopamine 32-44 microRNA 215 Homo sapiens 87-96 33909747-1 2021 Correction for "A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy" by Chen Tan et al., J. polydopamine 36-48 microRNA 215 Homo sapiens 91-100 33881417-0 2021 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy. polydopamine 20-32 microRNA 215 Homo sapiens 75-84 33885529-1 2021 A novel nanosystem of polydopamine-coated gold nanorods (AuNR@PDA) immobilised with molecules of hairpin DNA-conjugated distyryl boron dipyrromethene (DSBDP) was designed and fabricated for detection of microRNA-21 (miR-21). polydopamine 22-34 microRNA 21 Homo sapiens 203-214 33885529-1 2021 A novel nanosystem of polydopamine-coated gold nanorods (AuNR@PDA) immobilised with molecules of hairpin DNA-conjugated distyryl boron dipyrromethene (DSBDP) was designed and fabricated for detection of microRNA-21 (miR-21). polydopamine 22-34 microRNA 21 Homo sapiens 216-222 33964699-2 2021 Herein, an intelligent reactive oxygen species (ROS) nanogenerator Ce6/GOx@ZIF-8/PDA@MnO2 (denoted as CGZPM; Ce6, GOx, ZIF-8, PDA, MnO2 are chlorin e6, glucose oxidase, zeolitic imidazolate framework-8, polydopamine and manganese dioxide respectively) with O2-generating and GSH-/glucose-depleting abilities was constructed by a facile and green one-pot method. polydopamine 203-215 hydroxyacid oxidase 1 Homo sapiens 71-74 33869214-4 2021 Herein, we designed a silver (Ag) step-by-step cross-linking with the basic fibroblast growth factor (bFGF) by polydopamine (PDA) and heparin on titanium nanotube (TNT) as its cargo (TNT/PDA/Ag/bFGF) to improve the implant surface. polydopamine 111-123 fibroblast growth factor 2 Homo sapiens 70-100 33869214-4 2021 Herein, we designed a silver (Ag) step-by-step cross-linking with the basic fibroblast growth factor (bFGF) by polydopamine (PDA) and heparin on titanium nanotube (TNT) as its cargo (TNT/PDA/Ag/bFGF) to improve the implant surface. polydopamine 111-123 fibroblast growth factor 2 Homo sapiens 102-106 33869214-4 2021 Herein, we designed a silver (Ag) step-by-step cross-linking with the basic fibroblast growth factor (bFGF) by polydopamine (PDA) and heparin on titanium nanotube (TNT) as its cargo (TNT/PDA/Ag/bFGF) to improve the implant surface. polydopamine 125-128 fibroblast growth factor 2 Homo sapiens 70-100 33869214-4 2021 Herein, we designed a silver (Ag) step-by-step cross-linking with the basic fibroblast growth factor (bFGF) by polydopamine (PDA) and heparin on titanium nanotube (TNT) as its cargo (TNT/PDA/Ag/bFGF) to improve the implant surface. polydopamine 125-128 fibroblast growth factor 2 Homo sapiens 102-106 33621797-1 2021 In this work, cellulose filter paper (CFP), which is inexpensive and commercially available, was used as the carrier, and the immobilized alpha-glucosidase was obtained by two steps: firstly, the surface of CFP was modified by polydopamine/polyethyleneimine (PDA/PEI) co-deposition method to obtain CFP-PDA/PEI with a uniform coating of rich positive charge; subsequently, alpha-glucosidase was immobilized on the CFP-PDA/PEI by electrostatic adsorption. polydopamine 227-239 sucrase-isomaltase Homo sapiens 138-155 33651054-2 2021 Herein, we developed a flower-like MnO2-coated polydopamine (PDA@MnO2) core-shell nanoplatform with the surface adsorption of HSP70-silencing DNAzyme (DZ) for enhanced PPT. polydopamine 47-59 heat shock protein family A (Hsp70) member 4 Homo sapiens 126-131 33594879-5 2021 The MSCs on the PDA-coated substrate showed a lower level of interleukin 6 (IL-6), one of the senescence-associated inflammatory components. polydopamine 16-19 interleukin 6 Homo sapiens 61-74 33594879-5 2021 The MSCs on the PDA-coated substrate showed a lower level of interleukin 6 (IL-6), one of the senescence-associated inflammatory components. polydopamine 16-19 interleukin 6 Homo sapiens 76-80 33594879-6 2021 Cellular senescence-specific genes, such as p53 and p21, were downregulated on the PDA-coated substrate, while the stemness-related gene, OCT4, was upregulated. polydopamine 83-86 tumor protein p53 Homo sapiens 44-47 33594879-6 2021 Cellular senescence-specific genes, such as p53 and p21, were downregulated on the PDA-coated substrate, while the stemness-related gene, OCT4, was upregulated. polydopamine 83-86 H3 histone pseudogene 16 Homo sapiens 52-55 33594879-6 2021 Cellular senescence-specific genes, such as p53 and p21, were downregulated on the PDA-coated substrate, while the stemness-related gene, OCT4, was upregulated. polydopamine 83-86 POU class 5 homeobox 1 Homo sapiens 138-142 32506802-3 2021 The purpose of this study is to create a CD200 immobilized biomaterial surface through polydopamine coating to suppress macrophage cell adhesion and reduce inflammatory cytokine secretion accordingly by macrophages. polydopamine 87-99 CD200 antigen Mus musculus 41-46 33615046-0 2021 Polydopamine-modified collagen sponge scaffold as a novel dermal regeneration template with sustained release of platelet-rich plasma to accelerate skin repair: A one-step strategy. polydopamine 0-12 proline rich protein HaeIII subfamily 1 Mus musculus 113-133 33325928-2 2021 Here, the metal-organic frameworks (MOFs) based on iron(iii) carboxylate material (MIL-101-NH2) were in situ decorated on stabilized polydopamine nanoparticles (PDANPs), which subsequently loaded glucose oxidase (GOx) via hyaluronic acid (HA) coating to structure the one-for-all intelligent core-shell nanoparticles (HG-MIL@PDANPs). polydopamine 133-145 hydroxyacid oxidase 1 Homo sapiens 196-211 33325928-2 2021 Here, the metal-organic frameworks (MOFs) based on iron(iii) carboxylate material (MIL-101-NH2) were in situ decorated on stabilized polydopamine nanoparticles (PDANPs), which subsequently loaded glucose oxidase (GOx) via hyaluronic acid (HA) coating to structure the one-for-all intelligent core-shell nanoparticles (HG-MIL@PDANPs). polydopamine 133-145 hydroxyacid oxidase 1 Homo sapiens 213-216 33470115-0 2021 Electron Spin Relaxation Studies of Polydopamine Radicals. polydopamine 36-48 spindlin 1 Homo sapiens 9-13 33535625-0 2021 Polydopamine Ultrathin Film Growth on Mica via In-Situ Polymerization of Dopamine with Applications for Silver-Based Antimicrobial Coatings. polydopamine 0-12 MHC class I polypeptide-related sequence A Homo sapiens 38-42 33535625-3 2021 We present a systematic study demonstrating the growth of a PDA thin film on the surface of mica in consecutive short deposition time intervals. polydopamine 60-63 MHC class I polypeptide-related sequence A Homo sapiens 92-96 33434248-3 2021 In this contribution, we prepared a multifunctional melanin-like polydopamine (PDA) nanocarrier decorated with a small-molecule PSMA inhibitor, N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-(S)-l-lysine (DCL). polydopamine 65-77 folate hydrolase 1 Homo sapiens 128-132 33434248-3 2021 In this contribution, we prepared a multifunctional melanin-like polydopamine (PDA) nanocarrier decorated with a small-molecule PSMA inhibitor, N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-(S)-l-lysine (DCL). polydopamine 79-82 folate hydrolase 1 Homo sapiens 128-132 33289738-3 2020 Herein, a new bioinspired molecular assembly strategy based on human serum albumin@polydopamine/Fe nanocomposites (HSA@PDA/Fe NCs) was proposed, in which Fe(iii)/Fe(ii) were anchored on HSA supported on PDA. polydopamine 83-95 albumin Homo sapiens 69-82 33130319-6 2021 In this study, we generated recombinant DNase-1-coated polydopamine-poly(ethylene glycol) nanoparticulates (named long-acting DNase-1), and hypothesized that exogenous administration of long-acting DNase-1 may suppress SARS-CoV-2-mediated neutrophil activities and the cytokine storm. polydopamine 55-67 deoxyribonuclease 1 Homo sapiens 40-47 33130319-6 2021 In this study, we generated recombinant DNase-1-coated polydopamine-poly(ethylene glycol) nanoparticulates (named long-acting DNase-1), and hypothesized that exogenous administration of long-acting DNase-1 may suppress SARS-CoV-2-mediated neutrophil activities and the cytokine storm. polydopamine 55-67 deoxyribonuclease 1 Homo sapiens 126-133 33130319-6 2021 In this study, we generated recombinant DNase-1-coated polydopamine-poly(ethylene glycol) nanoparticulates (named long-acting DNase-1), and hypothesized that exogenous administration of long-acting DNase-1 may suppress SARS-CoV-2-mediated neutrophil activities and the cytokine storm. polydopamine 55-67 deoxyribonuclease 1 Homo sapiens 126-133 33653494-3 2021 Herein, we developed a hollow polydopamine nanoparticle (H-PDA)-based nano-delivery system (O/P-HP) that contained OXA and a dual PI3K/mTOR inhibitor PKI-587 with complementary effects for combating drug resistance in cancer chemotherapy. polydopamine 30-42 SRY-box transcription factor 3 Homo sapiens 94-98 33653494-3 2021 Herein, we developed a hollow polydopamine nanoparticle (H-PDA)-based nano-delivery system (O/P-HP) that contained OXA and a dual PI3K/mTOR inhibitor PKI-587 with complementary effects for combating drug resistance in cancer chemotherapy. polydopamine 30-42 mechanistic target of rapamycin kinase Homo sapiens 135-139 33412905-3 2021 METHODS: Nitinol FD (Silk Vista Baby) and flat disks were dip-coated with a CD31-mimetic peptide via an intermediate layer of polydopamine. polydopamine 126-138 platelet and endothelial cell adhesion molecule 1 Homo sapiens 76-80 33412905-7 2021 RESULTS: In vitro, CD31-mimetic coated disks displayed reduced adhesion of blood elements while favoring endothelial cell attachment and confluence, compared to bare and polydopamine disks. polydopamine 170-182 platelet and endothelial cell adhesion molecule 1 Homo sapiens 19-23 33477338-3 2021 For this purpose, a polydopamine (PDA)-MIP was designed for bovine serum albumin (BSA) recognition. polydopamine 20-32 albumin Homo sapiens 67-80 33477338-3 2021 For this purpose, a polydopamine (PDA)-MIP was designed for bovine serum albumin (BSA) recognition. polydopamine 34-37 albumin Homo sapiens 67-80 33437362-0 2020 Polydopamine coating with static magnetic field promotes the osteogenic differentiation of human bone-derived mesenchymal stem cells on three-dimensional printed porous titanium scaffolds by upregulation of the BMP-Smads signaling pathway. polydopamine 0-12 bone morphogenetic protein 1 Homo sapiens 211-214 33437362-17 2020 In conclusion, the osteogenic differentiation of hBMSCs on polydopamine coating scaffolds could be enhanced by SMF stimulation by upregulation of the BMP-Smads signaling pathway. polydopamine 59-71 bone morphogenetic protein 1 Homo sapiens 150-153 33140761-3 2020 Herein, we constructed gas-generating mesoporous silica nanoparticles (MSNs) that can load ammonium bicarbonate (ABC) and doxorubicin (DOX) within the pores, encapsulate indocyanine green (ICG) onto the polydopamine (PDA) layer, and modify the RGD peptide on the outer surface [denoted as M(abc)-DOX@PDA-ICG-PEG-RGD] for triggered drug release and targeted chemophotothermal combination therapy. polydopamine 203-215 gastrin Homo sapiens 23-26 33140761-3 2020 Herein, we constructed gas-generating mesoporous silica nanoparticles (MSNs) that can load ammonium bicarbonate (ABC) and doxorubicin (DOX) within the pores, encapsulate indocyanine green (ICG) onto the polydopamine (PDA) layer, and modify the RGD peptide on the outer surface [denoted as M(abc)-DOX@PDA-ICG-PEG-RGD] for triggered drug release and targeted chemophotothermal combination therapy. polydopamine 217-220 gastrin Homo sapiens 23-26 32693732-4 2020 In order to control macrophage polarization, IL-4 was conjugated to titanium dioxide nanotubes (TNTs) through polydopamine, and successful fabrication was checked by scanning electron microscopy (SEM), atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS) and contact angle, respectively. polydopamine 110-122 interleukin 4 Homo sapiens 45-49 33304787-3 2020 We designed an anti-claudin 3 (CLDN3) antibody containing a single cysteine residue, h4G3cys, then linked it to the maleimide group of lipid polydopamine hybrid nanoparticles (LPNs). polydopamine 141-153 claudin 3 Homo sapiens 20-29 32324097-3 2020 Lactoferrin was immobilized on electrospun nanofibers (LF50) by exploiting an adhesive polydopamine coating method. polydopamine 87-99 lactotransferrin Mus musculus 0-11 32324097-9 2020 Taken together, the lactoferrin immobilization onto the nanofiber by polydopamine chemistry may be an effective delivery method for improving bone regeneration while regulating the inflammation. polydopamine 69-81 lactotransferrin Mus musculus 20-31 34035190-3 2020 In order to make efficient use of bFGF, PCL electrospun fibrous membrane is firstly surface-coated by self-polymerization of dopamine, and followed by immobilization of heparin via covalent conjugation to the polydopamine (PDA) layer. polydopamine 209-221 fibroblast growth factor 2 Mus musculus 34-38 33175189-1 2020 A photothermal and fluorescent dual-mode assay for sensitive organophosphate pesticides (Ops) determination is reported based on alkaline phosphatase (ALP)-inhibition-induced formation of polydopamine (PDA) nanoparticles. polydopamine 188-200 alkaline phosphatase, placental Homo sapiens 129-149 33175189-1 2020 A photothermal and fluorescent dual-mode assay for sensitive organophosphate pesticides (Ops) determination is reported based on alkaline phosphatase (ALP)-inhibition-induced formation of polydopamine (PDA) nanoparticles. polydopamine 188-200 alkaline phosphatase, placental Homo sapiens 151-154 33175189-1 2020 A photothermal and fluorescent dual-mode assay for sensitive organophosphate pesticides (Ops) determination is reported based on alkaline phosphatase (ALP)-inhibition-induced formation of polydopamine (PDA) nanoparticles. polydopamine 202-205 alkaline phosphatase, placental Homo sapiens 129-149 33175189-1 2020 A photothermal and fluorescent dual-mode assay for sensitive organophosphate pesticides (Ops) determination is reported based on alkaline phosphatase (ALP)-inhibition-induced formation of polydopamine (PDA) nanoparticles. polydopamine 202-205 alkaline phosphatase, placental Homo sapiens 151-154 33175189-9 2020 Graphical abstract A photothermal and fluorescent dual-mode biosensor for sensitive Ops detection was reported based on alkaline phosphatase (ALP)-inhibition-induced formation of polydopamine (PDA) nanoparticles. polydopamine 179-191 alkaline phosphatase, placental Homo sapiens 120-140 33175189-9 2020 Graphical abstract A photothermal and fluorescent dual-mode biosensor for sensitive Ops detection was reported based on alkaline phosphatase (ALP)-inhibition-induced formation of polydopamine (PDA) nanoparticles. polydopamine 179-191 alkaline phosphatase, placental Homo sapiens 142-145 33175189-9 2020 Graphical abstract A photothermal and fluorescent dual-mode biosensor for sensitive Ops detection was reported based on alkaline phosphatase (ALP)-inhibition-induced formation of polydopamine (PDA) nanoparticles. polydopamine 193-196 alkaline phosphatase, placental Homo sapiens 120-140 33175189-9 2020 Graphical abstract A photothermal and fluorescent dual-mode biosensor for sensitive Ops detection was reported based on alkaline phosphatase (ALP)-inhibition-induced formation of polydopamine (PDA) nanoparticles. polydopamine 193-196 alkaline phosphatase, placental Homo sapiens 142-145 34035190-5 2020 The loading yield of bFGF on heparin-immobilized PDA-coated PCL membrane significantly increases to around 7 times as compared with that of pure PCL membrane. polydopamine 49-52 fibroblast growth factor 2 Mus musculus 21-25 33167589-1 2020 In this paper, a high sensitivity and high stability quartz crystal microbalance (QCM) humidity sensor using polydopamine (PDA) coated cellulose nanocrystal (CNC)/graphene oxide (GO) (PDA@CNC/GO) nanocomposite as sensitive material is demonstrated. polydopamine 109-121 protein kinase cAMP-dependent type I regulatory subunit alpha Homo sapiens 184-191 33167589-1 2020 In this paper, a high sensitivity and high stability quartz crystal microbalance (QCM) humidity sensor using polydopamine (PDA) coated cellulose nanocrystal (CNC)/graphene oxide (GO) (PDA@CNC/GO) nanocomposite as sensitive material is demonstrated. polydopamine 123-126 protein kinase cAMP-dependent type I regulatory subunit alpha Homo sapiens 158-161 33167589-1 2020 In this paper, a high sensitivity and high stability quartz crystal microbalance (QCM) humidity sensor using polydopamine (PDA) coated cellulose nanocrystal (CNC)/graphene oxide (GO) (PDA@CNC/GO) nanocomposite as sensitive material is demonstrated. polydopamine 123-126 protein kinase cAMP-dependent type I regulatory subunit alpha Homo sapiens 184-191 33304787-3 2020 We designed an anti-claudin 3 (CLDN3) antibody containing a single cysteine residue, h4G3cys, then linked it to the maleimide group of lipid polydopamine hybrid nanoparticles (LPNs). polydopamine 141-153 claudin 3 Homo sapiens 31-36 32798756-3 2020 Herein, heterostructured Bi2O2CO3 (BOC)/reduced graphene oxide (rGO)/polydopamine (PDA) (BGP) photocatalysts were first designed through a green chemical method. polydopamine 69-81 bone gamma-carboxyglutamate protein Homo sapiens 89-92 32590178-0 2020 Corn derivative mesoporous carbon microspheres supported hydrophilic polydopamine for development of new membrane: Water treatment containing bovine serum albumin. polydopamine 69-81 albumin Homo sapiens 149-162 32798756-3 2020 Herein, heterostructured Bi2O2CO3 (BOC)/reduced graphene oxide (rGO)/polydopamine (PDA) (BGP) photocatalysts were first designed through a green chemical method. polydopamine 83-86 bone gamma-carboxyglutamate protein Homo sapiens 89-92 33178410-6 2020 The surface of the PLGA/MH composite scaffold was modified with polydopamine (PDA) to effectively immobilize BMP2 on the PLGA/MH composite scaffold. polydopamine 64-76 bone morphogenetic protein 2 Mus musculus 109-113 33178410-6 2020 The surface of the PLGA/MH composite scaffold was modified with polydopamine (PDA) to effectively immobilize BMP2 on the PLGA/MH composite scaffold. polydopamine 78-81 bone morphogenetic protein 2 Mus musculus 109-113 32585536-1 2020 AgNPs were immobilized on titania nanotubes (TNT) by chelation of polydopamine (PD) to generate a TNT/PD/AgNPs (TPAS) via a simple dipping method. polydopamine 66-78 chromosome 16 open reading frame 82 Homo sapiens 45-48 33116494-5 2020 The resulting FM3 was preloaded with therapeutic cisplatin and coated with polydopamine layer, so-called FS3P/C. polydopamine 75-87 neuromedin U receptor 1 Homo sapiens 14-17 32749079-5 2020 To enhance biological activity, polydopamine (pDA) is used to graft BMP-2 on the surface of the 3D-PLA-BMP-2 scaffold. polydopamine 32-44 bone morphogenetic protein 2 Oryctolagus cuniculus 68-73 32749079-5 2020 To enhance biological activity, polydopamine (pDA) is used to graft BMP-2 on the surface of the 3D-PLA-BMP-2 scaffold. polydopamine 32-44 bone morphogenetic protein 2 Oryctolagus cuniculus 103-108 32749079-5 2020 To enhance biological activity, polydopamine (pDA) is used to graft BMP-2 on the surface of the 3D-PLA-BMP-2 scaffold. polydopamine 46-49 bone morphogenetic protein 2 Oryctolagus cuniculus 68-73 32749079-5 2020 To enhance biological activity, polydopamine (pDA) is used to graft BMP-2 on the surface of the 3D-PLA-BMP-2 scaffold. polydopamine 46-49 bone morphogenetic protein 2 Oryctolagus cuniculus 103-108 33005827-4 2021 In addition, polydopamine (PDA) nanoparticles were used as carrier for stromal-cell derived factor-1 (SDF-1alpha). polydopamine 13-25 C-X-C motif chemokine ligand 12 Homo sapiens 71-100 33005827-4 2021 In addition, polydopamine (PDA) nanoparticles were used as carrier for stromal-cell derived factor-1 (SDF-1alpha). polydopamine 27-30 C-X-C motif chemokine ligand 12 Homo sapiens 71-100 32717184-0 2020 alpha-Glucosidase immobilization on polydopamine-coated cellulose filter paper and enzyme inhibitor screening. polydopamine 36-48 sucrase-isomaltase Homo sapiens 0-17 32548975-0 2020 A Magnetic Iron Oxide/Polydopamine Coating Can Improve Osteogenesis of 3D-Printed Porous Titanium Scaffolds with a Static Magnetic Field by Upregulating the TGFbeta-Smads Pathway. polydopamine 22-34 transforming growth factor alpha Homo sapiens 157-164 32498912-3 2020 The high performance of the immunosensor is attributed to the high surface area from porous graphene and the strong adhesion of polydopamine, allowing a high load of the primary antibody of PSA, as well as the highly electrocatalytic activity of the Cu3(BTC)2 (BTC = benzene-1,3,5-tricarboxylic acid) MOF toward H2O2 to provide greatly amplified sensitivity. polydopamine 128-140 kallikrein related peptidase 3 Homo sapiens 190-193 32789323-0 2020 Controlled release of anti-VEGF by redox-responsive polydopamine nanoparticles. polydopamine 52-64 vascular endothelial growth factor A Homo sapiens 27-31 32913927-3 2021 Connective tissue growth factor (CTGF) and transforming growth factor-beta3 (TGF-beta3) were loaded onto polydopamine nanoparticles, which were mixed with bone marrow mesenchymal stem cells (BMSCs) for regenerating and simulating the structure and function of the nucleus pulposus and annular fibrosus. polydopamine 105-117 cellular communication network factor 2 Homo sapiens 0-31 32913927-3 2021 Connective tissue growth factor (CTGF) and transforming growth factor-beta3 (TGF-beta3) were loaded onto polydopamine nanoparticles, which were mixed with bone marrow mesenchymal stem cells (BMSCs) for regenerating and simulating the structure and function of the nucleus pulposus and annular fibrosus. polydopamine 105-117 cellular communication network factor 2 Homo sapiens 33-37 32913927-3 2021 Connective tissue growth factor (CTGF) and transforming growth factor-beta3 (TGF-beta3) were loaded onto polydopamine nanoparticles, which were mixed with bone marrow mesenchymal stem cells (BMSCs) for regenerating and simulating the structure and function of the nucleus pulposus and annular fibrosus. polydopamine 105-117 transforming growth factor beta 3 Homo sapiens 77-86 32786553-3 2020 This study reports a polydopamine (PDA) intercalated TFNi nanofiltration membrane (PA-PSF2, PDA coating time at 2hr) that possessed nearly an order of magnitude higher water permeance of 14.8 +- 0.4 Lm-2h-1bar-1 compared to the control TFC membrane (PA-PFS0) of 2.4 +- 0.5 Lm-2h-1bar-1. polydopamine 21-33 GINS complex subunit 2 Homo sapiens 86-90 32786553-3 2020 This study reports a polydopamine (PDA) intercalated TFNi nanofiltration membrane (PA-PSF2, PDA coating time at 2hr) that possessed nearly an order of magnitude higher water permeance of 14.8 +- 0.4 Lm-2h-1bar-1 compared to the control TFC membrane (PA-PFS0) of 2.4 +- 0.5 Lm-2h-1bar-1. polydopamine 35-38 GINS complex subunit 2 Homo sapiens 86-90 32899269-0 2020 Immobilization of BMP-2 and VEGF within Multilayered Polydopamine-Coated Scaffolds and the Resulting Osteogenic and Angiogenic Synergy of Co-Cultured Human Mesenchymal Stem Cells and Human Endothelial Progenitor Cells. polydopamine 53-65 bone morphogenetic protein 2 Homo sapiens 18-23 32899269-0 2020 Immobilization of BMP-2 and VEGF within Multilayered Polydopamine-Coated Scaffolds and the Resulting Osteogenic and Angiogenic Synergy of Co-Cultured Human Mesenchymal Stem Cells and Human Endothelial Progenitor Cells. polydopamine 53-65 vascular endothelial growth factor A Homo sapiens 28-32 32487386-2 2020 In this paper, we aimed to develop a polydopamine (PDA) coated chromium-cobalt (CoCr) stent functionalised with EP224283 (Endotis Pharma SA), which combines both a GPIIbIIIa antagonist (tirofiban moiety) and a factor Xa inhibitor (idraparinux moiety) to reduce acute stent thrombosis. polydopamine 37-49 coagulation factor X Homo sapiens 210-219 32487386-2 2020 In this paper, we aimed to develop a polydopamine (PDA) coated chromium-cobalt (CoCr) stent functionalised with EP224283 (Endotis Pharma SA), which combines both a GPIIbIIIa antagonist (tirofiban moiety) and a factor Xa inhibitor (idraparinux moiety) to reduce acute stent thrombosis. polydopamine 51-54 coagulation factor X Homo sapiens 210-219 32377980-4 2020 Towards this goal, here we report polydopamine-coated mesoporous silica nanoparticles (MSNs) that can be stably incorporated within the macroporous muRB scaffolds, and allow tunable release of transforming growth factor (TGF)-beta3. polydopamine 34-46 transforming growth factor, beta 3 Mus musculus 193-231 32533226-0 2020 A new fluorescence sensor developed with polydopamine nanospheres for the detection of anti-PLA2R antibody biomarkers of idiopathic membranous nephropathy. polydopamine 41-53 phospholipase A2 receptor 1 Homo sapiens 92-97 32533226-3 2020 In the present study, a polydopamine nanosphere-based fluorescent sensor was constructed for direct detection of anti-PLA2R antibodies in human serum. polydopamine 24-36 phospholipase A2 receptor 1 Homo sapiens 118-123 32377980-5 2020 We hypothesize that increasing concentration of polydopamine coating on MSNs will slow down TGF- beta3 release, and TGF-beta3 release from polydopamine-coated MSNs can enhance MSC-based cartilage formation in vitro and in vivo. polydopamine 48-60 transforming growth factor, beta 3 Mus musculus 92-102 32377980-5 2020 We hypothesize that increasing concentration of polydopamine coating on MSNs will slow down TGF- beta3 release, and TGF-beta3 release from polydopamine-coated MSNs can enhance MSC-based cartilage formation in vitro and in vivo. polydopamine 139-151 transforming growth factor, beta 3 Mus musculus 116-125 32330380-2 2020 Herein, we created a novel Fe3O4@polydopamine (PDA)@Bovine Serum Albumin (BSA)-Bi2S3 composite as a theranostic agent, by chemically-linking the Fe3O4@PDA with BSA-Bi2S3 via the amidation between the carboxyl groups of BSA and the amino groups of PDA. polydopamine 33-45 albumin Homo sapiens 59-72 32714901-7 2020 PDA induced massive proliferation of neural stem cells and promoted the expression of Ki-67. polydopamine 0-3 antigen identified by monoclonal antibody Ki 67 Mus musculus 86-91 32343757-3 2020 We therefore designed a stable coating of adenosine for biomaterial surfaces through polydopamine chemistry to control osteogenesis and osteoclastogenesis via A2bR signaling. polydopamine 85-97 adenosine A2b receptor Mus musculus 159-163 32338259-0 2020 Rapid and sensitive detection of NGAL for the prediction of acute kidney injury via a polydopamine nanosphere/aptamer nanocomplex coupled with DNase I-assisted recycling amplification. polydopamine 86-98 lipocalin 2 Mus musculus 33-37 32336102-7 2020 With almost equal surface content of PSBMA, the PSBMA-PDA-PP exhibited a more superior ability against macrophages adhesion and proliferation, and showed more significantly decreased releases of TNF-alpha and IL-6 (p < 0.05) than those of PSBMA@PDA-PP, fundamentally attributed to its more neutral surface potential and the protection for polyphenols of PDA from oxidation with PSBMA as the outer-layer. polydopamine 54-57 tumor necrosis factor Homo sapiens 195-204 32336102-7 2020 With almost equal surface content of PSBMA, the PSBMA-PDA-PP exhibited a more superior ability against macrophages adhesion and proliferation, and showed more significantly decreased releases of TNF-alpha and IL-6 (p < 0.05) than those of PSBMA@PDA-PP, fundamentally attributed to its more neutral surface potential and the protection for polyphenols of PDA from oxidation with PSBMA as the outer-layer. polydopamine 54-57 interleukin 6 Homo sapiens 209-213 32338259-3 2020 In this work, a nanocomplex composed of a polydopamine nanosphere (PDANS) and a fluorophore-labelled aptamer has been constructed for the detection of NGAL using a DNase I-assisted recycling amplification strategy. polydopamine 42-54 lipocalin 2 Mus musculus 151-155 32338259-3 2020 In this work, a nanocomplex composed of a polydopamine nanosphere (PDANS) and a fluorophore-labelled aptamer has been constructed for the detection of NGAL using a DNase I-assisted recycling amplification strategy. polydopamine 42-54 deoxyribonuclease I Mus musculus 164-171 32092201-5 2020 Amyloid fibers of recombinant Pmel17 had a similar property with HEWL fibers in modulating PD formation. polydopamine 91-93 premelanosome protein Homo sapiens 30-36 32192327-0 2020 Integrating Polydopamine Nanosphere/Aptamers Nanoplatform with DNase-I-assisted Recycling Amplification Strategy for Simultaneous Detection of MMP-9 and MMP-2 During Renal Interstitial Fibrosis. polydopamine 12-24 matrix metallopeptidase 9 Mus musculus 143-148 32192327-0 2020 Integrating Polydopamine Nanosphere/Aptamers Nanoplatform with DNase-I-assisted Recycling Amplification Strategy for Simultaneous Detection of MMP-9 and MMP-2 During Renal Interstitial Fibrosis. polydopamine 12-24 matrix metallopeptidase 2 Mus musculus 153-158 32192327-3 2020 Herein, a strategy based on the nanoplatform composed of the polydopamine nanosphere and fluorescence labelled aptamers is developed to simultaneously detect MMP-9 and MMP-2 with DNase-I-assisted recycling signal amplification. polydopamine 61-73 matrix metallopeptidase 9 Mus musculus 158-163 32192327-3 2020 Herein, a strategy based on the nanoplatform composed of the polydopamine nanosphere and fluorescence labelled aptamers is developed to simultaneously detect MMP-9 and MMP-2 with DNase-I-assisted recycling signal amplification. polydopamine 61-73 matrix metallopeptidase 2 Mus musculus 168-173 32192327-3 2020 Herein, a strategy based on the nanoplatform composed of the polydopamine nanosphere and fluorescence labelled aptamers is developed to simultaneously detect MMP-9 and MMP-2 with DNase-I-assisted recycling signal amplification. polydopamine 61-73 deoxyribonuclease I Mus musculus 179-186 31967110-7 2020 Furthermore, the LBL@MSN-Ag nanoparticles were deposited on the surface of polydopamine-modified Ti substrates. polydopamine 75-87 moesin Rattus norvegicus 21-24 32187963-3 2020 Our previous study has loaded decorin on titanium (Ti) surface by polydopamine (DOPA) as an anchor to enhance osseointegration. polydopamine 66-78 decorin Mus musculus 30-37 32228925-4 2020 A poly(dopamine) (DOP) coating was employed onto TiO2 nanotubes (T/DOP) to functionalized with IL-4 (T/DOP-IL4). polydopamine 2-16 interleukin 4 Homo sapiens 95-99 32228925-4 2020 A poly(dopamine) (DOP) coating was employed onto TiO2 nanotubes (T/DOP) to functionalized with IL-4 (T/DOP-IL4). polydopamine 18-21 interleukin 4 Homo sapiens 95-99 32228925-4 2020 A poly(dopamine) (DOP) coating was employed onto TiO2 nanotubes (T/DOP) to functionalized with IL-4 (T/DOP-IL4). polydopamine 67-70 interleukin 4 Homo sapiens 95-99 32228925-4 2020 A poly(dopamine) (DOP) coating was employed onto TiO2 nanotubes (T/DOP) to functionalized with IL-4 (T/DOP-IL4). polydopamine 67-70 interleukin 4 Homo sapiens 95-99 32228925-5 2020 Then, a carboxymethyl chitosan hydrogel layer (CG) was generated on T/DOP-IL4 to control IL-4 release and RGD peptide immobilization. polydopamine 70-73 interleukin 4 Homo sapiens 74-77 31677912-5 2020 PDA layer exhibited a high affinity toward Pb(II) by chelating with amino groups. polydopamine 0-3 submaxillary gland androgen regulated protein 3B Homo sapiens 43-49 31865193-4 2020 The nanoplatform (PES-Au@PDA, 63.3 +- 3.1 nm) comprises AuNS coated with the photothermal conversion agent polydopamine (PDA) for enhanced radiotherapy and photothermal therapy, as well as PES (loading efficiency of PES approximately 40%), a small molecular inhibitor against HSPA5 to amplify the pro-apoptotic unfolded protein response (UPR). polydopamine 25-28 pescadillo ribosomal biogenesis factor 1 Homo sapiens 18-21 31865193-4 2020 The nanoplatform (PES-Au@PDA, 63.3 +- 3.1 nm) comprises AuNS coated with the photothermal conversion agent polydopamine (PDA) for enhanced radiotherapy and photothermal therapy, as well as PES (loading efficiency of PES approximately 40%), a small molecular inhibitor against HSPA5 to amplify the pro-apoptotic unfolded protein response (UPR). polydopamine 107-119 pescadillo ribosomal biogenesis factor 1 Homo sapiens 18-21 31865193-4 2020 The nanoplatform (PES-Au@PDA, 63.3 +- 3.1 nm) comprises AuNS coated with the photothermal conversion agent polydopamine (PDA) for enhanced radiotherapy and photothermal therapy, as well as PES (loading efficiency of PES approximately 40%), a small molecular inhibitor against HSPA5 to amplify the pro-apoptotic unfolded protein response (UPR). polydopamine 121-124 pescadillo ribosomal biogenesis factor 1 Homo sapiens 18-21 31865193-6 2020 Results from in vitro and in vivo studies demonstrate that PES-Au@PDA can specially activate pro-apoptotic UPR cascades, leading to remarkably improved radiotherapy and photothermal therapy efficiencies. polydopamine 66-69 pescadillo ribosomal biogenesis factor 1 Homo sapiens 59-62 31476446-0 2020 Recuperative effect of metformin loaded Polydopamine Nanoformulation promoting EZH2 mediated proteasomal degradation of phospho-alpha-Synuclein in Parkinson"s disease model. polydopamine 40-52 enhancer of zeste 2 polycomb repressive complex 2 subunit Homo sapiens 79-83 31476446-0 2020 Recuperative effect of metformin loaded Polydopamine Nanoformulation promoting EZH2 mediated proteasomal degradation of phospho-alpha-Synuclein in Parkinson"s disease model. polydopamine 40-52 synuclein alpha Homo sapiens 128-143 31891476-0 2020 Ca2+ Mediated Surface Polydopamine Engineering to Program Dendritic Cell Maturation. polydopamine 22-34 carbonic anhydrase 2 Homo sapiens 0-3 31891476-2 2020 Mediated by Ca2+, a quick convenient yet cytocompatible method is used to achieve surface engineering, by which polydopamine nanostructures can be in situ grown onto dendritic cell (DC) surface within 10 min. polydopamine 112-124 carbonic anhydrase 2 Homo sapiens 12-15 31891476-3 2020 Ca2+, as the physical bridge between the negative cell surface and polydopamine, avoids the direct chemical polymerization of polydopamine onto the cell surface, critically important to maintain the cell viability. polydopamine 67-79 carbonic anhydrase 2 Homo sapiens 0-3 31891476-3 2020 Ca2+, as the physical bridge between the negative cell surface and polydopamine, avoids the direct chemical polymerization of polydopamine onto the cell surface, critically important to maintain the cell viability. polydopamine 126-138 carbonic anhydrase 2 Homo sapiens 0-3 31816239-0 2020 Polydopamine-PEG-Folic Acid Conjugate Film Engineered TiO2 Nanotube Arrays for Photoelectrochemical Sensing of Folate Binding Protein. polydopamine 0-12 folate receptor alpha Homo sapiens 111-133 31387029-5 2019 Then, the immobilized COX-2 with different activities were prepared using different immobilization methods, including Ni2+ affinity-oriented immobilization, polydopamine (PDA) covalent immobilization, and conventional glutaraldehyde (GA) covalent immobilization. polydopamine 157-169 mitochondrially encoded cytochrome c oxidase II Homo sapiens 22-27 31751121-0 2019 JQ1-Loaded Polydopamine Nanoplatform Inhibits c-MYC/Programmed Cell Death Ligand 1 to Enhance Photothermal Therapy for Triple-Negative Breast Cancer. polydopamine 11-23 CD274 antigen Mus musculus 52-82 31836746-3 2019 The as-prepared Au-PDA@SiO2 nanospheres were used to fabricate electrochemically reduced graphene oxide (rGO) modified glassy carbon electrode (Au-PDA@SiO2/rGO/GCE) for electrochemical determination of cefotaxime. polydopamine 19-22 guanylate cyclase 2E, pseudogene Homo sapiens 160-163 31817825-0 2019 Silicone Rubber Composites with High Breakdown Strength and Low Dielectric Loss Based on Polydopamine Coated Mica. polydopamine 89-101 MHC class I polypeptide-related sequence A Homo sapiens 109-113 31817825-2 2019 In this work, polydopamine coated mica (mica-PDA) was synthesized via bioinspired dopamine self-polymerization, and mica-PDA-filled SR composite (SR/mica-PDA-VTMS) was prepared using vinyl tri-methoxysilane (VTMS) as a silane coupling agent which serves as the molecular bridges between the organic rubber and the inorganic filler. polydopamine 14-26 MHC class I polypeptide-related sequence A Homo sapiens 34-38 31817825-2 2019 In this work, polydopamine coated mica (mica-PDA) was synthesized via bioinspired dopamine self-polymerization, and mica-PDA-filled SR composite (SR/mica-PDA-VTMS) was prepared using vinyl tri-methoxysilane (VTMS) as a silane coupling agent which serves as the molecular bridges between the organic rubber and the inorganic filler. polydopamine 14-26 MHC class I polypeptide-related sequence A Homo sapiens 40-44 31817825-2 2019 In this work, polydopamine coated mica (mica-PDA) was synthesized via bioinspired dopamine self-polymerization, and mica-PDA-filled SR composite (SR/mica-PDA-VTMS) was prepared using vinyl tri-methoxysilane (VTMS) as a silane coupling agent which serves as the molecular bridges between the organic rubber and the inorganic filler. polydopamine 14-26 MHC class I polypeptide-related sequence A Homo sapiens 40-44 31817825-2 2019 In this work, polydopamine coated mica (mica-PDA) was synthesized via bioinspired dopamine self-polymerization, and mica-PDA-filled SR composite (SR/mica-PDA-VTMS) was prepared using vinyl tri-methoxysilane (VTMS) as a silane coupling agent which serves as the molecular bridges between the organic rubber and the inorganic filler. polydopamine 14-26 MHC class I polypeptide-related sequence A Homo sapiens 40-44 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 199-211 ubiquitin C-terminal hydrolase L1 Homo sapiens 29-35 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 199-211 L1 cell adhesion molecule Mus musculus 106-110 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 199-211 L1 cell adhesion molecule Mus musculus 120-124 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 199-211 L1 cell adhesion molecule Mus musculus 120-124 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 199-211 L1 cell adhesion molecule Mus musculus 120-124 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 199-211 L1 cell adhesion molecule Mus musculus 120-124 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 199-211 L1 cell adhesion molecule Mus musculus 120-124 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 213-216 ubiquitin C-terminal hydrolase L1 Homo sapiens 29-35 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 213-216 L1 cell adhesion molecule Mus musculus 106-110 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 213-216 L1 cell adhesion molecule Mus musculus 120-124 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 213-216 L1 cell adhesion molecule Mus musculus 120-124 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 213-216 L1 cell adhesion molecule Mus musculus 120-124 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 213-216 L1 cell adhesion molecule Mus musculus 120-124 31561093-6 2019 The operational range of the UCHL-1 immunosensor developed with Polynorepinephrine pNE-modified is 0.1 pg mL-1 - 105 pg mL-1 (LOD: 1.91 pg mL-1), and 1 pg mL-1 - 105 pg mL-1 (LOD: 0.70 pg mL-1) with Polydopamine (pDA) modification, satisfying the clinical range. polydopamine 213-216 L1 cell adhesion molecule Mus musculus 120-124 31549644-5 2019 The optimization results demonstrated that the UiO-66-NH2/graphene oxide (UNG) composite membrane (PUF/PDA/UNG) which was loaded on polyurethane foam modified with polydopamine (PUF/PDA) had the best properties. polydopamine 164-176 uracil DNA glycosylase Homo sapiens 74-77 31549644-5 2019 The optimization results demonstrated that the UiO-66-NH2/graphene oxide (UNG) composite membrane (PUF/PDA/UNG) which was loaded on polyurethane foam modified with polydopamine (PUF/PDA) had the best properties. polydopamine 164-176 NME/NM23 nucleoside diphosphate kinase 2 Homo sapiens 99-102 31758327-1 2019 A binary magnetic metal-organic framework (MOF)-functionalized material (magG@PDA@Ni-MOF@Fe-MOF) was prepared through grafting Ni-MOF and Fe-MOF on magnetic (Fe3O4) graphene with polydopamine (PDA) as a middle layer. polydopamine 78-81 lysine acetyltransferase 8 Homo sapiens 18-48 31758327-1 2019 A binary magnetic metal-organic framework (MOF)-functionalized material (magG@PDA@Ni-MOF@Fe-MOF) was prepared through grafting Ni-MOF and Fe-MOF on magnetic (Fe3O4) graphene with polydopamine (PDA) as a middle layer. polydopamine 179-191 lysine acetyltransferase 8 Homo sapiens 18-48 31758327-1 2019 A binary magnetic metal-organic framework (MOF)-functionalized material (magG@PDA@Ni-MOF@Fe-MOF) was prepared through grafting Ni-MOF and Fe-MOF on magnetic (Fe3O4) graphene with polydopamine (PDA) as a middle layer. polydopamine 193-196 lysine acetyltransferase 8 Homo sapiens 18-48 31409467-1 2019 A sensitive nanocomplex probe prepared from fluorescent polydopamine nanoparticles (F-PDA) and cobalt oxyhydroxide (CoOOH) nanosheets was established for the determination of alpha-glucosidase activity. polydopamine 56-68 sucrase-isomaltase Homo sapiens 175-192 31783048-0 2020 Photothermally triggered cytosolic drug delivery of glucose functionalized polydopamine nanoparticles in response to tumor microenvironment for the GLUT1-targeting chemo-phototherapy. polydopamine 75-87 solute carrier family 2 member 1 Homo sapiens 148-153 31588457-2 2019 Herein, we report a facile and novel one-pot synthetic approach for the fabrication of polydopamine-folate carbon dots (PFCDs) as theranostic nanocarriers for the image-guided PTT targeting of prostate cancer (PCa) cells that express a prostate-specific membrane antigen (PSMA) (folate hydrolase 1). polydopamine 87-113 folate hydrolase 1 Homo sapiens 236-270 31588457-2 2019 Herein, we report a facile and novel one-pot synthetic approach for the fabrication of polydopamine-folate carbon dots (PFCDs) as theranostic nanocarriers for the image-guided PTT targeting of prostate cancer (PCa) cells that express a prostate-specific membrane antigen (PSMA) (folate hydrolase 1). polydopamine 87-113 folate hydrolase 1 Homo sapiens 272-276 31588457-2 2019 Herein, we report a facile and novel one-pot synthetic approach for the fabrication of polydopamine-folate carbon dots (PFCDs) as theranostic nanocarriers for the image-guided PTT targeting of prostate cancer (PCa) cells that express a prostate-specific membrane antigen (PSMA) (folate hydrolase 1). polydopamine 87-113 folate hydrolase 1 Homo sapiens 279-297 31600673-7 2019 The PSB-PDA coated implants showed a significantly decreased expression of glial fibrillary acidic protein (GFAP), a marker for reactive astrocytes, within 70 mum from the electrode-tissue interface (p < 0.05). polydopamine 8-11 glial fibrillary acidic protein Mus musculus 75-106 31600673-7 2019 The PSB-PDA coated implants showed a significantly decreased expression of glial fibrillary acidic protein (GFAP), a marker for reactive astrocytes, within 70 mum from the electrode-tissue interface (p < 0.05). polydopamine 8-11 glial fibrillary acidic protein Mus musculus 108-112 31387029-5 2019 Then, the immobilized COX-2 with different activities were prepared using different immobilization methods, including Ni2+ affinity-oriented immobilization, polydopamine (PDA) covalent immobilization, and conventional glutaraldehyde (GA) covalent immobilization. polydopamine 171-174 mitochondrially encoded cytochrome c oxidase II Homo sapiens 22-27 31373150-0 2019 Modulating macrophage polarization on titanium implant surface by poly(dopamine)-assisted immobilization of IL4. polydopamine 66-80 interleukin 4 Homo sapiens 108-111 31382096-2 2019 In this work, we developed a rapid, sensitive and inexpensive method for albumin detection based on the polydopamine (PDA) bi-functionalized glass chip and surface-enhanced Raman scattering (SERS) tag. polydopamine 104-116 albumin Homo sapiens 73-80 31382096-2 2019 In this work, we developed a rapid, sensitive and inexpensive method for albumin detection based on the polydopamine (PDA) bi-functionalized glass chip and surface-enhanced Raman scattering (SERS) tag. polydopamine 118-121 albumin Homo sapiens 73-80 31373150-2 2019 PURPOSE: The aim of this study is to investigate whether the poly(dopamine) (pDA)-assisted immobilization of IL4 on titanium surfaces could modulate the inflammatory profile of macrophages in vitro and search for the possibility of enhancing implant integration in this way. polydopamine 61-75 interleukin 4 Homo sapiens 109-112 31373150-2 2019 PURPOSE: The aim of this study is to investigate whether the poly(dopamine) (pDA)-assisted immobilization of IL4 on titanium surfaces could modulate the inflammatory profile of macrophages in vitro and search for the possibility of enhancing implant integration in this way. polydopamine 77-80 interleukin 4 Homo sapiens 109-112 31536357-0 2019 Using A Spin-Coater to Capture Adhesive Species during Polydopamine Thin-Film Fabrication. polydopamine 55-67 spindlin 1 Homo sapiens 8-12 31536357-1 2019 Spin-coating was evaluated as a technique to study events that occur during polydopamine (PDA) thin-film formation. polydopamine 90-93 spindlin 1 Homo sapiens 0-4 31536357-1 2019 Spin-coating was evaluated as a technique to study events that occur during polydopamine (PDA) thin-film formation. polydopamine 76-88 spindlin 1 Homo sapiens 0-4 31536357-10 2019 When these conditions were applied in a modified dip-coating method, comparable PDA films were fabricated as those obtained from spin-coating. polydopamine 80-83 spindlin 1 Homo sapiens 129-133 31180646-1 2019 Polydopamine (PDA)-coated or encapsulating Cu3(PO4)2 (Cu3(PO4)2@PDA) nanosheets were synthesized, allowing the C-reaction protein (CRP) antibody to be attached electrostatically for immunosensing of CRP with simple photothermal detection. polydopamine 0-12 C-reactive protein Homo sapiens 111-129 31347625-4 2019 Specifically, PDA encapsulation can reliably form SPNs that are uniform in size (~65 nm) and facilitate the rapid purification of SPN bioconjugates by centrifugation which is difficult to achieve using traditional methods for preparing SPN bioconjugates. polydopamine 14-17 DEAF1 transcription factor Homo sapiens 50-53 31347625-4 2019 Specifically, PDA encapsulation can reliably form SPNs that are uniform in size (~65 nm) and facilitate the rapid purification of SPN bioconjugates by centrifugation which is difficult to achieve using traditional methods for preparing SPN bioconjugates. polydopamine 14-17 DEAF1 transcription factor Homo sapiens 130-133 31195144-6 2019 Furthermore, VEGF was conjugated onto the surface of the membrane by reacting with polydopamine (PDA) for quick release. polydopamine 83-95 vascular endothelial growth factor A Homo sapiens 13-17 31195144-6 2019 Furthermore, VEGF was conjugated onto the surface of the membrane by reacting with polydopamine (PDA) for quick release. polydopamine 97-100 vascular endothelial growth factor A Homo sapiens 13-17 31075686-4 2019 Polydopamine was used as a binding layer to attach the E-cadherin to the titanium surface in two ways: 1) by attaching protein A to the polydopamine followed by E-cadherin (aligned orientation) or 2) by direct attachment of the E-cadherin to the polydopamine (random orientation). polydopamine 0-12 cadherin 1 Homo sapiens 55-65 31075686-4 2019 Polydopamine was used as a binding layer to attach the E-cadherin to the titanium surface in two ways: 1) by attaching protein A to the polydopamine followed by E-cadherin (aligned orientation) or 2) by direct attachment of the E-cadherin to the polydopamine (random orientation). polydopamine 0-12 cadherin 1 Homo sapiens 161-171 31075686-4 2019 Polydopamine was used as a binding layer to attach the E-cadherin to the titanium surface in two ways: 1) by attaching protein A to the polydopamine followed by E-cadherin (aligned orientation) or 2) by direct attachment of the E-cadherin to the polydopamine (random orientation). polydopamine 0-12 cadherin 1 Homo sapiens 161-171 31075686-4 2019 Polydopamine was used as a binding layer to attach the E-cadherin to the titanium surface in two ways: 1) by attaching protein A to the polydopamine followed by E-cadherin (aligned orientation) or 2) by direct attachment of the E-cadherin to the polydopamine (random orientation). polydopamine 136-148 cadherin 1 Homo sapiens 55-65 31075686-4 2019 Polydopamine was used as a binding layer to attach the E-cadherin to the titanium surface in two ways: 1) by attaching protein A to the polydopamine followed by E-cadherin (aligned orientation) or 2) by direct attachment of the E-cadherin to the polydopamine (random orientation). polydopamine 246-258 cadherin 1 Homo sapiens 55-65 31222649-9 2019 PDA/Fe3O4/BC can treat actual electroplating wastewater with Cr(VI) concentration from 20 mg L-1 to less than 0.2 mg L-1, which met the PRC discharge standard (GB/21900-2008) of electroplating pollutants. polydopamine 0-3 immunoglobulin kappa variable 1-16 Homo sapiens 93-96 31222649-9 2019 PDA/Fe3O4/BC can treat actual electroplating wastewater with Cr(VI) concentration from 20 mg L-1 to less than 0.2 mg L-1, which met the PRC discharge standard (GB/21900-2008) of electroplating pollutants. polydopamine 0-3 immunoglobulin kappa variable 1-16 Homo sapiens 117-120 31564871-3 2019 Methods and materials: In this study, we constructed nanoparticles (NPs) using polydopamine to carry two peptides that simultaneously bind integrin alphaIIbbeta3 and P-selectin on activated platelets to enhance the targeting of NPs to thrombus. polydopamine 79-91 selectin P Homo sapiens 166-176 31034755-4 2019 In this study, HGF behavior on random/aligned poly (e-caprolactone) (PCL) and polydopamine (PDA)-coated PCL electrospun scaffolds was investigated in a common medium and in basic fibroblast growth factor (bFGF) medium. polydopamine 78-90 hepatocyte growth factor Homo sapiens 15-18 31034755-4 2019 In this study, HGF behavior on random/aligned poly (e-caprolactone) (PCL) and polydopamine (PDA)-coated PCL electrospun scaffolds was investigated in a common medium and in basic fibroblast growth factor (bFGF) medium. polydopamine 92-95 hepatocyte growth factor Homo sapiens 15-18 31171219-0 2019 A novel polydopamine electrochemiluminescence organic nanoparticle-based biosensor for parathyroid hormone detection. polydopamine 8-20 parathyroid hormone Homo sapiens 87-106 31171219-1 2019 In this work, polydopamine electrochemiluminescence (ECL)-organic nanoparticles (EONs) based immunosensing strategy was designed for parathyroid hormone (PTH) detection. polydopamine 14-26 parathyroid hormone Homo sapiens 133-152 31048253-0 2019 Colorimetric detection of blood glucose based on GOx@ZIF-8@Fe-polydopamine cascade reaction. polydopamine 62-74 hydroxyacid oxidase 1 Homo sapiens 49-52 31336697-7 2019 To promote the cellular uptake of the MSN@PDA particles, they were further coated with a polyethylene imine (PEI)-polyethylene glycol (PEG) copolymer. polydopamine 42-45 moesin Homo sapiens 38-41 31334217-4 2019 Additionally, catalase was used as a model enzyme to be encapsulated into PDA hollow capsules and its bio-functionality was found to remain active. polydopamine 74-77 catalase Homo sapiens 14-22 31180646-1 2019 Polydopamine (PDA)-coated or encapsulating Cu3(PO4)2 (Cu3(PO4)2@PDA) nanosheets were synthesized, allowing the C-reaction protein (CRP) antibody to be attached electrostatically for immunosensing of CRP with simple photothermal detection. polydopamine 0-12 C-reactive protein Homo sapiens 131-134 31069351-3 2019 This study reports a facile method of retaining full enzymatic activity by immobilizing glucose oxidase (GOx) into core-shell nanoparticles with polydopamine (PDA) sandwiched between a gold nanoparticle (Au NP) core and a calcium phosphate (CaP) shell (Au@PDA@CaP). polydopamine 145-157 hydroxyacid oxidase 1 Homo sapiens 88-103 31069351-3 2019 This study reports a facile method of retaining full enzymatic activity by immobilizing glucose oxidase (GOx) into core-shell nanoparticles with polydopamine (PDA) sandwiched between a gold nanoparticle (Au NP) core and a calcium phosphate (CaP) shell (Au@PDA@CaP). polydopamine 145-157 hydroxyacid oxidase 1 Homo sapiens 105-108 31069351-3 2019 This study reports a facile method of retaining full enzymatic activity by immobilizing glucose oxidase (GOx) into core-shell nanoparticles with polydopamine (PDA) sandwiched between a gold nanoparticle (Au NP) core and a calcium phosphate (CaP) shell (Au@PDA@CaP). polydopamine 159-162 hydroxyacid oxidase 1 Homo sapiens 88-103 31069351-3 2019 This study reports a facile method of retaining full enzymatic activity by immobilizing glucose oxidase (GOx) into core-shell nanoparticles with polydopamine (PDA) sandwiched between a gold nanoparticle (Au NP) core and a calcium phosphate (CaP) shell (Au@PDA@CaP). polydopamine 159-162 hydroxyacid oxidase 1 Homo sapiens 105-108 31222566-3 2019 The 3D-printed scaffolds were then grafted with human bone morphogenetic protein-2 (BMP-2) via the actions of polydopamine (PDA) coatings. polydopamine 110-122 bone morphogenetic protein 2 Homo sapiens 54-82 31222566-3 2019 The 3D-printed scaffolds were then grafted with human bone morphogenetic protein-2 (BMP-2) via the actions of polydopamine (PDA) coatings. polydopamine 110-122 bone morphogenetic protein 2 Homo sapiens 84-89 31222566-3 2019 The 3D-printed scaffolds were then grafted with human bone morphogenetic protein-2 (BMP-2) via the actions of polydopamine (PDA) coatings. polydopamine 124-127 bone morphogenetic protein 2 Homo sapiens 54-82 31222566-3 2019 The 3D-printed scaffolds were then grafted with human bone morphogenetic protein-2 (BMP-2) via the actions of polydopamine (PDA) coatings. polydopamine 124-127 bone morphogenetic protein 2 Homo sapiens 84-89 31117415-2 2019 Herein a simple and portable photothermal biosensor was developed for sensitive detection of ALP enzyme based on the formation of polydopamine (PDA) nanoparticles using a thermometer or temperature discoloration sticker as readout. polydopamine 130-142 alkaline phosphatase, placental Homo sapiens 93-96 31117415-2 2019 Herein a simple and portable photothermal biosensor was developed for sensitive detection of ALP enzyme based on the formation of polydopamine (PDA) nanoparticles using a thermometer or temperature discoloration sticker as readout. polydopamine 144-147 alkaline phosphatase, placental Homo sapiens 93-96 31117415-6 2019 Thus, a portable biosensor based on the photothermal properties of PDA nanoparticles for ALP enzyme detection was established with a detection limit as low as 0.1 U/L (thermometer) and 1 U/L (temperature discoloration sticker). polydopamine 67-70 alkaline phosphatase, placental Homo sapiens 89-92 31088069-3 2019 These were then coated with tropoelastin (TROPO) through polydopamine (PDA) linking, to mimic the native extracellular matrix (ECM) composition and elasticity. polydopamine 57-69 elastin Homo sapiens 28-40 31088069-3 2019 These were then coated with tropoelastin (TROPO) through polydopamine (PDA) linking, to mimic the native extracellular matrix (ECM) composition and elasticity. polydopamine 57-69 elastin Homo sapiens 42-47 31074145-2 2019 Here, we investigated the potential of bone regeneration using novel nanocomposite polydopamine-laced hydroxyapatite collagen calcium silicate (HCCS-PDA) scaffolds with two different pore sizes, 250 and 500 mum. polydopamine 83-95 holocytochrome c synthase Rattus norvegicus 144-148 31140527-2 2019 To overcome these limitations, a tumor-specific and pH/NIR dual-responsive multifunctional nanocarrier coated with mussel inspired polydopamine and further conjugated with targeting molecular hyaluronic acid (HA) was designed and fabricated for synergistic targeted chemo-photothermal therapy. polydopamine 131-143 NOC2 like nucleolar associated transcriptional repressor Mus musculus 55-58 30970162-3 2019 On modification with polydopamine (PDA), PDA-Ag2 S was obtained, which showed outstanding capacity for inducing reactive oxygen species (increased by 1.69 times). polydopamine 21-33 angiotensin II receptor type 1 Homo sapiens 45-50 30970162-3 2019 On modification with polydopamine (PDA), PDA-Ag2 S was obtained, which showed outstanding capacity for inducing reactive oxygen species (increased by 1.69 times). polydopamine 35-38 angiotensin II receptor type 1 Homo sapiens 45-50 31046224-0 2019 Interfacial Property Modulation of PIM-1 through Polydopamine-Derived Submicrospheres for Enhanced CO2/N2 Separation Performance. polydopamine 49-61 Pim-1 proto-oncogene, serine/threonine kinase Homo sapiens 35-40 30711758-5 2019 The analyte cTnI collected via Fe3O4@PDA-dAb immune probe can be specially recognized by cAb immobilized on the sensing platform. polydopamine 37-41 troponin I3, cardiac type Homo sapiens 12-16 32073578-2 2019 In this study, a strategy has been developed to target these vulnerable weaknesses of cancer cells using glucose oxidase (GOx) and polydopamine (PDA) functionalized iron oxide nanoparticles (Fe3O4@PDA/GOx NPs). polydopamine 131-143 hydroxyacid oxidase 1, liver Mus musculus 201-204 33395787-1 2019 To provide superior substrates and determine the specific species of immobilized nano zero-valent iron (NZVI) system, polyacrylonitrile (PAN) membrane was functionalized by bio-inspired polydopamine (PDA) and poly(l-DOPA) (PDOPA) for efficient immobilization of NZVI. polydopamine 186-198 adenosine deaminase 2 Homo sapiens 137-140 33395787-1 2019 To provide superior substrates and determine the specific species of immobilized nano zero-valent iron (NZVI) system, polyacrylonitrile (PAN) membrane was functionalized by bio-inspired polydopamine (PDA) and poly(l-DOPA) (PDOPA) for efficient immobilization of NZVI. polydopamine 200-203 adenosine deaminase 2 Homo sapiens 137-140 32255127-4 2019 In particular, we have designed immunoadjuvant nanomedicine carriers on the basis of polydopamine (PDA) simultaneously loaded with resiquimod (R848)-a kind of toll-like receptor 7 (TLR7) agonist-and carbon dots (CDs)-a fluorescent agent. polydopamine 85-97 toll like receptor 7 Homo sapiens 181-185 32255127-4 2019 In particular, we have designed immunoadjuvant nanomedicine carriers on the basis of polydopamine (PDA) simultaneously loaded with resiquimod (R848)-a kind of toll-like receptor 7 (TLR7) agonist-and carbon dots (CDs)-a fluorescent agent. polydopamine 99-102 toll like receptor 7 Homo sapiens 159-179 30712573-0 2019 In situ formation of fluorescent polydopamine catalyzed by peroxidase-mimicking FeCo-LDH for pyrophosphate ion and pyrophosphatase activity detection. polydopamine 33-45 inorganic pyrophosphatase 1 Homo sapiens 115-130 30712573-2 2019 In this work, we proposed a new fluorescent assay for PPi and PPase activity detection based on the competitive coordination chemistry of Fe3+ between PPi and an in situ formed fluorescent polydopamine (PDA). polydopamine 189-201 inorganic pyrophosphatase 1 Homo sapiens 62-67 30712573-2 2019 In this work, we proposed a new fluorescent assay for PPi and PPase activity detection based on the competitive coordination chemistry of Fe3+ between PPi and an in situ formed fluorescent polydopamine (PDA). polydopamine 203-206 inorganic pyrophosphatase 1 Homo sapiens 62-67 30590344-4 2019 Thus, it is highly anticipated that PMPC-b-PDMAEMA modified polydopamine nanoparticles can serve as a powerful drug delivery system for combined pH-sensitive drug release and near-infrared photothermal therapeutic. polydopamine 60-72 peptidase, mitochondrial processing subunit beta Homo sapiens 36-42 30592990-4 2019 The adiponectin (APN) protein membrane was deposited on the substrate via polydopamine-assisted deposition. polydopamine 74-86 adiponectin, C1Q and collagen domain containing Homo sapiens 4-15 30592990-4 2019 The adiponectin (APN) protein membrane was deposited on the substrate via polydopamine-assisted deposition. polydopamine 74-86 adiponectin, C1Q and collagen domain containing Homo sapiens 17-20 30484006-0 2019 Degradation Products of Polydopamine Restrained Inflammatory Response of LPS-Stimulated Macrophages Through Mediation TLR-4-MYD88 Dependent Signaling Pathways by Antioxidant. polydopamine 24-36 toll like receptor 4 Homo sapiens 118-123 30484006-0 2019 Degradation Products of Polydopamine Restrained Inflammatory Response of LPS-Stimulated Macrophages Through Mediation TLR-4-MYD88 Dependent Signaling Pathways by Antioxidant. polydopamine 24-36 MYD88 innate immune signal transduction adaptor Homo sapiens 124-129 30484006-3 2019 Herein, we investigated whether degradable products of PDA could affect inflammatory response in lipopolysaccharide (LPS)-stimulated human THP-1-derived macrophages. polydopamine 55-58 GLI family zinc finger 2 Homo sapiens 139-144 30484006-8 2019 Furthermore, macrophages showed no cytotoxicity after PDA extract treatment with or without LPS, while the release levels of TNF-alpha and IL-6 by LPS-induced macrophages were decreased in dose-dependent by PDA extract treatment. polydopamine 207-210 tumor necrosis factor Homo sapiens 125-134 30484006-8 2019 Furthermore, macrophages showed no cytotoxicity after PDA extract treatment with or without LPS, while the release levels of TNF-alpha and IL-6 by LPS-induced macrophages were decreased in dose-dependent by PDA extract treatment. polydopamine 207-210 interleukin 6 Homo sapiens 139-143 30484006-10 2019 Similarly, PDA extracts effectively inhibited LPS-induced NF-kappaB trans-locating into nuclear by inactivation of the phosphorylation of IKK-alpha/beta and IKbeta-alpha. polydopamine 11-14 component of inhibitor of nuclear factor kappa B kinase complex Homo sapiens 138-147 30938485-3 2019 3D porous nanowire networks with surface functionalization of polydopamine make them a promising biocompatible microenvironment for immobilizing acetylcholinesterase (AChE) and constructing enzyme-based biosensors for sensitive detection of organophosphorus compounds. polydopamine 62-74 acetylcholinesterase (Cartwright blood group) Homo sapiens 145-165 30938485-3 2019 3D porous nanowire networks with surface functionalization of polydopamine make them a promising biocompatible microenvironment for immobilizing acetylcholinesterase (AChE) and constructing enzyme-based biosensors for sensitive detection of organophosphorus compounds. polydopamine 62-74 acetylcholinesterase (Cartwright blood group) Homo sapiens 167-171 32073578-2 2019 In this study, a strategy has been developed to target these vulnerable weaknesses of cancer cells using glucose oxidase (GOx) and polydopamine (PDA) functionalized iron oxide nanoparticles (Fe3O4@PDA/GOx NPs). polydopamine 145-148 hydroxyacid oxidase 1, liver Mus musculus 201-204 32073578-3 2019 PDA is first deposited on the surfaces of iron oxide NPs through self-polymerization, and then GOx is covalently linked with PDA upon mixing the enzyme and Fe3O4@PDA under alkaline conditions. polydopamine 0-3 hydroxyacid oxidase 1, liver Mus musculus 95-98 32073578-3 2019 PDA is first deposited on the surfaces of iron oxide NPs through self-polymerization, and then GOx is covalently linked with PDA upon mixing the enzyme and Fe3O4@PDA under alkaline conditions. polydopamine 125-128 hydroxyacid oxidase 1, liver Mus musculus 95-98 32073578-3 2019 PDA is first deposited on the surfaces of iron oxide NPs through self-polymerization, and then GOx is covalently linked with PDA upon mixing the enzyme and Fe3O4@PDA under alkaline conditions. polydopamine 125-128 hydroxyacid oxidase 1, liver Mus musculus 95-98 30453227-5 2019 We confirmed that the coated-PDA layer was evenly deposited on the bare polycaprolactone (PCL) scaffold and could enable abundant VEGF immobilization with enhanced hydrophilicity. polydopamine 29-32 vascular endothelial growth factor A Homo sapiens 130-134 30606519-3 2019 Herein, we synthesized polydopamine doped mesoporous silica-coated reduced graphene oxide (rGO/MSN/PDA) by simply adding dopamine hydrochloride into the oil-water biphasic reaction system as a multifunctional drug carrier for anticancer treatment, which combines chemotherapy and photothermal therapy. polydopamine 23-35 moesin Homo sapiens 95-98 31164601-4 2019 A critical-sized defect (CSD) was created in the center of the calvarium of Sprague Dawley rats to implant porous polydopamine-laced hydroxyapatite collagen calcium silicate (HCCS-PDA), a novel nanocomposite scaffold. polydopamine 114-126 holocytochrome c synthase Rattus norvegicus 175-179 30689334-6 2019 Furthermore, the results indicated that PDA coating exerted direct enhancing on the adhesion, proliferation and osteogenic differentiation of bone marrow derived mesenchymal stromal cells (BMSCs) through FAK and p38 signaling pathways. polydopamine 40-43 protein tyrosine kinase 2 Homo sapiens 204-207 30689334-6 2019 Furthermore, the results indicated that PDA coating exerted direct enhancing on the adhesion, proliferation and osteogenic differentiation of bone marrow derived mesenchymal stromal cells (BMSCs) through FAK and p38 signaling pathways. polydopamine 40-43 mitogen-activated protein kinase 14 Homo sapiens 212-215 30287005-0 2018 Efficient removal of Pb(II), Cr(VI) and organic dyes by polydopamine modified chitosan aerogels. polydopamine 56-68 submaxillary gland androgen regulated protein 3B Homo sapiens 21-27 30388565-3 2019 Herein, an effective and facile approach was designed to construct a bi-enzymatic and bi-nanospherical signal amplification system for fabrication of biosensors based on the designed polydopamine(PDA)-laccase@Au-glucose dehydrogenase. polydopamine 183-195 hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase Homo sapiens 212-233 32254937-1 2018 By coupling tyrosinase (Tyr) and beta-galactosidase (Gal) into one redox-cycling scheme, an enzyme cascade-based electrochemical immunosensor with boosted selectivity and sensitivity was constructed using polydopamine-functionalized multiwalled carbon nanotube (MWCNTs-PDA) nanohybrid modified electrodes. polydopamine 205-217 tyrosinase Homo sapiens 12-22 32254937-1 2018 By coupling tyrosinase (Tyr) and beta-galactosidase (Gal) into one redox-cycling scheme, an enzyme cascade-based electrochemical immunosensor with boosted selectivity and sensitivity was constructed using polydopamine-functionalized multiwalled carbon nanotube (MWCNTs-PDA) nanohybrid modified electrodes. polydopamine 205-217 tyrosinase Homo sapiens 24-27 30265990-5 2019 Then, utilizing a polydopamine (pDA)-assisted coating strategy, bone morphogenetic protein-2 (BMP-2)-derived peptides were further immobilized onto the 3D scaffolds to obtain the resulting nano-hydroxyapatite/PLLA/gelatin-peptide (nHA/PLA/GEL-PEP) 3D nanofibrous scaffolds capable of sustained release. polydopamine 18-30 bone morphogenetic protein 2 Rattus norvegicus 64-92 30265990-5 2019 Then, utilizing a polydopamine (pDA)-assisted coating strategy, bone morphogenetic protein-2 (BMP-2)-derived peptides were further immobilized onto the 3D scaffolds to obtain the resulting nano-hydroxyapatite/PLLA/gelatin-peptide (nHA/PLA/GEL-PEP) 3D nanofibrous scaffolds capable of sustained release. polydopamine 18-30 bone morphogenetic protein 2 Rattus norvegicus 94-99 30265990-5 2019 Then, utilizing a polydopamine (pDA)-assisted coating strategy, bone morphogenetic protein-2 (BMP-2)-derived peptides were further immobilized onto the 3D scaffolds to obtain the resulting nano-hydroxyapatite/PLLA/gelatin-peptide (nHA/PLA/GEL-PEP) 3D nanofibrous scaffolds capable of sustained release. polydopamine 32-35 bone morphogenetic protein 2 Rattus norvegicus 64-92 30265990-5 2019 Then, utilizing a polydopamine (pDA)-assisted coating strategy, bone morphogenetic protein-2 (BMP-2)-derived peptides were further immobilized onto the 3D scaffolds to obtain the resulting nano-hydroxyapatite/PLLA/gelatin-peptide (nHA/PLA/GEL-PEP) 3D nanofibrous scaffolds capable of sustained release. polydopamine 32-35 bone morphogenetic protein 2 Rattus norvegicus 94-99 30484642-1 2018 A bionanocomposite with artificial binding pockets for a DNA repair enzyme has been developed by in situ assembly of an affinity protein with a surrounding contact surface of polydopamine on the surface of silica coated magnetic nanoparticles via molecular imprinting reactions. polydopamine 175-187 DNA ligase 4 Homo sapiens 57-74 30562983-3 2018 We have utilized this novel system to form polydopamine particles, containing transferrin (PDA/Tf). polydopamine 43-55 transferrin Mus musculus 78-89 28845748-1 2018 A graphene oxide-polydopamine-(beta-cyclodextrin) (GPC) ultrafiltration membrane was fabricated by using the method of drop-coating combined with vacuum filtration. polydopamine 17-29 glycophorin C (Gerbich blood group) Homo sapiens 51-54 30403471-4 2018 Polydopamine-modified hyaluronic acid (HA-PDA) is coated on the MIL-100 surface to construct engineering MOF nanoparticles (MCH NPs). polydopamine 0-12 modifier of chinchilla Mus musculus 124-127 30092308-2 2018 The polydopamine (PD)-coated HBC hydrogels were prepared by the dopamine self-polymerization on the surface of HBC hydrogel with different coating time, termed as P30, P60 and P120, respectively. polydopamine 4-16 centromere protein V Homo sapiens 163-166 30092308-2 2018 The polydopamine (PD)-coated HBC hydrogels were prepared by the dopamine self-polymerization on the surface of HBC hydrogel with different coating time, termed as P30, P60 and P120, respectively. polydopamine 4-16 interferon induced protein with tetratricopeptide repeats 3 Homo sapiens 168-171 30092308-2 2018 The polydopamine (PD)-coated HBC hydrogels were prepared by the dopamine self-polymerization on the surface of HBC hydrogel with different coating time, termed as P30, P60 and P120, respectively. polydopamine 4-16 catenin delta 1 Homo sapiens 176-180 29725988-0 2018 Polydopamine-assisted BMP-2 immobilization on titanium surface enhances the osteogenic potential of periodontal ligament stem cells via integrin-mediated cell-matrix adhesion. polydopamine 0-12 bone morphogenetic protein 2 Homo sapiens 22-27 29725988-2 2018 Thus, this study determined the osteoconductive/osteoinductive properties of titanium (Ti) surfaces coated with PDA and the facilitation of the PDA layer to immobilize bone morphogenetic protein-2 (BMP-2) on Ti substrates. polydopamine 144-147 bone morphogenetic protein 2 Homo sapiens 168-196 30555233-3 2018 Methods: To increase the amount of HA and aid faster osseointegration, we prepared a HA coating using a biomimetic process assisted by polydopamine (PDA) on the HA/P66 substrate. polydopamine 135-147 polymerase (DNA-directed), delta 3, accessory subunit Mus musculus 161-167 30555233-3 2018 Methods: To increase the amount of HA and aid faster osseointegration, we prepared a HA coating using a biomimetic process assisted by polydopamine (PDA) on the HA/P66 substrate. polydopamine 149-152 polymerase (DNA-directed), delta 3, accessory subunit Mus musculus 161-167 30555233-7 2018 The formation of the HA coating on the PDA film greatly increased the hydrophilicity and surface roughness of HA/P66. polydopamine 39-42 polymerase (DNA-directed), delta 3, accessory subunit Mus musculus 110-116 30555233-10 2018 At 8 weeks after surgery, micro-computed tomography scanning (micro-CT) and hematoxylin-eosin (HE) staining revealed that more new bones were formed around the HA/P66 scaffold that was modified with a PDA-assisted HA coating. polydopamine 201-204 polymerase (DNA-directed), delta 3, accessory subunit Mus musculus 160-166 30125880-2 2018 Herein, a facile electrochemical enzymatic nanoreactor (CYP3A4/PNGFs) is constructed by immobilizing CYP3A4 inside polydopamine (PDA) modified nanoporous graphene foams (PNGFs) whose pore diameter is controllable by the template of silica spheres. polydopamine 115-127 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 56-62 30125880-2 2018 Herein, a facile electrochemical enzymatic nanoreactor (CYP3A4/PNGFs) is constructed by immobilizing CYP3A4 inside polydopamine (PDA) modified nanoporous graphene foams (PNGFs) whose pore diameter is controllable by the template of silica spheres. polydopamine 115-127 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 101-107 30125880-2 2018 Herein, a facile electrochemical enzymatic nanoreactor (CYP3A4/PNGFs) is constructed by immobilizing CYP3A4 inside polydopamine (PDA) modified nanoporous graphene foams (PNGFs) whose pore diameter is controllable by the template of silica spheres. polydopamine 129-132 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 56-62 30125880-2 2018 Herein, a facile electrochemical enzymatic nanoreactor (CYP3A4/PNGFs) is constructed by immobilizing CYP3A4 inside polydopamine (PDA) modified nanoporous graphene foams (PNGFs) whose pore diameter is controllable by the template of silica spheres. polydopamine 129-132 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 101-107 32254653-0 2018 Two-photon fluorescent polydopamine nanodots for CAR-T cell function verification and tumor cell/tissue detection. polydopamine 23-35 CXADR pseudogene 1 Homo sapiens 49-52 31105257-0 2018 Enzymatically Active Polydopamine @ Alkaline Phosphatase Nanoparticles Produced by NaIO4 Oxidation of Dopamine. polydopamine 21-33 alkaline phosphatase, placental Homo sapiens 36-56 31105257-3 2018 Herein, we demonstrate that size-controlled and colloidally stable PDA-based nanoparticles can be obtained in acidic conditions, where spontaneous auto-oxidation of dopamine is suppressed, using sodium periodate as the oxidant and a protein, like alkaline phosphatase (ALP), as a templating agent. polydopamine 67-70 alkaline phosphatase, placental Homo sapiens 247-267 31105257-3 2018 Herein, we demonstrate that size-controlled and colloidally stable PDA-based nanoparticles can be obtained in acidic conditions, where spontaneous auto-oxidation of dopamine is suppressed, using sodium periodate as the oxidant and a protein, like alkaline phosphatase (ALP), as a templating agent. polydopamine 67-70 alkaline phosphatase, placental Homo sapiens 269-272 30148952-2 2018 Interestingly, we reveal that they can be readily quenched ("turn off") via a facile surface coating with bioinspired polydopamine (PDA) polymerized from dopamine (DA), resulting from PDA-triggered TRL resonance energy transfer (TRL-RET). polydopamine 118-130 ret proto-oncogene Homo sapiens 233-236 30151523-9 2018 H&E staining showed Fe3O4@PDA NP-labeled NK cells, under a magnetic field, had higher intra-tumoral iron density and increased accumulation of CD56+ NK cells. polydopamine 30-33 neural cell adhesion molecule 1 Homo sapiens 147-151 30148952-2 2018 Interestingly, we reveal that they can be readily quenched ("turn off") via a facile surface coating with bioinspired polydopamine (PDA) polymerized from dopamine (DA), resulting from PDA-triggered TRL resonance energy transfer (TRL-RET). polydopamine 132-135 ret proto-oncogene Homo sapiens 233-236 30148952-2 2018 Interestingly, we reveal that they can be readily quenched ("turn off") via a facile surface coating with bioinspired polydopamine (PDA) polymerized from dopamine (DA), resulting from PDA-triggered TRL resonance energy transfer (TRL-RET). polydopamine 184-187 ret proto-oncogene Homo sapiens 233-236 29974910-0 2018 A redox cycling-amplified electrochemical immunosensor for alpha-fetoprotein sensitive detection via polydopamine nanolabels. polydopamine 101-113 alpha fetoprotein Homo sapiens 59-76 30030176-2 2018 Herein we report in situ promotion of wound healing by a photothermal therapy (PTT) assisted nanocatalytic antibacterial system utilizing a polydopamine (PDA) coating on hydroxyapatite (HAp) incorporated with gold nanoparticles (Au-HAp). polydopamine 140-152 hemaglutinin-associated protein Escherichia coli 186-189 30030176-2 2018 Herein we report in situ promotion of wound healing by a photothermal therapy (PTT) assisted nanocatalytic antibacterial system utilizing a polydopamine (PDA) coating on hydroxyapatite (HAp) incorporated with gold nanoparticles (Au-HAp). polydopamine 140-152 hemaglutinin-associated protein Escherichia coli 232-235 30030176-2 2018 Herein we report in situ promotion of wound healing by a photothermal therapy (PTT) assisted nanocatalytic antibacterial system utilizing a polydopamine (PDA) coating on hydroxyapatite (HAp) incorporated with gold nanoparticles (Au-HAp). polydopamine 154-157 hemaglutinin-associated protein Escherichia coli 186-189 30030176-2 2018 Herein we report in situ promotion of wound healing by a photothermal therapy (PTT) assisted nanocatalytic antibacterial system utilizing a polydopamine (PDA) coating on hydroxyapatite (HAp) incorporated with gold nanoparticles (Au-HAp). polydopamine 154-157 hemaglutinin-associated protein Escherichia coli 232-235 30030176-8 2018 STATEMENT OF SIGNIFICANCE: This study presents in situ promotion of wound healing by a low-temperature photothermal therapy (PTT) assisted nanocatalytic antibacterial system utilizing a polydopamine (PDA) coating on hydroxyapatite (HAp) incorporated with gold nanoparticles (Au-HAp). polydopamine 186-198 hemaglutinin-associated protein Escherichia coli 232-235 30030176-8 2018 STATEMENT OF SIGNIFICANCE: This study presents in situ promotion of wound healing by a low-temperature photothermal therapy (PTT) assisted nanocatalytic antibacterial system utilizing a polydopamine (PDA) coating on hydroxyapatite (HAp) incorporated with gold nanoparticles (Au-HAp). polydopamine 186-198 hemaglutinin-associated protein Escherichia coli 278-281 30030176-8 2018 STATEMENT OF SIGNIFICANCE: This study presents in situ promotion of wound healing by a low-temperature photothermal therapy (PTT) assisted nanocatalytic antibacterial system utilizing a polydopamine (PDA) coating on hydroxyapatite (HAp) incorporated with gold nanoparticles (Au-HAp). polydopamine 200-203 hemaglutinin-associated protein Escherichia coli 232-235 30030176-8 2018 STATEMENT OF SIGNIFICANCE: This study presents in situ promotion of wound healing by a low-temperature photothermal therapy (PTT) assisted nanocatalytic antibacterial system utilizing a polydopamine (PDA) coating on hydroxyapatite (HAp) incorporated with gold nanoparticles (Au-HAp). polydopamine 200-203 hemaglutinin-associated protein Escherichia coli 278-281 30056720-2 2018 In this paper, the PDA shell on the MSN surface was obtained through oxidative self-polymerization under the alkaline condition. polydopamine 19-22 moesin Homo sapiens 36-39 29974910-1 2018 A sandwich-type electrochemical immunosensor for sensitive detection of a tumor marker, alpha-fetoprotein (AFP), was fabricated by employing polydopamine-detection antibody nanoparticles (PDANPs-Ab2) as selective redox cycling-based signal amplifiers on an electrodeposited nano-gold electrode. polydopamine 141-153 alpha fetoprotein Homo sapiens 88-105 29974910-1 2018 A sandwich-type electrochemical immunosensor for sensitive detection of a tumor marker, alpha-fetoprotein (AFP), was fabricated by employing polydopamine-detection antibody nanoparticles (PDANPs-Ab2) as selective redox cycling-based signal amplifiers on an electrodeposited nano-gold electrode. polydopamine 141-153 alpha fetoprotein Homo sapiens 107-110 29726733-3 2018 TiO2 nanotubes with a diameter of 110 nm were anodized at a constant voltage of 30 V, and fibronectin was immobilized onto the TiO2 nanotubes using polydopamine. polydopamine 148-160 fibronectin 1 Homo sapiens 90-101 30960653-5 2018 The polydopamine (PDA) was rapidly deposited on silk fabric and the dyeing process was optimized as follows: the concentration of DA was 2 g L-1, and that of Fe3+ was 2 mmol L-1; the total reaction time was 50 min and reacted at 50 C; 9 mmol L-1 Ox was added at 20 min. polydopamine 4-16 immunoglobulin kappa variable 1-16 Homo sapiens 141-144 30960653-5 2018 The polydopamine (PDA) was rapidly deposited on silk fabric and the dyeing process was optimized as follows: the concentration of DA was 2 g L-1, and that of Fe3+ was 2 mmol L-1; the total reaction time was 50 min and reacted at 50 C; 9 mmol L-1 Ox was added at 20 min. polydopamine 4-16 immunoglobulin kappa variable 1-16 Homo sapiens 174-177 30960653-5 2018 The polydopamine (PDA) was rapidly deposited on silk fabric and the dyeing process was optimized as follows: the concentration of DA was 2 g L-1, and that of Fe3+ was 2 mmol L-1; the total reaction time was 50 min and reacted at 50 C; 9 mmol L-1 Ox was added at 20 min. polydopamine 4-16 immunoglobulin kappa variable 1-16 Homo sapiens 174-177 30960653-5 2018 The polydopamine (PDA) was rapidly deposited on silk fabric and the dyeing process was optimized as follows: the concentration of DA was 2 g L-1, and that of Fe3+ was 2 mmol L-1; the total reaction time was 50 min and reacted at 50 C; 9 mmol L-1 Ox was added at 20 min. polydopamine 18-21 immunoglobulin kappa variable 1-16 Homo sapiens 141-144 30960653-5 2018 The polydopamine (PDA) was rapidly deposited on silk fabric and the dyeing process was optimized as follows: the concentration of DA was 2 g L-1, and that of Fe3+ was 2 mmol L-1; the total reaction time was 50 min and reacted at 50 C; 9 mmol L-1 Ox was added at 20 min. polydopamine 18-21 immunoglobulin kappa variable 1-16 Homo sapiens 174-177 30960653-5 2018 The polydopamine (PDA) was rapidly deposited on silk fabric and the dyeing process was optimized as follows: the concentration of DA was 2 g L-1, and that of Fe3+ was 2 mmol L-1; the total reaction time was 50 min and reacted at 50 C; 9 mmol L-1 Ox was added at 20 min. polydopamine 18-21 immunoglobulin kappa variable 1-16 Homo sapiens 174-177 29786420-5 2018 Polydopamine-coated VNP20009 targeted hypoxic areas of the solid tumors, and near-infrared laser irradiation of the tumors induced heating due to polydopamine. polydopamine 0-12 immunoglobulin heavy variable 1-64 Mus musculus 20-23 32254463-3 2018 Herein, a novel single wavelength near infrared (NIR) laser-induced magnetically targeted theranostic nanoplatform has been successfully designed and synthesized for the first time based on polydopamine (PDA)/aluminum phthalocyanine (AlPc)/bovine serum albumin (BSA) coated magnetic Prussian blue nanoparticles (Fe3O4@PB NPs) for multiple imaging-guided combinatorial cancer therapy. polydopamine 190-202 albumin Bos taurus 247-260 29748992-3 2018 Increasing concentration and decreasing pKb of amines cause the reaction equilibrium to shift toward the product polydopamine (PDA). polydopamine 113-125 AKT serine/threonine kinase 1 Homo sapiens 40-43 29748992-3 2018 Increasing concentration and decreasing pKb of amines cause the reaction equilibrium to shift toward the product polydopamine (PDA). polydopamine 127-130 AKT serine/threonine kinase 1 Homo sapiens 40-43 29783745-3 2018 In this work, we developed a novel photothermal and photodynamic therapeutic nanoplatform for treatment of cancer cells overexpressing integrin alphavbeta3 through the coating of polydopamine (PDA) on indocyanine green (ICG)-loaded laponite (LAP) and then further conjugating polyethylene glycol-arginine-glycine-aspartic acid (PEG-RGD) as targeted agents on the surface. polydopamine 179-191 integrin subunit alpha V Homo sapiens 135-155 29783745-3 2018 In this work, we developed a novel photothermal and photodynamic therapeutic nanoplatform for treatment of cancer cells overexpressing integrin alphavbeta3 through the coating of polydopamine (PDA) on indocyanine green (ICG)-loaded laponite (LAP) and then further conjugating polyethylene glycol-arginine-glycine-aspartic acid (PEG-RGD) as targeted agents on the surface. polydopamine 193-196 integrin subunit alpha V Homo sapiens 135-155 32254463-3 2018 Herein, a novel single wavelength near infrared (NIR) laser-induced magnetically targeted theranostic nanoplatform has been successfully designed and synthesized for the first time based on polydopamine (PDA)/aluminum phthalocyanine (AlPc)/bovine serum albumin (BSA) coated magnetic Prussian blue nanoparticles (Fe3O4@PB NPs) for multiple imaging-guided combinatorial cancer therapy. polydopamine 204-207 albumin Bos taurus 247-260 29938191-2 2018 The resultant hybrid nanoparticles (named as MCP) show enhanced photothermal conversion efficiency in comparison with pure polydopamine or MnCo nanoparticles (NPs) synthesized under a similar method and, therefore, show great potential for photothermal therapy (PTT) in vivo. polydopamine 123-135 CD46 molecule Homo sapiens 45-48 29654372-1 2018 The authors describe an electrochemical aptasensor for thrombin that is based on the use of a glassy carbon electrode (GCE) modified with polydopamine that is loaded with silver nanoparticles (PDA/AgNPs). polydopamine 138-150 coagulation factor II, thrombin Homo sapiens 55-63 29654372-9 2018 Graphical abstract Schematic of an electrochemical aptasensor for sensitive and selective thrombin detection based on the use of a self-polymerized polydopamine film loaded with silver nanoparticles. polydopamine 148-160 coagulation factor II, thrombin Homo sapiens 90-98 29561589-4 2018 In this study, low-dose BMP-2 of 1 mug was used to design PLA-PD-BMP for functionalization of polylactic acid (PLA) implants via mussel-inspired polydopamine (PD) assist. polydopamine 145-157 bone morphogenetic protein 2 Homo sapiens 24-29 29561589-4 2018 In this study, low-dose BMP-2 of 1 mug was used to design PLA-PD-BMP for functionalization of polylactic acid (PLA) implants via mussel-inspired polydopamine (PD) assist. polydopamine 145-157 bone morphogenetic protein 1 Homo sapiens 24-27 29561589-4 2018 In this study, low-dose BMP-2 of 1 mug was used to design PLA-PD-BMP for functionalization of polylactic acid (PLA) implants via mussel-inspired polydopamine (PD) assist. polydopamine 62-64 bone morphogenetic protein 2 Homo sapiens 24-29 29561589-4 2018 In this study, low-dose BMP-2 of 1 mug was used to design PLA-PD-BMP for functionalization of polylactic acid (PLA) implants via mussel-inspired polydopamine (PD) assist. polydopamine 62-64 bone morphogenetic protein 1 Homo sapiens 24-27 29561589-6 2018 The obtained PLA-PD-BMP surface immobilized with this low BMP-2 dose can endow the implants with abilities of introducing strong stem cell adhesion and enhanced osteogenicity. polydopamine 17-19 bone morphogenetic protein 1 Homo sapiens 20-23 29561589-6 2018 The obtained PLA-PD-BMP surface immobilized with this low BMP-2 dose can endow the implants with abilities of introducing strong stem cell adhesion and enhanced osteogenicity. polydopamine 17-19 bone morphogenetic protein 2 Homo sapiens 58-63 29594716-0 2018 Controlled synthesis of polydopamine: A new strategy for highly sensitive fluorescence turn-on detection of acetylcholinesterase activity. polydopamine 24-36 acetylcholinesterase (Cartwright blood group) Homo sapiens 108-128 32254236-8 2018 Recombinant human bone morphogenetic protein-2 (rhBMP-2) was immobilized on the scaffolds via a polydopamine coating to induce osteogenic differentiation. polydopamine 96-108 bone morphogenetic protein 2 Homo sapiens 18-46 28871656-1 2018 A biomimetic Zein polydopamine based nanofiber scaffold was fabricated to deliver bone morphogenic protein-2 (BMP-2) peptide conjugated titanium dioxide nanoparticles in a sustained manner for investigating its osteogenic differentiation potential. polydopamine 18-30 bone morphogenetic protein 2 Homo sapiens 82-108 28871656-1 2018 A biomimetic Zein polydopamine based nanofiber scaffold was fabricated to deliver bone morphogenic protein-2 (BMP-2) peptide conjugated titanium dioxide nanoparticles in a sustained manner for investigating its osteogenic differentiation potential. polydopamine 18-30 bone morphogenetic protein 2 Homo sapiens 110-115 29594735-0 2018 Polydopamine nanodots are viable probes for fluorometric determination of the activity of alkaline phosphatase via the in situ regulation of a redox reaction triggered by the enzyme. polydopamine 0-12 alkaline phosphatase, placental Homo sapiens 90-110 29384352-0 2018 FRET Effect between Fluorescent Polydopamine Nanoparticles and MnO2 Nanosheets and Its Application for Sensitive Sensing of Alkaline Phosphatase. polydopamine 32-44 alkaline phosphatase, placental Homo sapiens 124-144 29327757-0 2018 Rapid and sensitive detection of neuron specific enolase with a polydopamine coated plasmonic chip utilizing a rear-side coupling method. polydopamine 64-76 enolase 2 Homo sapiens 33-56 29327757-1 2018 A rapid and sensitive detection of a cancer marker, neuron specific enolase (NSE), is demonstrated by using a disposable silver plasmonic chip functionalized with a mussel-inspired polydopamine (PDA) coating. polydopamine 181-193 enolase 2 Homo sapiens 52-75 29327757-1 2018 A rapid and sensitive detection of a cancer marker, neuron specific enolase (NSE), is demonstrated by using a disposable silver plasmonic chip functionalized with a mussel-inspired polydopamine (PDA) coating. polydopamine 181-193 enolase 2 Homo sapiens 77-80 29327757-1 2018 A rapid and sensitive detection of a cancer marker, neuron specific enolase (NSE), is demonstrated by using a disposable silver plasmonic chip functionalized with a mussel-inspired polydopamine (PDA) coating. polydopamine 195-198 enolase 2 Homo sapiens 52-75 29327757-1 2018 A rapid and sensitive detection of a cancer marker, neuron specific enolase (NSE), is demonstrated by using a disposable silver plasmonic chip functionalized with a mussel-inspired polydopamine (PDA) coating. polydopamine 195-198 enolase 2 Homo sapiens 77-80 29594735-9 2018 The method is based on the in-situ regulation of the formation of fluorescent polydopamine nanodots (PDA-NDs) through the competition between the KMnO4-induced polymerization of dopamine and ALP-directed ascorbic acid 2-phosphate (Asc-2P) hydrolysis. polydopamine 78-90 alkaline phosphatase, placental Homo sapiens 191-194 29527167-0 2018 Polydopamine-Functionalized CA-(PCL-ran-PLA) Nanoparticles for Target Delivery of Docetaxel and Chemo-photothermal Therapy of Breast Cancer. polydopamine 0-12 PHD finger protein 1 Homo sapiens 32-35 29527167-2 2018 Herein, we reported a synergistic chemo-photothermal strategy based on aptamer (Apt)-polydopamine (pD) functionalized CA-(PCL-ran-PLA) nanoparticles (NPs) for effective delivery of docetaxel (DTX) and enhanced therapeutic effect. polydopamine 85-97 PHD finger protein 1 Homo sapiens 122-125 29527167-2 2018 Herein, we reported a synergistic chemo-photothermal strategy based on aptamer (Apt)-polydopamine (pD) functionalized CA-(PCL-ran-PLA) nanoparticles (NPs) for effective delivery of docetaxel (DTX) and enhanced therapeutic effect. polydopamine 99-101 PHD finger protein 1 Homo sapiens 122-125 29594716-9 2018 Graphical abstract Controlled synthesis of polydopamine for the highly sensitive and selective sensing of AChE activity is reported for the first time. polydopamine 43-55 acetylcholinesterase (Cartwright blood group) Homo sapiens 106-110 29176036-3 2018 FN was covalently immobilized onto the surface of a Tetronic -based hydrogel at two different concentrations (1 and 5 mug ml-1) for stable adhesion of the multi-layered cell sheet, followed by polydopamine coating. polydopamine 193-205 fibronectin 1 Homo sapiens 0-2 29594480-0 2018 Aptamer based electrochemiluminescent thrombin assay using carbon dots anchored onto silver-decorated polydopamine nanospheres. polydopamine 102-114 coagulation factor II, thrombin Homo sapiens 38-46 29594480-12 2018 Graphical abstract Carbon dots (C-dots) placed on polydopamine nanospheres loaded with silver nanoparticles (PDANS@Ag) for electrochemiluminescent (ECL) detection of thrombin. polydopamine 50-62 coagulation factor II, thrombin Homo sapiens 166-174 28881440-3 2017 The current study employs a mussel-inspired polydopamine to immobilize PRP on gelatin microspheres (GMs) with the purpose of bridging adipose micro-tissues to help implanted fat survive (GM-pDA-PRP). polydopamine 44-56 complement component 4 binding protein alpha Homo sapiens 71-74 32264518-1 2017 Herein, a novel immunosensing strategy was designed for the sensitive fluorescence/visual detection of alpha-fetoprotein (AFP), by combining the enzyme-controlled formation of polydopamine (PDA) nanoparticles with the dissolution of manganese dioxide (MnO2) nanoflakes. polydopamine 176-188 alpha fetoprotein Homo sapiens 103-120 32264518-1 2017 Herein, a novel immunosensing strategy was designed for the sensitive fluorescence/visual detection of alpha-fetoprotein (AFP), by combining the enzyme-controlled formation of polydopamine (PDA) nanoparticles with the dissolution of manganese dioxide (MnO2) nanoflakes. polydopamine 176-188 alpha fetoprotein Homo sapiens 122-125 32264518-1 2017 Herein, a novel immunosensing strategy was designed for the sensitive fluorescence/visual detection of alpha-fetoprotein (AFP), by combining the enzyme-controlled formation of polydopamine (PDA) nanoparticles with the dissolution of manganese dioxide (MnO2) nanoflakes. polydopamine 190-193 alpha fetoprotein Homo sapiens 103-120 32264518-1 2017 Herein, a novel immunosensing strategy was designed for the sensitive fluorescence/visual detection of alpha-fetoprotein (AFP), by combining the enzyme-controlled formation of polydopamine (PDA) nanoparticles with the dissolution of manganese dioxide (MnO2) nanoflakes. polydopamine 190-193 alpha fetoprotein Homo sapiens 122-125 28609715-4 2017 In order to immobilize insulin antibody, adhesive polydopamine (PDA) film formed by self-polymerization of dopamine was fabricated onto BiOBr/Ag2S modified electrode. polydopamine 50-62 angiotensin II receptor type 1 Homo sapiens 142-146 28609715-4 2017 In order to immobilize insulin antibody, adhesive polydopamine (PDA) film formed by self-polymerization of dopamine was fabricated onto BiOBr/Ag2S modified electrode. polydopamine 64-67 angiotensin II receptor type 1 Homo sapiens 142-146 28609715-5 2017 Moreover, PDA film could further enhance the visible light absorption of BiOBr/Ag2S. polydopamine 10-13 angiotensin II receptor type 1 Homo sapiens 79-83 29137454-0 2017 Determination of Cancer Cell-Based pH-Sensitive Fluorescent Carbon Nanoparticles of Cross-Linked Polydopamine by Fluorescence Sensing of Alkaline Phosphatase Activity on Coated Surfaces and Aqueous Solution. polydopamine 97-109 alkaline phosphatase, placental Homo sapiens 137-157 29568455-2 2017 Here, we fabricated spherical polydopamine/mesoporous calcium phosphate hollow JNPs (PDA/mCaP H-JNPs) via a novel and facile approach. polydopamine 30-42 non-SMC condensin I complex, subunit H Mus musculus 89-95 28881440-3 2017 The current study employs a mussel-inspired polydopamine to immobilize PRP on gelatin microspheres (GMs) with the purpose of bridging adipose micro-tissues to help implanted fat survive (GM-pDA-PRP). polydopamine 44-56 complement component 4 binding protein alpha Homo sapiens 194-197 28866159-5 2017 In the present study, Heparin and VEGF were immobilized via self-polymerization and deposition of polydopamine (PDA) on polyurethane (PU) nanofibrous scaffolds to improve endothelialization. polydopamine 98-110 vascular endothelial growth factor A Homo sapiens 34-38 28414557-1 2017 We reported a simple polydopamine (PDA)-based surface modification method to prepare novel targeted doxorubicin-loaded mesoporous silica nanoparticles and peptide CSNRDARRC conjugation (DOX-loaded MSNs@PDA-PEP) for enhancing the therapeutic effects on bladder cancer. polydopamine 21-33 progestagen associated endometrial protein Homo sapiens 206-209 28414557-1 2017 We reported a simple polydopamine (PDA)-based surface modification method to prepare novel targeted doxorubicin-loaded mesoporous silica nanoparticles and peptide CSNRDARRC conjugation (DOX-loaded MSNs@PDA-PEP) for enhancing the therapeutic effects on bladder cancer. polydopamine 35-38 progestagen associated endometrial protein Homo sapiens 206-209 28866159-5 2017 In the present study, Heparin and VEGF were immobilized via self-polymerization and deposition of polydopamine (PDA) on polyurethane (PU) nanofibrous scaffolds to improve endothelialization. polydopamine 112-115 vascular endothelial growth factor A Homo sapiens 34-38 28866159-12 2017 This method of surface modification (immobilization of Heparin, VEGF by PDA layer) is suggested as a promising modification technique to increase hemocompatibility of small-diameter vascular grafts. polydopamine 72-75 vascular endothelial growth factor A Homo sapiens 64-68 28902980-2 2017 This study describes the design and synthesis of myoglobin and polydopamine-engineered surface-enhanced Raman scattering (MP-SERS) nanoprobes with strong, tunable SERS signals that allow for specifically detecting and imaging ROS sensitively and quantitatively. polydopamine 63-75 seryl-tRNA synthetase 2, mitochondrial Homo sapiens 125-129 28902980-2 2017 This study describes the design and synthesis of myoglobin and polydopamine-engineered surface-enhanced Raman scattering (MP-SERS) nanoprobes with strong, tunable SERS signals that allow for specifically detecting and imaging ROS sensitively and quantitatively. polydopamine 63-75 seryl-tRNA synthetase 2, mitochondrial Homo sapiens 163-167 28902980-3 2017 The study shows that a polydopamine nanolayer can facilitate the modification of Raman-active myoglobins and satellite Au nanoparticles (s-AuNPs) to a plasmonic core AuNP (c-AuNP) in a controllable manner and the generation of plasmonically coupled hot spots between a c-AuNP and s-AuNPs that can induce strong SERS signals. polydopamine 23-35 seryl-tRNA synthetase 2, mitochondrial Homo sapiens 311-315 28525853-0 2017 Photoelectrochemical sensitive detection of insulin based on CdS/polydopamine co-sensitized WO3 nanorod and signal amplification of carbon nanotubes@polydopamine. polydopamine 65-77 insulin Homo sapiens 44-51 28525853-0 2017 Photoelectrochemical sensitive detection of insulin based on CdS/polydopamine co-sensitized WO3 nanorod and signal amplification of carbon nanotubes@polydopamine. polydopamine 149-161 insulin Homo sapiens 44-51 28525853-1 2017 An ultrasensitive photoelectrochemical sandwich immunosensor was designed for detection of insulin based on WO3/CdS/polydopamine (WO3/CdS/PDA) co-sensitized and PDA@carbon nanotubes (PDA@CNT) conjugates for signal amplification. polydopamine 116-128 insulin Homo sapiens 91-98 29021583-3 2017 In this study, the in vitro osteogenic effects of polydopamine-laced hydroxyapatite collagen calcium silicate (HCCS-PDA) were examined by culturing rat mesenchymal stem cells (rMSCs) on HCCS-PDA and HCCS coated plates. polydopamine 50-62 holocytochrome c synthase Rattus norvegicus 111-115 29021583-3 2017 In this study, the in vitro osteogenic effects of polydopamine-laced hydroxyapatite collagen calcium silicate (HCCS-PDA) were examined by culturing rat mesenchymal stem cells (rMSCs) on HCCS-PDA and HCCS coated plates. polydopamine 50-62 holocytochrome c synthase Rattus norvegicus 186-190 29021583-3 2017 In this study, the in vitro osteogenic effects of polydopamine-laced hydroxyapatite collagen calcium silicate (HCCS-PDA) were examined by culturing rat mesenchymal stem cells (rMSCs) on HCCS-PDA and HCCS coated plates. polydopamine 50-62 holocytochrome c synthase Rattus norvegicus 186-190 28585085-4 2017 After immobilization of antibodies (anti-EpCAM), polydopamine-encapsulated gold nanorods show high specificity to target cancer cells. polydopamine 49-61 epithelial cell adhesion molecule Homo sapiens 41-46 28535433-2 2017 A commercial NF90 membrane was first coated with polydopamine (PDA) followed by in situ immobilization of silver nanoparticles (AgNPs). polydopamine 49-61 interleukin enhancer binding factor 3 Homo sapiens 13-17 28535433-2 2017 A commercial NF90 membrane was first coated with polydopamine (PDA) followed by in situ immobilization of silver nanoparticles (AgNPs). polydopamine 63-66 interleukin enhancer binding factor 3 Homo sapiens 13-17 28663144-7 2017 Importantly, the optimized PMEN and PEG-OH coatings were easily duplicated on other substrates due to universal adhesion of the PDA layer, showed excellent resistance to platelet, bacteria and proteins, and no significant difference in the antifouling performances was observed. polydopamine 128-131 PEG Bos taurus 36-39 28663144-12 2017 In this study, PEG and zwitterion polymers, the most widely investigated polymers with best antifouling performance, are conveniently immobilized on different kinds of substrates from their aqueous solutions by precoating a polydopamine intermediate layer as the universal adhesive and readily re-modifiable surface. polydopamine 224-236 PEG Bos taurus 15-18 28894364-0 2017 EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer. polydopamine 29-41 epithelial cell adhesion molecule Homo sapiens 0-5 28894364-0 2017 EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer. polydopamine 29-41 immunoglobulin heavy diversity 1-7 Homo sapiens 93-96 28707627-3 2017 Inspired by the mussel adhesion mechanism, we developed polydopamine (PDA)-decorated bovine serum albumin microspheres (BSA-MS) and nano-hydroxyapatite (nano-HA), and assembled them to form bioactive coatings with micro/nano structures encapsulating bone morphogenetic protein-2 (BMP-2). polydopamine 56-68 bone morphogenetic protein 2 Homo sapiens 250-278 28707627-3 2017 Inspired by the mussel adhesion mechanism, we developed polydopamine (PDA)-decorated bovine serum albumin microspheres (BSA-MS) and nano-hydroxyapatite (nano-HA), and assembled them to form bioactive coatings with micro/nano structures encapsulating bone morphogenetic protein-2 (BMP-2). polydopamine 56-68 bone morphogenetic protein 2 Homo sapiens 280-285 28707627-5 2017 Second, BMP-2-encapsulated BSA microspheres were prepared through desolvation, and then were also decorated by PDA (pBSA-MS). polydopamine 111-114 bone morphogenetic protein 2 Homo sapiens 8-13 28608421-0 2017 Polydopamine mediated assembly of hydroxyapatite nanoparticles and bone morphogenetic protein-2 on magnesium alloys for enhanced corrosion resistance and bone regeneration. polydopamine 0-12 bone morphogenetic protein 2 Homo sapiens 67-95 28608421-3 2017 In this study, we developed a novel functional and biocompatible coating strategy through polydopamine mediated assembly of hydroxyapatite nanoparticles and growth factor, bone morphogenetic protein-2 (BMP-2), onto the surface of AZ31 Mg alloys. polydopamine 90-102 bone morphogenetic protein 2 Homo sapiens 172-200 28608421-3 2017 In this study, we developed a novel functional and biocompatible coating strategy through polydopamine mediated assembly of hydroxyapatite nanoparticles and growth factor, bone morphogenetic protein-2 (BMP-2), onto the surface of AZ31 Mg alloys. polydopamine 90-102 bone morphogenetic protein 2 Homo sapiens 202-207 28829566-3 2017 Porous structure and dimension of IOPC TiO2 can be precisely controlled for mimicking cellular components, and anti-EpCAM antibody was further modified on IOPC interface by conjugating with polydopamine (PDA). polydopamine 190-202 epithelial cell adhesion molecule Homo sapiens 116-121 28829566-3 2017 Porous structure and dimension of IOPC TiO2 can be precisely controlled for mimicking cellular components, and anti-EpCAM antibody was further modified on IOPC interface by conjugating with polydopamine (PDA). polydopamine 204-207 epithelial cell adhesion molecule Homo sapiens 116-121 28688985-7 2017 STATEMENT OF SIGNIFICANCE: The described EGFR targeted PLGA/polydopamine core-shell nanoparticle (PLGA/PD NP) is novel in the following aspects: Different from most photothermal converting nanomaterials, PLGA/PD NP is biodegradable, which eliminates the long-term safety concerns thwarting the clinical application of photothermal therapy. polydopamine 60-72 epidermal growth factor receptor Homo sapiens 41-45 28576035-0 2017 BMP-2 immobilized PLGA/hydroxyapatite fibrous scaffold via polydopamine stimulates osteoblast growth. polydopamine 59-71 bone morphogenetic protein 2 Mus musculus 0-5 28576035-4 2017 In order to effectively immobilize BMP-2 on PLGA/HA composite fibrous scaffolds, the surface of the scaffold was modified with polydopamine (PDA) (PDA-PLGA/HA). polydopamine 127-139 bone morphogenetic protein 2 Mus musculus 35-40 28576035-4 2017 In order to effectively immobilize BMP-2 on PLGA/HA composite fibrous scaffolds, the surface of the scaffold was modified with polydopamine (PDA) (PDA-PLGA/HA). polydopamine 141-144 bone morphogenetic protein 2 Mus musculus 35-40 28576035-5 2017 PDA was chosen as an adhesive polymeric bridge-layer between PLGA/HA fibrous scaffolds and BMP-2. polydopamine 0-3 bone morphogenetic protein 2 Mus musculus 91-96 28576035-8 2017 Furthermore, the PDA coating effectively immobilized BMP-2 on the PDA-PLGA/HA fibrous scaffold and a sustained release profile of BMP-2 was achieved in the BMP-2-immobilized PLGA/HA fibrous scaffold. polydopamine 17-20 bone morphogenetic protein 2 Mus musculus 53-58 28576035-8 2017 Furthermore, the PDA coating effectively immobilized BMP-2 on the PDA-PLGA/HA fibrous scaffold and a sustained release profile of BMP-2 was achieved in the BMP-2-immobilized PLGA/HA fibrous scaffold. polydopamine 17-20 bone morphogenetic protein 2 Mus musculus 130-135 28576035-8 2017 Furthermore, the PDA coating effectively immobilized BMP-2 on the PDA-PLGA/HA fibrous scaffold and a sustained release profile of BMP-2 was achieved in the BMP-2-immobilized PLGA/HA fibrous scaffold. polydopamine 17-20 bone morphogenetic protein 2 Mus musculus 130-135 28576035-8 2017 Furthermore, the PDA coating effectively immobilized BMP-2 on the PDA-PLGA/HA fibrous scaffold and a sustained release profile of BMP-2 was achieved in the BMP-2-immobilized PLGA/HA fibrous scaffold. polydopamine 66-69 bone morphogenetic protein 2 Mus musculus 53-58 28816311-3 2017 The enhanced photocatalytic performance of SiO2@PDA-2@BiOBr was ascribed to the decreased band-gap, higher surface area, and effectively photo-generated electron-hole pairs by the introduction of polydopamine (PDA). polydopamine 196-208 transcription factor AP-2 beta Homo sapiens 48-53 28842557-7 2017 Drug release studies show that facile release of the anticancer drug BTZ from the surface of the polydopamine-coated stent could be achieved by the dissociation between catechol groups of polydopamine and the boronic acid functionality of BTZ in a pH-dependent manner. polydopamine 97-109 CASC3 exon junction complex subunit Homo sapiens 69-72 28842557-7 2017 Drug release studies show that facile release of the anticancer drug BTZ from the surface of the polydopamine-coated stent could be achieved by the dissociation between catechol groups of polydopamine and the boronic acid functionality of BTZ in a pH-dependent manner. polydopamine 97-109 CASC3 exon junction complex subunit Homo sapiens 239-242 28842557-7 2017 Drug release studies show that facile release of the anticancer drug BTZ from the surface of the polydopamine-coated stent could be achieved by the dissociation between catechol groups of polydopamine and the boronic acid functionality of BTZ in a pH-dependent manner. polydopamine 188-200 CASC3 exon junction complex subunit Homo sapiens 69-72 28398436-2 2017 The hollow metal-polydopamine (PDA) particles are formed by a coordination assembly of metal ions (Co and Zn) and PDA, inheriting the morphology of MOF (ZIF-67 and ZIF-8) crystals. polydopamine 17-29 lysine acetyltransferase 8 Homo sapiens 148-151 28013019-0 2017 A novel immunosensing platform for highly sensitive prostate specific antigen detection based on dual-quenching of photocurrent from CdSe sensitized TiO2 electrode by gold nanoparticles decorated polydopamine nanospheres. polydopamine 196-208 kallikrein related peptidase 3 Homo sapiens 52-77 28224896-0 2017 Carboxylmethyl konjac glucomannan conjugated polydopamine composites for Pb(II) removal. polydopamine 45-57 submaxillary gland androgen regulated protein 3B Homo sapiens 73-79 28435266-0 2017 EGFR-targeted delivery of DOX-loaded Fe3O4@ polydopamine multifunctional nanocomposites for MRI and antitumor chemo-photothermal therapy. polydopamine 44-56 epidermal growth factor receptor Homo sapiens 0-4 28435266-2 2017 This study developed epidermal growth factor receptor (EGFR) antibody-directed polydopamine-coated Fe3O4 nanoparticles (Fe3O4@PDA NPs) for magnetic resonance imaging and antitumor chemo-photothermal therapy. polydopamine 79-91 epidermal growth factor receptor Homo sapiens 21-53 28435266-2 2017 This study developed epidermal growth factor receptor (EGFR) antibody-directed polydopamine-coated Fe3O4 nanoparticles (Fe3O4@PDA NPs) for magnetic resonance imaging and antitumor chemo-photothermal therapy. polydopamine 79-91 epidermal growth factor receptor Homo sapiens 55-59 33429630-5 2017 SEM images and FT-IR-ATR spectra suggested that the extent of polydopamine aggregation was crucial for the dyeing efficiency. polydopamine 62-74 ATR serine/threonine kinase Homo sapiens 21-24 28103529-4 2017 The purpose of the present study was to develop a polydopamine (pDA)-assisted BMP-2-derived peptide (designated as P24) surface modification strategy for improving the osteogenesis of the nHA/RHLC/PLA scaffold. polydopamine 50-62 bone morphogenetic protein 2 Homo sapiens 78-83 28103529-4 2017 The purpose of the present study was to develop a polydopamine (pDA)-assisted BMP-2-derived peptide (designated as P24) surface modification strategy for improving the osteogenesis of the nHA/RHLC/PLA scaffold. polydopamine 50-62 transmembrane p24 trafficking protein 2 Homo sapiens 115-118 28103529-4 2017 The purpose of the present study was to develop a polydopamine (pDA)-assisted BMP-2-derived peptide (designated as P24) surface modification strategy for improving the osteogenesis of the nHA/RHLC/PLA scaffold. polydopamine 64-67 bone morphogenetic protein 2 Homo sapiens 78-83 28103529-4 2017 The purpose of the present study was to develop a polydopamine (pDA)-assisted BMP-2-derived peptide (designated as P24) surface modification strategy for improving the osteogenesis of the nHA/RHLC/PLA scaffold. polydopamine 64-67 transmembrane p24 trafficking protein 2 Homo sapiens 115-118 28103529-7 2017 Our results showed that pDA-assisted surface modification could more efficiently mediate the immobilization of P24 peptide onto the scaffold surfaces than physical adsorption. polydopamine 24-27 transmembrane p24 trafficking protein 2 Homo sapiens 111-114 27151437-6 2017 The CQDs can be connected to the electrode surface through the combination of CEA with Ab1 and Ab2, and then the amplified electrochemiluminescence signal of CQDs was obtained with the synergistic effect of AgNPs, polydopamine, AuNPs and PEI-GO. polydopamine 214-226 CEA cell adhesion molecule 3 Homo sapiens 78-81 28159615-4 2017 ELP-RTA and ELP-DAAO have been separately immobilized on polydopamine-coated MnO2 nanorods. polydopamine 57-69 nuclear receptor subfamily 5 group A member 1 Homo sapiens 0-3 28159615-4 2017 ELP-RTA and ELP-DAAO have been separately immobilized on polydopamine-coated MnO2 nanorods. polydopamine 57-69 nuclear receptor subfamily 5 group A member 1 Homo sapiens 12-15 28159615-4 2017 ELP-RTA and ELP-DAAO have been separately immobilized on polydopamine-coated MnO2 nanorods. polydopamine 57-69 D-amino acid oxidase Homo sapiens 16-20 27699058-6 2016 Moreover, larger amount of bovine serum albumin (BSA) was immobilized onto PDA-Th150 coating and performed well in anti-platelet adhesion. polydopamine 75-78 albumin Homo sapiens 34-47 28335971-0 2017 Ultrasensitive immunosensor for prostate specific antigen using biomimetic polydopamine nanospheres as an electrochemiluminescence superquencher and antibody carriers. polydopamine 75-87 kallikrein related peptidase 3 Homo sapiens 32-57 27619527-0 2017 A novel upconversion@polydopamine core@shell nanoparticle based aptameric biosensor for biosensing and imaging of cytochrome c inside living cells. polydopamine 21-33 cytochrome c, somatic Homo sapiens 114-126 27619527-1 2017 Herein, a novel upconversion@polydopamine core@shell nanoparticle (termed as UCNP@PDA NP) -based aptameric biosensor has been fabricated for the quantitative analysis of cytochrome c (Cyt c) inside living cells, which comprises an UCNP@PDA NP, acting as an internal reference and fluorescence quenching agent, and Cy3 modified aptamer enabling ratiometric quantitative Cyt c measurement. polydopamine 29-41 cytochrome c, somatic Homo sapiens 170-182 27619527-1 2017 Herein, a novel upconversion@polydopamine core@shell nanoparticle (termed as UCNP@PDA NP) -based aptameric biosensor has been fabricated for the quantitative analysis of cytochrome c (Cyt c) inside living cells, which comprises an UCNP@PDA NP, acting as an internal reference and fluorescence quenching agent, and Cy3 modified aptamer enabling ratiometric quantitative Cyt c measurement. polydopamine 29-41 cytochrome c, somatic Homo sapiens 184-189 27619527-1 2017 Herein, a novel upconversion@polydopamine core@shell nanoparticle (termed as UCNP@PDA NP) -based aptameric biosensor has been fabricated for the quantitative analysis of cytochrome c (Cyt c) inside living cells, which comprises an UCNP@PDA NP, acting as an internal reference and fluorescence quenching agent, and Cy3 modified aptamer enabling ratiometric quantitative Cyt c measurement. polydopamine 29-41 cytochrome c, somatic Homo sapiens 369-374 32263532-4 2016 The extracellular matrix (collagen and fibronectin) adsorption was significantly higher on the substrates with the highest amount of PDA coating than on pure PCL. polydopamine 133-136 fibronectin 1 Homo sapiens 39-50 32263532-5 2016 Increased focal adhesion kinase (FAK) levels and enhanced cell attachment were observed upon an increase in PDA content. polydopamine 108-111 protein tyrosine kinase 2 Homo sapiens 10-31 32263532-5 2016 Increased focal adhesion kinase (FAK) levels and enhanced cell attachment were observed upon an increase in PDA content. polydopamine 108-111 protein tyrosine kinase 2 Homo sapiens 33-36 32263532-6 2016 The proliferation, alkaline phosphatase, osteogenesis-related proteins (OPN and BSP), and angiogenesis-related protein (vWF and ang-1) secretion of hMSCs were significantly stimulated when the PDA-coated concentration was increased. polydopamine 193-196 secreted phosphoprotein 1 Homo sapiens 72-75 32263532-6 2016 The proliferation, alkaline phosphatase, osteogenesis-related proteins (OPN and BSP), and angiogenesis-related protein (vWF and ang-1) secretion of hMSCs were significantly stimulated when the PDA-coated concentration was increased. polydopamine 193-196 integrin binding sialoprotein Homo sapiens 80-83 32263532-6 2016 The proliferation, alkaline phosphatase, osteogenesis-related proteins (OPN and BSP), and angiogenesis-related protein (vWF and ang-1) secretion of hMSCs were significantly stimulated when the PDA-coated concentration was increased. polydopamine 193-196 von Willebrand factor Homo sapiens 120-123 32263532-6 2016 The proliferation, alkaline phosphatase, osteogenesis-related proteins (OPN and BSP), and angiogenesis-related protein (vWF and ang-1) secretion of hMSCs were significantly stimulated when the PDA-coated concentration was increased. polydopamine 193-196 angiopoietin 1 Homo sapiens 128-133 27804287-3 2016 In this study, we developed a novel crown-like silica@polydopamine-DNA-CeO2 nanocomposite by assembly of silica@polydopamine-DNA1 nanoparticles decorated with satellite CeO2-DNA2 nanoparticles for detecting and imaging of microRNA-21 (miR-21) and hydrogen peroxide (H2O2) in simulated IR injury in living cells and in vivo. polydopamine 54-66 microRNA 21 Rattus norvegicus 222-233 27804287-3 2016 In this study, we developed a novel crown-like silica@polydopamine-DNA-CeO2 nanocomposite by assembly of silica@polydopamine-DNA1 nanoparticles decorated with satellite CeO2-DNA2 nanoparticles for detecting and imaging of microRNA-21 (miR-21) and hydrogen peroxide (H2O2) in simulated IR injury in living cells and in vivo. polydopamine 54-66 microRNA 21 Rattus norvegicus 235-241 27612725-3 2016 Subsequently, Fn was immobilized onto the fiber mats surface by the coupling reactive polydopamine (PDA) layer and Fn. polydopamine 86-98 fibronectin 1 Homo sapiens 14-16 27612725-3 2016 Subsequently, Fn was immobilized onto the fiber mats surface by the coupling reactive polydopamine (PDA) layer and Fn. polydopamine 100-103 fibronectin 1 Homo sapiens 14-16 27581753-0 2016 Polydopamine-Encapsulated Fe3O4 with an Adsorbed HSP70 Inhibitor for Improved Photothermal Inactivation of Bacteria. polydopamine 0-12 heat shock protein family A (Hsp70) member 4 Homo sapiens 49-54 27479294-9 2016 In addition, during GO modification process the pDA/TMC active layer also become harder and thinner with the aid of EDC/NHS. polydopamine 48-51 NHS actin remodeling regulator Homo sapiens 116-123 27581753-2 2016 In this study, a new type of nanoplatform (PDA@Fe3O4 + PES) was fabricated by using polydopamine (PDA, a photothermal conversion agent) to encapsulate Fe3O4 (a magnetic nanoparticle) and support 2-phenylethynesulfonamide (PES, an inhibitor of heat shock protein 70 (HSP70)). polydopamine 43-46 heat shock protein family A (Hsp70) member 4 Homo sapiens 243-264 27581753-2 2016 In this study, a new type of nanoplatform (PDA@Fe3O4 + PES) was fabricated by using polydopamine (PDA, a photothermal conversion agent) to encapsulate Fe3O4 (a magnetic nanoparticle) and support 2-phenylethynesulfonamide (PES, an inhibitor of heat shock protein 70 (HSP70)). polydopamine 43-46 heat shock protein family A (Hsp70) member 4 Homo sapiens 266-271 27581753-2 2016 In this study, a new type of nanoplatform (PDA@Fe3O4 + PES) was fabricated by using polydopamine (PDA, a photothermal conversion agent) to encapsulate Fe3O4 (a magnetic nanoparticle) and support 2-phenylethynesulfonamide (PES, an inhibitor of heat shock protein 70 (HSP70)). polydopamine 84-96 heat shock protein family A (Hsp70) member 4 Homo sapiens 243-264 27581753-2 2016 In this study, a new type of nanoplatform (PDA@Fe3O4 + PES) was fabricated by using polydopamine (PDA, a photothermal conversion agent) to encapsulate Fe3O4 (a magnetic nanoparticle) and support 2-phenylethynesulfonamide (PES, an inhibitor of heat shock protein 70 (HSP70)). polydopamine 84-96 heat shock protein family A (Hsp70) member 4 Homo sapiens 266-271 27581753-2 2016 In this study, a new type of nanoplatform (PDA@Fe3O4 + PES) was fabricated by using polydopamine (PDA, a photothermal conversion agent) to encapsulate Fe3O4 (a magnetic nanoparticle) and support 2-phenylethynesulfonamide (PES, an inhibitor of heat shock protein 70 (HSP70)). polydopamine 98-101 heat shock protein family A (Hsp70) member 4 Homo sapiens 243-264 27581753-2 2016 In this study, a new type of nanoplatform (PDA@Fe3O4 + PES) was fabricated by using polydopamine (PDA, a photothermal conversion agent) to encapsulate Fe3O4 (a magnetic nanoparticle) and support 2-phenylethynesulfonamide (PES, an inhibitor of heat shock protein 70 (HSP70)). polydopamine 98-101 heat shock protein family A (Hsp70) member 4 Homo sapiens 266-271 27484114-0 2016 Polydopamine Thin Films as Protein Linker Layer for Sensitive Detection of Interleukin-6 by Surface Plasmon Enhanced Fluorescence Spectroscopy. polydopamine 0-12 interleukin 6 Homo sapiens 75-88 32262729-2 2015 In this study, Ang-1 was firstly covalently conjugated onto polydopamine (PDA) coated 316L stainless steel (SS), aiming at developing an Ang-l modified surface for endothelialization. polydopamine 60-72 angiopoietin 1 Homo sapiens 15-20 32263308-2 2016 The microcapsule constructed with polydopamine (PDA) and ZIF-8 using CaCO3 templates could be utilized not only to provide the biocompatible and non-toxic microenvironment to immobilize GOx, but also as an efficient mimetic enzyme because of the peroxidase-like properties of ZIF-8. polydopamine 34-46 hydroxyacid oxidase 1 Homo sapiens 186-189 32263308-2 2016 The microcapsule constructed with polydopamine (PDA) and ZIF-8 using CaCO3 templates could be utilized not only to provide the biocompatible and non-toxic microenvironment to immobilize GOx, but also as an efficient mimetic enzyme because of the peroxidase-like properties of ZIF-8. polydopamine 48-51 hydroxyacid oxidase 1 Homo sapiens 186-189 27018964-0 2016 Decoration of heparin and bovine serum albumin on polysulfone membrane assisted via polydopamine strategy for hemodialysis. polydopamine 84-96 albumin Homo sapiens 33-46 32263282-5 2016 Herein, a competitive-type immunosensor was achieved through the biomimetic catalyst labeled prostate specific antigen competing with the target antigen of different concentrations to react with the specific antibody anchored on the poly(dopamine)-sensitized TiO2 signal crystal. polydopamine 233-247 kallikrein related peptidase 3 Homo sapiens 93-118 33465852-2 2016 BET surface area of obtained polydopamine nanotubes is 51.9 m2/g. polydopamine 29-41 delta/notch like EGF repeat containing Homo sapiens 0-3 27441208-4 2016 In this study, we used Staphylococcus aureus (S. aureus) as a proof-of-principle ESKAPE pathogen to demonstrate that an appropriate antibiotic (daptomycin) can be incorporated into polydopamine-coated gold nanocages (AuNC@PDA) and that daptomycin-loaded AuNC@PDA can be conjugated to antibodies targeting a species-specific surface protein (staphylococcal protein A; Spa) as a means of achieving selective delivery of the nanoconstructs directly to the bacterial cell surface. polydopamine 181-193 surfactant protein A2 Homo sapiens 367-370 26851086-4 2016 In this regard, new magnetic stationary phases based on polydopamine coating and Ti(4+) immobilization exploit the potential of IMAC enrichment and couple it with the versatility of magnetic solid phase extraction. polydopamine 56-68 C-C motif chemokine ligand 26 Homo sapiens 128-132 26568299-3 2016 Within this perspective, the present work reports on the UV-induced synthesis of PMMA and its more flexible poly(ethylene glycol) (PEG)-based derivative (PMMAPEG) and its subsequent surface decoration using polydopamine (PDA) as well as PDA combined with gelatin B (Gel B). polydopamine 207-219 matrix metallopeptidase 9 Homo sapiens 255-264 26568299-3 2016 Within this perspective, the present work reports on the UV-induced synthesis of PMMA and its more flexible poly(ethylene glycol) (PEG)-based derivative (PMMAPEG) and its subsequent surface decoration using polydopamine (PDA) as well as PDA combined with gelatin B (Gel B). polydopamine 207-219 matrix metallopeptidase 9 Homo sapiens 266-271 26568299-3 2016 Within this perspective, the present work reports on the UV-induced synthesis of PMMA and its more flexible poly(ethylene glycol) (PEG)-based derivative (PMMAPEG) and its subsequent surface decoration using polydopamine (PDA) as well as PDA combined with gelatin B (Gel B). polydopamine 221-224 matrix metallopeptidase 9 Homo sapiens 255-264 26568299-3 2016 Within this perspective, the present work reports on the UV-induced synthesis of PMMA and its more flexible poly(ethylene glycol) (PEG)-based derivative (PMMAPEG) and its subsequent surface decoration using polydopamine (PDA) as well as PDA combined with gelatin B (Gel B). polydopamine 221-224 matrix metallopeptidase 9 Homo sapiens 266-271 26717818-1 2016 In this work, we first designed and synthesized an IMAC material with Hf(4+) immobilized on polydopamine-coated magnetic graphene and applied it to phosphopeptides enrichment successfully. polydopamine 92-104 C-C motif chemokine ligand 26 Homo sapiens 51-55 26924362-0 2016 Polydopamine-assisted BMP-2-derived peptides immobilization on biomimetic copolymer scaffold for enhanced bone induction in vitro and in vivo. polydopamine 0-12 bone morphogenetic protein 2 Rattus norvegicus 22-27 26924362-1 2016 In this study, a polydopamine (pDA)-coated PLGA-[Asp-PEG]n scaffold was developed for sustained delivery of bone morphogenetic protein-2 (BMP-2)-derived peptide (designated as P24), and then used to address the hypothesis that P24 peptides delivered from the scaffolds could enhance bone induction in vitro and in vivo. polydopamine 17-29 bone morphogenetic protein 2 Rattus norvegicus 108-136 26924362-1 2016 In this study, a polydopamine (pDA)-coated PLGA-[Asp-PEG]n scaffold was developed for sustained delivery of bone morphogenetic protein-2 (BMP-2)-derived peptide (designated as P24), and then used to address the hypothesis that P24 peptides delivered from the scaffolds could enhance bone induction in vitro and in vivo. polydopamine 17-29 bone morphogenetic protein 2 Rattus norvegicus 138-143 26924362-1 2016 In this study, a polydopamine (pDA)-coated PLGA-[Asp-PEG]n scaffold was developed for sustained delivery of bone morphogenetic protein-2 (BMP-2)-derived peptide (designated as P24), and then used to address the hypothesis that P24 peptides delivered from the scaffolds could enhance bone induction in vitro and in vivo. polydopamine 31-34 bone morphogenetic protein 2 Rattus norvegicus 108-136 26924362-1 2016 In this study, a polydopamine (pDA)-coated PLGA-[Asp-PEG]n scaffold was developed for sustained delivery of bone morphogenetic protein-2 (BMP-2)-derived peptide (designated as P24), and then used to address the hypothesis that P24 peptides delivered from the scaffolds could enhance bone induction in vitro and in vivo. polydopamine 31-34 bone morphogenetic protein 2 Rattus norvegicus 138-143 26925721-3 2016 In this study, by manipulating self-polymerization and strong adhesive characteristics of dopamine, we developed a facile method to enhance the transvaginal repair by modifying PP meshes with polydopamine (PDA), which allowed easy grafting of basic fibroblast growth factor (bFGF) onto the surface of PP. polydopamine 206-209 fibroblast growth factor 2 Homo sapiens 243-273 26925721-3 2016 In this study, by manipulating self-polymerization and strong adhesive characteristics of dopamine, we developed a facile method to enhance the transvaginal repair by modifying PP meshes with polydopamine (PDA), which allowed easy grafting of basic fibroblast growth factor (bFGF) onto the surface of PP. polydopamine 206-209 fibroblast growth factor 2 Homo sapiens 275-279 27121654-1 2016 We describe a facile, general, and highly efficient approach to obtain polydopamine-coated molecularly imprinted polymer based on halloysite nanotubes for bovine serum albumin. polydopamine 71-83 albumin Homo sapiens 162-175 26478309-7 2016 Increased focal adhesion kinase (FAK) and collagen I levels and enhanced cell attachment and cell cycle progression were observed upon an increase in PDA content. polydopamine 150-153 protein tyrosine kinase 2 Homo sapiens 10-31 26478309-7 2016 Increased focal adhesion kinase (FAK) and collagen I levels and enhanced cell attachment and cell cycle progression were observed upon an increase in PDA content. polydopamine 150-153 protein tyrosine kinase 2 Homo sapiens 33-36 32262729-2 2015 In this study, Ang-1 was firstly covalently conjugated onto polydopamine (PDA) coated 316L stainless steel (SS), aiming at developing an Ang-l modified surface for endothelialization. polydopamine 60-72 angiogenin Homo sapiens 15-18 32262729-2 2015 In this study, Ang-1 was firstly covalently conjugated onto polydopamine (PDA) coated 316L stainless steel (SS), aiming at developing an Ang-l modified surface for endothelialization. polydopamine 74-77 angiopoietin 1 Homo sapiens 15-20 32262729-2 2015 In this study, Ang-1 was firstly covalently conjugated onto polydopamine (PDA) coated 316L stainless steel (SS), aiming at developing an Ang-l modified surface for endothelialization. polydopamine 74-77 angiogenin Homo sapiens 15-18 26075880-1 2015 A photoelectrochemical biosensing chip was constructed through the mussel-inspired polydopamine coating strategy, which demonstrated improved photo-to-electric conversion performance for the CdS/TiO2-ITO chip, and was used for the direct immobilization of captured antibodies and the detection of CD146 in the absence of additional electron donors/acceptors. polydopamine 83-95 CDP-diacylglycerol synthase 1 Homo sapiens 191-194 26078185-3 2015 In this work, we initially immobilized titanium ions on polydopamine (PDA)-modified ZipTip pipette tips (denoted as IMAC ZipTip pipette tip) for simple and quick enrichment of phosphopeptides. polydopamine 56-68 C-C motif chemokine ligand 26 Homo sapiens 116-120 26078185-3 2015 In this work, we initially immobilized titanium ions on polydopamine (PDA)-modified ZipTip pipette tips (denoted as IMAC ZipTip pipette tip) for simple and quick enrichment of phosphopeptides. polydopamine 70-73 C-C motif chemokine ligand 26 Homo sapiens 116-120 26449443-3 2015 In this study, protein-repulsive polydopamine-poly(ethylene oxide) (PDA-PEO) surfaces were functionalized with an RGD-containing peptide (RGD), with a collagen-derived peptide binding fibronectin (Col), or by a combination of these peptides (RGD + Col, ratio 1:1) in concentrations of 90 fmol/cm(2) and 700 fmol/cm(2) for each peptide type. polydopamine 33-45 fibronectin 1 Bos taurus 184-195 26452937-0 2015 Novel polydopamine imprinting layers coated magnetic carbon nanotubes for specific separation of lysozyme from egg white. polydopamine 6-18 lysozyme Homo sapiens 97-105 26452937-1 2015 Novel core-shell nanocomposites, consisting of magnetic carbon nanotubes (MCNTs) core surrounded by a thin polydopamine (PDA) imprinting shell for specific recognition of lysozyme (Lyz), were fabricated for the first time. polydopamine 121-124 lysozyme Homo sapiens 171-179 26452937-1 2015 Novel core-shell nanocomposites, consisting of magnetic carbon nanotubes (MCNTs) core surrounded by a thin polydopamine (PDA) imprinting shell for specific recognition of lysozyme (Lyz), were fabricated for the first time. polydopamine 121-124 lysozyme Homo sapiens 181-184 26075880-1 2015 A photoelectrochemical biosensing chip was constructed through the mussel-inspired polydopamine coating strategy, which demonstrated improved photo-to-electric conversion performance for the CdS/TiO2-ITO chip, and was used for the direct immobilization of captured antibodies and the detection of CD146 in the absence of additional electron donors/acceptors. polydopamine 83-95 melanoma cell adhesion molecule Homo sapiens 297-302 32262660-0 2015 Surface modification of poly(dimethylsiloxane) with a covalent antithrombin-heparin complex for the prevention of thrombosis: use of polydopamine as bonding agent. polydopamine 133-145 serpin family C member 1 Homo sapiens 63-75 32262660-2 2015 To prevent thrombosis triggered by blood-material contact, an antithrombin-heparin (ATH) covalent complex was coated on PDMS surface using polydopamine (PDA) as a "bioglue". polydopamine 139-151 serpin family C member 1 Homo sapiens 62-74 32262660-2 2015 To prevent thrombosis triggered by blood-material contact, an antithrombin-heparin (ATH) covalent complex was coated on PDMS surface using polydopamine (PDA) as a "bioglue". polydopamine 153-156 serpin family C member 1 Homo sapiens 62-74 25950171-0 2015 Biodegradable Microcarriers of Poly(Lactide-co-Glycolide) and Nano-Hydroxyapatite Decorated with IGF-1 via Polydopamine Coating for Enhancing Cell Proliferation and Osteogenic Differentiation. polydopamine 107-119 insulin-like growth factor 1 Mus musculus 97-102 25950171-1 2015 In this study, insulin-like growth factor 1 (IGF-1) was successfully immobilized on the poly(lactide-co-glycolide)/hydroxyapatite (PLGA/HA) and pure PLGA microcarriers via polydopamine (pDA). polydopamine 172-184 insulin-like growth factor 1 Mus musculus 15-43 25950171-1 2015 In this study, insulin-like growth factor 1 (IGF-1) was successfully immobilized on the poly(lactide-co-glycolide)/hydroxyapatite (PLGA/HA) and pure PLGA microcarriers via polydopamine (pDA). polydopamine 172-184 insulin-like growth factor 1 Mus musculus 45-50 25950171-1 2015 In this study, insulin-like growth factor 1 (IGF-1) was successfully immobilized on the poly(lactide-co-glycolide)/hydroxyapatite (PLGA/HA) and pure PLGA microcarriers via polydopamine (pDA). polydopamine 186-189 insulin-like growth factor 1 Mus musculus 15-43 25950171-1 2015 In this study, insulin-like growth factor 1 (IGF-1) was successfully immobilized on the poly(lactide-co-glycolide)/hydroxyapatite (PLGA/HA) and pure PLGA microcarriers via polydopamine (pDA). polydopamine 186-189 insulin-like growth factor 1 Mus musculus 45-50 26098135-2 2015 Inspired by mussels, biomimetic calcium phosphate apatite/polydopamine hybridized-polyethylene terephthalate (APA/PDA-PET) grafts were successfully prepared. polydopamine 58-70 glutamyl aminopeptidase Homo sapiens 110-121 26098135-7 2015 These results suggest that this mussel-inspired biomimetic method is an effective strategy for modifying artificial grafts, and the prepared APA/PDA-PET grafts, which possess a beneficial interface, can significantly improve in vivo osseointegration for ligament reconstruction via the synergistic effect of polydopamine and apatite. polydopamine 308-320 glutamyl aminopeptidase Homo sapiens 141-152 26147830-3 2015 In this study, MUC1 antibodies and albumin were immobilized onto the surface of gold nanorods using a "primer" of polydopamine (PD), a molecular mimic of catechol- and amine-rich mussel adhesive proteins. polydopamine 114-126 mucin 1, cell surface associated Homo sapiens 15-19 32261873-0 2014 Polydopamine-mediated long-term elution of the direct thrombin inhibitor bivalirudin from TiO2 nanotubes for improved vascular biocompatibility. polydopamine 0-12 coagulation factor II, thrombin Homo sapiens 54-62 25774882-2 2015 Using thiol-terminated short chain ethylene oxide oligomers (OEG) under aqueous conditions, we explore the creation of a model surface exhibiting resistance to nonspecific protein absorption (RPA) by engineering the surface properties of a PDA adlayer. polydopamine 240-243 replication protein A1 Homo sapiens 192-195 26373068-1 2015 Ag-coated polyacrylonitrile (PAN) nanofibers have been prepared by a novel, facile and green way that combined electrospinning technique and poly(dopamine)-assisted electroless plating method. polydopamine 141-154 adenosine deaminase 2 Homo sapiens 29-32 26373068-2 2015 Poly(dopamine) (PDOP) was formed by oxidation polymerization of dopamine on the surface of PAN nanofibers to promote the electroless plating of silver. polydopamine 0-14 adenosine deaminase 2 Homo sapiens 91-94 26373068-2 2015 Poly(dopamine) (PDOP) was formed by oxidation polymerization of dopamine on the surface of PAN nanofibers to promote the electroless plating of silver. polydopamine 16-20 adenosine deaminase 2 Homo sapiens 91-94 25736503-4 2015 Polydopamine (pDA)-mediated immobilization of vitronectin (VN) peptides results in surface functionalization of VN-dimer/pDA conjugates. polydopamine 0-12 vitronectin Homo sapiens 46-57 25736503-4 2015 Polydopamine (pDA)-mediated immobilization of vitronectin (VN) peptides results in surface functionalization of VN-dimer/pDA conjugates. polydopamine 0-12 vitronectin Homo sapiens 59-61 25736503-4 2015 Polydopamine (pDA)-mediated immobilization of vitronectin (VN) peptides results in surface functionalization of VN-dimer/pDA conjugates. polydopamine 0-12 vitronectin Homo sapiens 112-114 25736503-4 2015 Polydopamine (pDA)-mediated immobilization of vitronectin (VN) peptides results in surface functionalization of VN-dimer/pDA conjugates. polydopamine 14-17 vitronectin Homo sapiens 46-57 25736503-4 2015 Polydopamine (pDA)-mediated immobilization of vitronectin (VN) peptides results in surface functionalization of VN-dimer/pDA conjugates. polydopamine 14-17 vitronectin Homo sapiens 59-61 25736503-4 2015 Polydopamine (pDA)-mediated immobilization of vitronectin (VN) peptides results in surface functionalization of VN-dimer/pDA conjugates. polydopamine 14-17 vitronectin Homo sapiens 112-114 24673251-1 2014 In this work, a facile route was initially developed for preparation of a novel metal oxide affinity chromatography (MOAC) material by grafting titania nanoparticles on polydopamine (PD)-coated graphene (denoted as G@PD@TiO2). polydopamine 169-181 atypical chemokine receptor 1 (Duffy blood group) Mus musculus 215-219 24935183-0 2014 Activity of alkaline phosphatase adsorbed and grafted on "polydopamine" films. polydopamine 58-70 alkaline phosphatase, placental Homo sapiens 12-32 24935183-3 2014 Herein we show that alkaline phosphatase (ALP), as a model enzyme, adsorbs to "polydopamine" films and part of the adsorbed enzyme is rapidly desorbed in contact with Tris buffer. polydopamine 79-91 alkaline phosphatase, placental Homo sapiens 20-40 24935183-3 2014 Herein we show that alkaline phosphatase (ALP), as a model enzyme, adsorbs to "polydopamine" films and part of the adsorbed enzyme is rapidly desorbed in contact with Tris buffer. polydopamine 79-91 alkaline phosphatase, placental Homo sapiens 42-45 24911396-1 2014 Poly(dopamine)-treated graphene oxide/poly(vinyl alcohol) ("dG-O/PVA") composite films were made and characterized. polydopamine 0-14 diego Drosophila melanogaster 60-64 24911396-2 2014 G-O was modified with poly(dopamine) in aqueous solution and then chemically reduced to yield poly(dopamine)-treated reduced G-O. polydopamine 22-35 diego Drosophila melanogaster 0-3 24942379-0 2014 Effective immobilization of BMP-2 mediated by polydopamine coating on biodegradable nanofibers for enhanced in vivo bone formation. polydopamine 46-58 bone morphogenetic protein 2 Homo sapiens 28-33 24942379-2 2014 In this study, we developed bone morphogenetic protein-2(BMP-2) immobilized poly(l-lactide) (PLLA) nanofibers inspired by polydopamine, which could be ultimately used as membranes for guided bone regeneration, and investigated their effect on guidance of in vitro cell behavior and in vivo bone formation. polydopamine 122-134 bone morphogenetic protein 2 Homo sapiens 28-56 24942379-2 2014 In this study, we developed bone morphogenetic protein-2(BMP-2) immobilized poly(l-lactide) (PLLA) nanofibers inspired by polydopamine, which could be ultimately used as membranes for guided bone regeneration, and investigated their effect on guidance of in vitro cell behavior and in vivo bone formation. polydopamine 122-134 bone morphogenetic protein 2 Homo sapiens 57-62 24942379-3 2014 Surface chemical analysis of the nanofibers confirmed successful immobilization of BMP-2 mediated by polydopamine, and about 90% of BMP-2 was stably retained on the nanofiber surface for at least 28 days. polydopamine 101-113 bone morphogenetic protein 2 Homo sapiens 83-88 24942379-5 2014 More importantly, BMP-2 at a relatively small dose was highly active following implantation to the critical-sized defect in the cranium of mice; radiographic analysis demonstrated that 77.8 +- 11.7% of newly formed bone was filled within the defect for a BMP-2-immobilized groups at the concentration of 124 +- 9 ng/cm(2), as compared to 5.9 +- 1.0 and 34.1 +- 5.5% recovery, for a defect-only and a polydopamine-only group, respectively. polydopamine 400-412 bone morphogenetic protein 2 Mus musculus 18-23 24942379-7 2014 Taken together, our data support that the presentation of BMP-2 on the surface of nanofibers as immobilized by utilizing polydopamine chemistry may be an effective method to direct bone growth at relatively low local concentration. polydopamine 121-133 bone morphogenetic protein 2 Homo sapiens 58-63 24673251-1 2014 In this work, a facile route was initially developed for preparation of a novel metal oxide affinity chromatography (MOAC) material by grafting titania nanoparticles on polydopamine (PD)-coated graphene (denoted as G@PD@TiO2). polydopamine 183-185 atypical chemokine receptor 1 (Duffy blood group) Mus musculus 215-219 24292139-1 2014 An ultrasensitive non-enzymatic electrochemical carcinoembryonic antigen (CEA) immunosensor was fabricated by the immobilization of a monoclonal CEA antibody (anti-CEA) on a protein A (PA) attached-gold nanoparticles (AuNPs)-deposited electrochemically prepared polydopamine film (e-PD/AuNPs). polydopamine 262-274 CEA cell adhesion molecule 3 Homo sapiens 48-72 32263800-0 2014 bFGF-grafted electrospun fibrous scaffolds via poly(dopamine) for skin wound healing. polydopamine 47-60 fibroblast growth factor 2 Homo sapiens 0-4 32263800-4 2014 Polydopamine (PDA) forming the mussel foot protein was chosen as an adhesive polymeric bridge-layer between substrate poly(lactide-co-glycolide) (PLGA) fibers and bFGF. polydopamine 0-12 fibroblast growth factor 2 Homo sapiens 163-167 32263800-4 2014 Polydopamine (PDA) forming the mussel foot protein was chosen as an adhesive polymeric bridge-layer between substrate poly(lactide-co-glycolide) (PLGA) fibers and bFGF. polydopamine 14-17 fibroblast growth factor 2 Homo sapiens 163-167 24292139-1 2014 An ultrasensitive non-enzymatic electrochemical carcinoembryonic antigen (CEA) immunosensor was fabricated by the immobilization of a monoclonal CEA antibody (anti-CEA) on a protein A (PA) attached-gold nanoparticles (AuNPs)-deposited electrochemically prepared polydopamine film (e-PD/AuNPs). polydopamine 262-274 CEA cell adhesion molecule 3 Homo sapiens 74-77 24370115-1 2014 An Interleukin-6 (IL-6) electrochemical immunosensor was fabricated based on the Au nanoparticles (AuNP)-graphene-silica sol-gel as immobilization biointerface and AuNP-polydopamine (PDA)@carbon nanotubes (CNT) as the label of HRP-bound antibodies. polydopamine 169-181 interleukin 6 Homo sapiens 3-16 24370115-1 2014 An Interleukin-6 (IL-6) electrochemical immunosensor was fabricated based on the Au nanoparticles (AuNP)-graphene-silica sol-gel as immobilization biointerface and AuNP-polydopamine (PDA)@carbon nanotubes (CNT) as the label of HRP-bound antibodies. polydopamine 169-181 interleukin 6 Homo sapiens 18-22 32481962-5 2013 The aim of this study is to systematically investigate the effect of a polydopamine modification on the physicochemical and biological properties of AKT bioceramics, including attachment, proliferation, ALP activity and bone-related gene expression of tissue cells. polydopamine 71-83 thymoma viral proto-oncogene 1 Mus musculus 149-152 23640792-0 2014 In vitro response to alkaline phosphatase coatings immobilized onto titanium implants using electrospray deposition or polydopamine-assisted deposition. polydopamine 119-131 alkaline phosphatase, placental Homo sapiens 21-41 23640792-2 2014 Recently, it was shown that the enzyme alkaline phosphatase (ALP) could be efficiently immobilized onto titanium implants in a single step using polydopamine. polydopamine 145-157 alkaline phosphatase, placental Homo sapiens 39-59 23640792-2 2014 Recently, it was shown that the enzyme alkaline phosphatase (ALP) could be efficiently immobilized onto titanium implants in a single step using polydopamine. polydopamine 145-157 alkaline phosphatase, placental Homo sapiens 61-64 23640792-3 2014 We hypothesized that such polydopamine-ALP coatings can enhance the early attachment of cells and increase mineralization. polydopamine 26-38 alkaline phosphatase, placental Homo sapiens 39-42 23640792-4 2014 Therefore, the current study aimed at immobilization of ALP onto titanium by means of either one- or two-step polydopamine-assisted immobilization or electrospray deposition, the comparative characterization of these experimental substrates and subsequent cell behavioral analysis using primary osteoblast-like cells. polydopamine 110-122 alkaline phosphatase, placental Homo sapiens 56-59 24157695-5 2014 Furthermore, the formed self-assembled Ca-P/polydopamine composite nanolayer significantly enhances the surface roughness and hydrophilicity of beta-TCP ceramics, and stimulates the attachment, proliferation, alkaline phosphate (ALP) activity and bone-related gene expression (ALP, OCN, COL1 and Runx2) of human bone marrow stromal cells. polydopamine 44-56 bone gamma-carboxyglutamate protein Homo sapiens 282-285 24157695-5 2014 Furthermore, the formed self-assembled Ca-P/polydopamine composite nanolayer significantly enhances the surface roughness and hydrophilicity of beta-TCP ceramics, and stimulates the attachment, proliferation, alkaline phosphate (ALP) activity and bone-related gene expression (ALP, OCN, COL1 and Runx2) of human bone marrow stromal cells. polydopamine 44-56 RUNX family transcription factor 2 Homo sapiens 296-301 32481962-5 2013 The aim of this study is to systematically investigate the effect of a polydopamine modification on the physicochemical and biological properties of AKT bioceramics, including attachment, proliferation, ALP activity and bone-related gene expression of tissue cells. polydopamine 71-83 alopecia, recessive Mus musculus 203-206 32481962-6 2013 The results show that a self-assembled polydopamine layer on the surface of AKT bioceramics was formed by incubating AKT bioceramics in a dopamine/Tris-HCl solution. polydopamine 39-51 thymoma viral proto-oncogene 1 Mus musculus 76-79 32481962-6 2013 The results show that a self-assembled polydopamine layer on the surface of AKT bioceramics was formed by incubating AKT bioceramics in a dopamine/Tris-HCl solution. polydopamine 39-51 thymoma viral proto-oncogene 1 Mus musculus 117-120 32481962-7 2013 Polydopamine-modified AKT (PDB-AKT) bioceramics showed significantly improved surface roughness, hydrophilicity and apatite-mineralization ability compared to AKT bioceramics. polydopamine 0-12 thymoma viral proto-oncogene 1 Mus musculus 22-25 32481962-7 2013 Polydopamine-modified AKT (PDB-AKT) bioceramics showed significantly improved surface roughness, hydrophilicity and apatite-mineralization ability compared to AKT bioceramics. polydopamine 0-12 thymoma viral proto-oncogene 1 Mus musculus 31-34 32481962-7 2013 Polydopamine-modified AKT (PDB-AKT) bioceramics showed significantly improved surface roughness, hydrophilicity and apatite-mineralization ability compared to AKT bioceramics. polydopamine 0-12 thymoma viral proto-oncogene 1 Mus musculus 31-34 32481962-8 2013 In addition, the polydopamine modification distinctively enhanced the attachment, proliferation, alkaline phosphate activity and bone-related gene expression of MC3T3 cells on AKT bioceramics. polydopamine 17-29 thymoma viral proto-oncogene 1 Mus musculus 176-179 23941596-6 2013 Our study demonstrates that predeposition of a pDA layer facilitates highly efficient, simple immobilization of peptides derived from osteogenic growth factor (bone morphogenetic protein-2; BMP-2) on poly(lactic-co-glycolic acid) (PLGA) scaffolds via catechol chemistry. polydopamine 47-50 bone morphogenetic protein 2 Homo sapiens 160-188 23692917-1 2013 Bio-inspired Human Serum Albumin (HSA) imprinted polydopamine nano-layer was produced through oxidative polymerization of dopamine on the pore surface of HSA modified porous silica particles. polydopamine 49-61 albumin Homo sapiens 19-32 23848958-0 2013 Poly(dopamine)-assisted immobilization of Arg-Gly-Asp peptides, hydroxyapatite, and bone morphogenic protein-2 on titanium to improve the osteogenesis of bone marrow stem cells. polydopamine 0-14 bone morphogenetic protein 2 Homo sapiens 84-110 23231507-3 2013 In the current study, a 1-step polydopamine-based approach was applied for alkaline phosphatase (ALP) and bone morphogenetic protein-2 (BMP-2) immobilization, and compared to the conventional 2-step polydopamine-based immobilization and plain adsorption. polydopamine 31-43 bone morphogenetic protein 2 Rattus norvegicus 106-134 23231507-3 2013 In the current study, a 1-step polydopamine-based approach was applied for alkaline phosphatase (ALP) and bone morphogenetic protein-2 (BMP-2) immobilization, and compared to the conventional 2-step polydopamine-based immobilization and plain adsorption. polydopamine 31-43 bone morphogenetic protein 2 Rattus norvegicus 136-141 23231507-11 2013 The biological behavior of ALP and BMP-2 coatings immobilized using polydopamine (1- and 2-step) as well as adsorption was assessed by culturing rat bone marrow cells, which revealed that the cell responses to the various experimental groups were not statistically different. polydopamine 68-80 bone morphogenetic protein 2 Rattus norvegicus 35-40 23941596-6 2013 Our study demonstrates that predeposition of a pDA layer facilitates highly efficient, simple immobilization of peptides derived from osteogenic growth factor (bone morphogenetic protein-2; BMP-2) on poly(lactic-co-glycolic acid) (PLGA) scaffolds via catechol chemistry. polydopamine 47-50 bone morphogenetic protein 2 Homo sapiens 190-195 23208101-1 2013 In this study, a novel biomolecule immobilization approach has been proposed to the synthesis of multi-functional core-shell glucose oxidase-Au-polydopamine-Fe3O4 magnetic bionanoparticles (GOx-Au-PDA-Fe3O4 MBNPs) using the one-pot chemical polymerization method. polydopamine 144-156 hydroxyacid oxidase 1 Homo sapiens 190-193 23471770-0 2013 Direct adhesion of endothelial cells to bioinspired poly(dopamine) coating through endogenous fibronectin and integrin alpha5 beta1. polydopamine 52-66 fibronectin 1 Homo sapiens 94-105 23269073-3 2013 First, polydopamine-based PBNCs with glucose oxidase (GOx) entrapped at high load/activity and Au nanoparticles (AuNPs) dispersed in high abundance on the surface were prepared through a chemical/biochemical synthesis method, as proven by UV-vis spectrophotometry, digital imaging, and transmission electron microscopy. polydopamine 7-19 hydroxyacid oxidase 1 Homo sapiens 37-52 23055400-8 2013 Utilizing the reactivity of polydopamine films to immobilize BMP-7 peptide onto metal substrates may provide a promising approach for applications in situations where reduction of inflammation around implants would be beneficial in improving surgical outcome, bone healing, and implant integration. polydopamine 28-40 bone morphogenetic protein 7 Mus musculus 61-66 23261471-5 2013 The polydopamine modification enhanced the cell adhesion and viability, and also promoted the neuronal differentiation of NGF-stimulated PC12 cells, as evidenced by the elongation of neurites and expression of neuronal differentiation markers, by increasing the activation of NGF/Trk-Rho GTPase signal pathway. polydopamine 4-16 neurotrophic receptor tyrosine kinase 1 Rattus norvegicus 280-283 22275174-6 2012 Polydopamine coatings were also utilized to effectively immobilize extracellular matrix proteins (i.e., fibronectin) on the surface of polydopamine-coated, electrospun fibers, resulting in enhancement of NIH3T3 cell attachment, spreading, and cytoskeletal development. polydopamine 0-12 fibronectin 1 Mus musculus 104-115 22983398-0 2012 Highly electrically conductive layered carbon derived from polydopamine and its functions in SnO2-based lithium ion battery anodes. polydopamine 59-71 strawberry notch homolog 1 Homo sapiens 93-96 22566466-0 2012 Immobilization of the direct thrombin inhibitor-bivalirudin on 316L stainless steel via polydopamine and the resulting effects on hemocompatibility in vitro. polydopamine 88-100 coagulation factor II, thrombin Homo sapiens 29-37 22617001-3 2012 Polydopamine was deposited on the surface of biocompatible poly(L-lactide-co-epsilon-caprolactone) (PLCL) elastomer, on which vascular endothelial growth factor (VEGF) was subsequently immobilized by simple dipping. polydopamine 0-12 phospholipase C like 1 (inactive) Homo sapiens 100-104 22617001-3 2012 Polydopamine was deposited on the surface of biocompatible poly(L-lactide-co-epsilon-caprolactone) (PLCL) elastomer, on which vascular endothelial growth factor (VEGF) was subsequently immobilized by simple dipping. polydopamine 0-12 vascular endothelial growth factor A Homo sapiens 126-160 22617001-3 2012 Polydopamine was deposited on the surface of biocompatible poly(L-lactide-co-epsilon-caprolactone) (PLCL) elastomer, on which vascular endothelial growth factor (VEGF) was subsequently immobilized by simple dipping. polydopamine 0-12 vascular endothelial growth factor A Homo sapiens 162-166 22617001-5 2012 Immobilization of VEGF on the polydopamine-deposited PLCL films was effective (19.8 +- 0.4 and 197.4 +- 19.7 ng/cm(2) for DPv20 and DPv200 films, respectively), and biotin-mediated labeling of immobilized VEGF revealed that the fluorescence intensity increased as a function of the concentration of VEGF solution. polydopamine 30-42 vascular endothelial growth factor A Homo sapiens 18-22 22617001-5 2012 Immobilization of VEGF on the polydopamine-deposited PLCL films was effective (19.8 +- 0.4 and 197.4 +- 19.7 ng/cm(2) for DPv20 and DPv200 films, respectively), and biotin-mediated labeling of immobilized VEGF revealed that the fluorescence intensity increased as a function of the concentration of VEGF solution. polydopamine 30-42 phospholipase C like 1 (inactive) Homo sapiens 53-57 22617001-5 2012 Immobilization of VEGF on the polydopamine-deposited PLCL films was effective (19.8 +- 0.4 and 197.4 +- 19.7 ng/cm(2) for DPv20 and DPv200 films, respectively), and biotin-mediated labeling of immobilized VEGF revealed that the fluorescence intensity increased as a function of the concentration of VEGF solution. polydopamine 30-42 vascular endothelial growth factor A Homo sapiens 205-209 22617001-5 2012 Immobilization of VEGF on the polydopamine-deposited PLCL films was effective (19.8 +- 0.4 and 197.4 +- 19.7 ng/cm(2) for DPv20 and DPv200 films, respectively), and biotin-mediated labeling of immobilized VEGF revealed that the fluorescence intensity increased as a function of the concentration of VEGF solution. polydopamine 30-42 vascular endothelial growth factor A Homo sapiens 205-209 22275174-6 2012 Polydopamine coatings were also utilized to effectively immobilize extracellular matrix proteins (i.e., fibronectin) on the surface of polydopamine-coated, electrospun fibers, resulting in enhancement of NIH3T3 cell attachment, spreading, and cytoskeletal development. polydopamine 135-147 fibronectin 1 Mus musculus 104-115 21605961-2 2011 In this study, we present a bio-inspired coating of synthetic biodegradable poly(L-lactide-co-e-caprolactone) (PLCL) films by using polydopamine for tunable cell behaviors such as adhesion and proliferation. polydopamine 132-144 phospholipase C like 1 (inactive) Homo sapiens 111-115 21605961-3 2011 Polydopamine coating decreased the water contact angles of the PLCL film from 75 to 40 , while the amount of coated polydopamine increased from 0.6 mug/cm(2) to 177.9 mug/cm(2). polydopamine 0-12 phospholipase C like 1 (inactive) Homo sapiens 63-67 21497492-0 2011 Immobilization of bovine serum albumin onto porous polyethylene membranes using strongly attached polydopamine as a spacer. polydopamine 98-110 albumin Homo sapiens 25-38 21497492-3 2011 Subsequently, bovine serum albumin (BSA) was bound onto the obtained PE/pDA composite membranes via the coupling between BSA and the reactive polydopamine layer. polydopamine 72-75 albumin Homo sapiens 21-34 21497492-3 2011 Subsequently, bovine serum albumin (BSA) was bound onto the obtained PE/pDA composite membranes via the coupling between BSA and the reactive polydopamine layer. polydopamine 142-154 albumin Homo sapiens 21-34 21381690-2 2011 Polydopamine was employed as the intermediate layer for the conjugation of BMP2. polydopamine 0-12 bone morphogenetic protein 2 Homo sapiens 75-79 19963265-9 2010 Therefore utilizing the reactivity of polydopamine films to immobilize VEGF onto metal substrates may provide a promising approach for application in situations where revascularization around implants would be beneficial in improving bone healing and implant integration. polydopamine 38-50 vascular endothelial growth factor A Homo sapiens 71-75 33973580-6 2021 In this study, stem cell membrane (SCM) camouflaged polydopamine nanoparticles carrying DOX and PD-L1 siRNA (PDA-DOX/siPD-L1@SCM) were constructed for targeting prostate cancer (PCa) bone metastases. polydopamine 52-64 CD274 molecule Homo sapiens 96-101 34838324-3 2022 For strategy I, TYR sensing was carried out from 1.00 to 7.80 U/mL with the detection limit (LOD) of 0.20 U/mL based on the fluorescence resonance energy transfer (FRET) between the fluorescein isothiocyanate (FITC) and the in situ generated polydopamine dots (PDA-dots). polydopamine 242-254 tyrosinase Bos taurus 16-19 34719875-1 2022 A cancer-mitochondria dual-targeting nanoparticle based on lactose and ferrocenium derivatives conjugated polydopamine (PDA@Lac/Fc/Hyp) was constructed, which exhibited cancer-targeting and mitochondria-targeting ability deriving from lactose and ferrocenium derivatives due to the specific carbohydrate-protein interaction and cationic species properties, respectively. polydopamine 106-118 phosphate regulating endopeptidase homolog X-linked Homo sapiens 131-134 34738221-2 2022 Electropolymerization in the presence of a template (MLT) was utilized as a convenient and effective strategy to generate imprinted p-Dop films on peptide nanotubes (PNTs) modified graphite electrodes (PGEs). polydopamine 132-137 prostaglandin E synthase Homo sapiens 202-206 34653692-0 2022 A combination of hybrid polydopamine-human keratinocyte growth factor nanoparticles and sodium hyaluronate for the efficient prevention of postoperative abdominal adhesion formation. polydopamine 24-36 fibroblast growth factor 7 Homo sapiens 43-69 34653692-3 2022 In this study, we fabricated hybrid polydopamine (PDA)-KGF nanoparticles (PDA-KGF NPs) by using an in situ self-assembly and polymerization method. polydopamine 36-48 fibroblast growth factor 7 Homo sapiens 55-58 34653692-3 2022 In this study, we fabricated hybrid polydopamine (PDA)-KGF nanoparticles (PDA-KGF NPs) by using an in situ self-assembly and polymerization method. polydopamine 50-53 fibroblast growth factor 7 Homo sapiens 55-58 34653692-16 2022 In this article, we fabricated hybrid polydopamine (PDA)-KGF nanoparticles (PDA-KGF NPs), which extend KGF bioactivity, effectively prevent PAA. polydopamine 38-50 fibroblast growth factor 7 Homo sapiens 57-60 34653692-16 2022 In this article, we fabricated hybrid polydopamine (PDA)-KGF nanoparticles (PDA-KGF NPs), which extend KGF bioactivity, effectively prevent PAA. polydopamine 38-50 fibroblast growth factor 7 Homo sapiens 103-106 34653692-16 2022 In this article, we fabricated hybrid polydopamine (PDA)-KGF nanoparticles (PDA-KGF NPs), which extend KGF bioactivity, effectively prevent PAA. polydopamine 52-55 fibroblast growth factor 7 Homo sapiens 57-60 34653692-16 2022 In this article, we fabricated hybrid polydopamine (PDA)-KGF nanoparticles (PDA-KGF NPs), which extend KGF bioactivity, effectively prevent PAA. polydopamine 52-55 fibroblast growth factor 7 Homo sapiens 103-106 34718179-3 2022 Herein, to overcome tumor-associated hypoxia, and further achieve tumor-targeted synergistic chemotherapy/PDT/photothermal therapy (PTT), we have constructed a biodegradable oxygen-producing nanoplatform (named Ini@PM-HP), which was composed of the porous metal-organic framework (PCN-224(Mn)), the poly (ADP-ribose) polymerase (PARP) inhibitor (Iniparib), and the polydopamine-modified hyaluronic acid (HA-PDA). polydopamine 365-377 PHD finger protein 5A Homo sapiens 211-214 34635265-3 2022 Herein, an electrochemical molecularly imprinted polymer (MIP) sensor based on polydopamine-reduced graphene oxide/polyacrylamide composite (PDA-rGO/PAM) was constructed successfully to detect domoic acid. polydopamine 79-91 peptidylglycine alpha-amidating monooxygenase Homo sapiens 149-152 34507161-3 2021 Herein, we proposed an electrochemical aptasensor for CEA detection based on the amplification driven by polydopamine functional graphene and Pd-Pt nanodendrites (PDA@Gr/Pd-PtNDs), conjugated hemin/G-quadruplex (hemin/G4), which possess mimicking peroxidases activity. polydopamine 105-117 CEA cell adhesion molecule 3 Homo sapiens 54-57 34910838-4 2022 This nanoreactor, consisting of a catalase-mimicking shell (Pt nanocatalyst) and a photothermal core (polydopamine), was rationally designed for achieving the near-infrared radiation (NIR)-guided/accelerated oxygen supplementation on tumor site, and for relieving the A2AR-mediated immunosuppression without toxicity concern. polydopamine 102-114 adenosine A2a receptor Homo sapiens 268-272 34846416-0 2021 Polydopamine nanospheres coated with bovine serum albumin permit enhanced cell differentiation: fundamental mechanism and practical application for protein coating formation. polydopamine 0-12 albumin Homo sapiens 44-57 34846416-4 2021 Polydopamine nanospheres (PDANS) coated with bovine serum albumin (BSA) are examined in this study due to their wide biomedical potential. polydopamine 0-12 albumin Homo sapiens 52-65 34782897-4 2021 The MPPF nanoprobes were constructed by the covalent functionalization of polydopamine (PDA) coated MoS2 nanosheets (NSs) with Cy7-labeled furin substrate peptides. polydopamine 74-86 mago homolog, exon junction complex core component Mus musculus 100-104 34782897-4 2021 The MPPF nanoprobes were constructed by the covalent functionalization of polydopamine (PDA) coated MoS2 nanosheets (NSs) with Cy7-labeled furin substrate peptides. polydopamine 74-86 furin (paired basic amino acid cleaving enzyme) Mus musculus 139-144 34782897-4 2021 The MPPF nanoprobes were constructed by the covalent functionalization of polydopamine (PDA) coated MoS2 nanosheets (NSs) with Cy7-labeled furin substrate peptides. polydopamine 88-91 mago homolog, exon junction complex core component Mus musculus 100-104 34782897-4 2021 The MPPF nanoprobes were constructed by the covalent functionalization of polydopamine (PDA) coated MoS2 nanosheets (NSs) with Cy7-labeled furin substrate peptides. polydopamine 88-91 furin (paired basic amino acid cleaving enzyme) Mus musculus 139-144 34786942-3 2021 MPFPT NSs were prepared by covalent modification of poly(ethylene glycol) (PEG) and triphenylphosphonium (TPP) on polydopamine (PDA)-Fe3+coated MoS2 NSs. polydopamine 114-126 mago homolog, exon junction complex core component Mus musculus 144-148 34786942-3 2021 MPFPT NSs were prepared by covalent modification of poly(ethylene glycol) (PEG) and triphenylphosphonium (TPP) on polydopamine (PDA)-Fe3+coated MoS2 NSs. polydopamine 128-131 mago homolog, exon junction complex core component Mus musculus 144-148 34726401-0 2021 Transmembrane MUC18 Targeted Polydopamine Nanoparticles and a Mild Photothermal Effect Synergistically Disrupt Actin Cytoskeleton and Migration of Cancer Cells. polydopamine 29-41 melanoma cell adhesion molecule Homo sapiens 14-19 34600360-4 2021 The ability of MIP layer to bind to EGFR epitope endowed the MD (DOX@MIP) particles to recognize EGFR-overexpressing cancer cells, while the pH-responsiveness and photothermal conversion ability of PDA (polydopamine) achieved chemo-photothermal synergistic effects upon NIR irradiation. polydopamine 198-201 epidermal growth factor receptor Homo sapiens 36-40 34600360-4 2021 The ability of MIP layer to bind to EGFR epitope endowed the MD (DOX@MIP) particles to recognize EGFR-overexpressing cancer cells, while the pH-responsiveness and photothermal conversion ability of PDA (polydopamine) achieved chemo-photothermal synergistic effects upon NIR irradiation. polydopamine 198-201 epidermal growth factor receptor Homo sapiens 97-101 34600360-4 2021 The ability of MIP layer to bind to EGFR epitope endowed the MD (DOX@MIP) particles to recognize EGFR-overexpressing cancer cells, while the pH-responsiveness and photothermal conversion ability of PDA (polydopamine) achieved chemo-photothermal synergistic effects upon NIR irradiation. polydopamine 203-215 epidermal growth factor receptor Homo sapiens 36-40 34600360-4 2021 The ability of MIP layer to bind to EGFR epitope endowed the MD (DOX@MIP) particles to recognize EGFR-overexpressing cancer cells, while the pH-responsiveness and photothermal conversion ability of PDA (polydopamine) achieved chemo-photothermal synergistic effects upon NIR irradiation. polydopamine 203-215 epidermal growth factor receptor Homo sapiens 97-101 34857268-0 2021 A polydopamine-assisted strontium-substituted apatite coating for titanium promotes osteogenesis and angiogenesis via FAK/MAPK and PI3K/AKT signaling pathways. polydopamine 2-14 protein tyrosine kinase 2 Homo sapiens 118-121 34857268-0 2021 A polydopamine-assisted strontium-substituted apatite coating for titanium promotes osteogenesis and angiogenesis via FAK/MAPK and PI3K/AKT signaling pathways. polydopamine 2-14 AKT serine/threonine kinase 1 Homo sapiens 136-139 34817697-1 2021 A novel time-resolved fluorescence (TRF) pobe is constructed to detect human serum albumin (HSA) by exploiting ZnGeO:Mn persistent luminescence nanorods (ZnGeO:Mn PLNRs) and polydopamine nanoparticles (PDA NPs). polydopamine 174-186 albumin Homo sapiens 77-90 34726401-2 2021 Herein, we demonstrate that targeting MUC18 with polydopamine nanoparticles (PDA NPs) and a mild photothermal effect can completely cease the migration of melanoma and breast cancer cells without killing the cells. polydopamine 49-61 melanoma cell adhesion molecule Homo sapiens 38-43 34881239-0 2021 Immobilization of Glycogen Synthase Kinase-3beta Inhibitor on 316L Stainless Steel via Polydopamine to Accelerate Endothelialization. polydopamine 87-99 glycogen synthase kinase 3 beta Homo sapiens 18-48 34592398-2 2021 Here, a bioactive MSCs-sEV-loaded electrospun silk fibroin/poly(epsilon-caprolactone) (SF/PCL) scaffold was synthesized via a mussel-inspired immobilization strategy assisted by polydopamine (pDA). polydopamine 178-190 kallikrein 1-related peptidase C9 Rattus norvegicus 23-26 34592398-2 2021 Here, a bioactive MSCs-sEV-loaded electrospun silk fibroin/poly(epsilon-caprolactone) (SF/PCL) scaffold was synthesized via a mussel-inspired immobilization strategy assisted by polydopamine (pDA). polydopamine 192-195 kallikrein 1-related peptidase C9 Rattus norvegicus 23-26 34613693-4 2021 The PDA shell keeps depleting the Ga3+ from the EGaIn nanoalloys when the synthesis proceeds, leading to a Ga3+-coordinated PDA coating and a smaller nanoalloy. polydopamine 4-7 succinyl-CoA:glutarate-CoA transferase Homo sapiens 34-37 34869260-0 2021 Polydopamine Coating-Mediated Immobilization of BMP-2 on Polyethylene Terephthalate-Based Artificial Ligaments for Enhanced Bioactivity. polydopamine 0-12 bone morphogenetic protein 2 Oryctolagus cuniculus 48-53 34869260-4 2021 In this study, we immobilized bone morphogenetic protein-2 (BMP-2) on the surface of PET ligaments mediated by polydopamine (PDA) coating and investigated the bioactivation and graft-to-bone healing effect of the modified grafts in vivo and in vitro. polydopamine 111-123 bone morphogenetic protein 2 Oryctolagus cuniculus 30-58 34869260-4 2021 In this study, we immobilized bone morphogenetic protein-2 (BMP-2) on the surface of PET ligaments mediated by polydopamine (PDA) coating and investigated the bioactivation and graft-to-bone healing effect of the modified grafts in vivo and in vitro. polydopamine 111-123 bone morphogenetic protein 2 Oryctolagus cuniculus 60-65 34869260-4 2021 In this study, we immobilized bone morphogenetic protein-2 (BMP-2) on the surface of PET ligaments mediated by polydopamine (PDA) coating and investigated the bioactivation and graft-to-bone healing effect of the modified grafts in vivo and in vitro. polydopamine 125-128 bone morphogenetic protein 2 Oryctolagus cuniculus 30-58 34869260-4 2021 In this study, we immobilized bone morphogenetic protein-2 (BMP-2) on the surface of PET ligaments mediated by polydopamine (PDA) coating and investigated the bioactivation and graft-to-bone healing effect of the modified grafts in vivo and in vitro. polydopamine 125-128 bone morphogenetic protein 2 Oryctolagus cuniculus 60-65 34869260-16 2021 Conclusion: The immobilization of BMP-2 mediated by polydopamine coating on PET artificial ligament surface could enhance the compatibility and bioactivity of the scaffolds and the graft-to-bone healing in vivo. polydopamine 52-64 bone morphogenetic protein 2 Oryctolagus cuniculus 34-39 34869291-2 2021 Here, an ultrasensitive photoelectrochemical (PEC) sensor based on ZnO@polydopamine/Au nanocomposites was constructed for quantitative detection of Abeta. polydopamine 71-83 amyloid beta precursor protein Homo sapiens 148-153 34623365-4 2021 In this work, the Tn antigen was synthesized and immobilized on a surface plasmon resonance sensor coated with a polydopamine/polyethylene oxide mixed layer used both as an anchoring surface for Tn capture moieties and to minimize surface fouling. polydopamine 113-125 C-type lectin domain family 3 member B Homo sapiens 195-197 34623365-4 2021 In this work, the Tn antigen was synthesized and immobilized on a surface plasmon resonance sensor coated with a polydopamine/polyethylene oxide mixed layer used both as an anchoring surface for Tn capture moieties and to minimize surface fouling. polydopamine 113-125 C-type lectin domain family 3 member B Homo sapiens 18-20 34535918-9 2021 In a proof-of-concept experiment, the polydopamine nanobottles are used for temperature-controlled release of thrombin to trigger the formation of fibrin gels in situ. polydopamine 38-50 coagulation factor II, thrombin Homo sapiens 110-118 34613693-4 2021 The PDA shell keeps depleting the Ga3+ from the EGaIn nanoalloys when the synthesis proceeds, leading to a Ga3+-coordinated PDA coating and a smaller nanoalloy. polydopamine 4-7 succinyl-CoA:glutarate-CoA transferase Homo sapiens 107-110 34613693-4 2021 The PDA shell keeps depleting the Ga3+ from the EGaIn nanoalloys when the synthesis proceeds, leading to a Ga3+-coordinated PDA coating and a smaller nanoalloy. polydopamine 124-127 succinyl-CoA:glutarate-CoA transferase Homo sapiens 107-110 34613693-6 2021 The reaction of Ga3+-coordinated PDA-coated nanoalloys with nitrogen dioxide gas is presented as an example for demonstrating the functionality of such hybrid composites. polydopamine 33-36 succinyl-CoA:glutarate-CoA transferase Homo sapiens 16-19 34355712-5 2021 When it was used to construct an electrochemical immunosensor for carcinoembryonic antigen (CEA) detection, polydopamine (CuFe-MoC@NG@PDA) was coated on its outer surface to increase the antibody loading and MoS2-Au NPs were used as substrates to improve Ab1 immobilization and accelerate electron transfer at the electrode interface, thereby improving the response signal of the immunosensor. polydopamine 108-120 CEA cell adhesion molecule 3 Homo sapiens 66-90 34654435-0 2021 A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1). polydopamine 2-14 ring-box 1 Homo sapiens 125-129 34654435-0 2021 A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1). polydopamine 2-14 ring-box 1 Homo sapiens 131-135 34472855-0 2021 Polydopamine-Coated Poly(l-lactide) Nanofibers with Controlled Release of VEGF and BMP-2 as a Regenerative Periosteum. polydopamine 0-12 vascular endothelial growth factor A Homo sapiens 74-78 34472855-0 2021 Polydopamine-Coated Poly(l-lactide) Nanofibers with Controlled Release of VEGF and BMP-2 as a Regenerative Periosteum. polydopamine 0-12 bone morphogenetic protein 2 Homo sapiens 83-88 34641257-0 2021 Bio-Based and Robust Polydopamine Coated Nanocellulose/Amyloid Composite Aerogel for Fast and Wide-Spectrum Water Purification. polydopamine 21-33 Fas activated serine/threonine kinase Homo sapiens 85-89 34512795-3 2021 As a proof of concept, polydopamine nanoparticles were synthesized via a simple in situ polymerization in which the nanoparticles were conjugated with the SARS-CoV-2 spike protein S1 subunit and the TLR7/8 agonist R848. polydopamine 23-35 surface glycoprotein Severe acute respiratory syndrome coronavirus 2 166-171 34512795-3 2021 As a proof of concept, polydopamine nanoparticles were synthesized via a simple in situ polymerization in which the nanoparticles were conjugated with the SARS-CoV-2 spike protein S1 subunit and the TLR7/8 agonist R848. polydopamine 23-35 toll like receptor 7 Homo sapiens 199-205 34512795-7 2021 These results show that erythrocyte-mediated systemic antiviral immunization using viral antigen- and TLR agonist-presenting polydopamine nanoparticles-a generalizable method applicable to many viral infections-is effective new approach to developing vaccines against severe infectious diseases. polydopamine 125-137 tlr None 102-105 34522935-2 2021 The resulting Dox-encapsulated polydopamine (PDA) nanoparticles were further conjugated with molecules of a zinc(II) phthalocyanine (Pc)-based photosensitiser and a peptide containing the heptapeptide QRHKPRE sequence (labelled as QRH) that can target the epidermal growth factor receptor (EGFR) overexpressed in cancer cells. polydopamine 31-43 epidermal growth factor receptor Mus musculus 256-288 34522935-2 2021 The resulting Dox-encapsulated polydopamine (PDA) nanoparticles were further conjugated with molecules of a zinc(II) phthalocyanine (Pc)-based photosensitiser and a peptide containing the heptapeptide QRHKPRE sequence (labelled as QRH) that can target the epidermal growth factor receptor (EGFR) overexpressed in cancer cells. polydopamine 31-43 epidermal growth factor receptor Mus musculus 290-294 34660198-0 2021 Immobilization of bioactive vascular endothelial growth factor onto Ca-deficient hydroxyapatite-coated Mg by covalent bonding using polydopamine. polydopamine 132-144 vascular endothelial growth factor A Rattus norvegicus 28-62 34660198-4 2021 Methods: Mg was firstly coated with Ca-deficient hydroxyapatite (CDHA) via hydrothermal treatment, and polydopamine (DOPA) was then used as the connecting medium to immobilize vascular endothelial growth factor (VEGF) on the CDHA coating. polydopamine 103-115 vascular endothelial growth factor A Rattus norvegicus 176-210 34660198-4 2021 Methods: Mg was firstly coated with Ca-deficient hydroxyapatite (CDHA) via hydrothermal treatment, and polydopamine (DOPA) was then used as the connecting medium to immobilize vascular endothelial growth factor (VEGF) on the CDHA coating. polydopamine 103-115 vascular endothelial growth factor A Rattus norvegicus 212-216 34660198-8 2021 VEGF could be firmly immobilized on Mg via polydopamine. polydopamine 43-55 vascular endothelial growth factor A Rattus norvegicus 0-4 34604092-6 2021 The key material of CNC NPs is the polydopamine (PDA), which, through self-assembling, forms a rigid shell that contains doxorubicin (DOX) and NIF fluorescent dye IR780 on the surface of the perfluorohexane (PFH) microbubbles. polydopamine 35-47 S100 calcium binding protein A9 Homo sapiens 143-146 34604092-6 2021 The key material of CNC NPs is the polydopamine (PDA), which, through self-assembling, forms a rigid shell that contains doxorubicin (DOX) and NIF fluorescent dye IR780 on the surface of the perfluorohexane (PFH) microbubbles. polydopamine 49-52 S100 calcium binding protein A9 Homo sapiens 143-146 34355712-5 2021 When it was used to construct an electrochemical immunosensor for carcinoembryonic antigen (CEA) detection, polydopamine (CuFe-MoC@NG@PDA) was coated on its outer surface to increase the antibody loading and MoS2-Au NPs were used as substrates to improve Ab1 immobilization and accelerate electron transfer at the electrode interface, thereby improving the response signal of the immunosensor. polydopamine 108-120 CEA cell adhesion molecule 3 Homo sapiens 92-95 34324292-6 2021 Herein, we demonstrate a highly active and adsorbing filter tip for cigarettes, fabricated by decorating polydopamine (PDA) on the surface of a commercial filter tip in situ. polydopamine 105-117 TOR signaling pathway regulator Homo sapiens 60-63 34399895-1 2021 A rationally designed multifunctional polydopamine (PDA)-coated metal-organic frameworks (MOFs) biosensors for detection of miRNA-122 with Zn2+-triggered aggregation-induced enhancement (AIE) and synergistic chem-photothermal therapy in vitro was developed for the first time. polydopamine 38-50 microRNA 122 Homo sapiens 124-133 34399895-1 2021 A rationally designed multifunctional polydopamine (PDA)-coated metal-organic frameworks (MOFs) biosensors for detection of miRNA-122 with Zn2+-triggered aggregation-induced enhancement (AIE) and synergistic chem-photothermal therapy in vitro was developed for the first time. polydopamine 52-55 microRNA 122 Homo sapiens 124-133 34514258-0 2021 Preparation of CNTs Coated with Polydopamine-Ni Complexes and Their Catalytic Effects on the Decomposition of CL-20. polydopamine 32-44 epithelial membrane protein 1 Homo sapiens 110-115 34514258-1 2021 To improve the condensed-phase reaction rate of epsilon-CL-20, polydopamine (PDA)-nickel complex-coated multiwalled carbon nanotubes (CNTs) have been prepared and used as combustion catalysts. polydopamine 63-75 epithelial membrane protein 1 Homo sapiens 56-61 34514258-1 2021 To improve the condensed-phase reaction rate of epsilon-CL-20, polydopamine (PDA)-nickel complex-coated multiwalled carbon nanotubes (CNTs) have been prepared and used as combustion catalysts. polydopamine 77-80 epithelial membrane protein 1 Homo sapiens 56-61 34324292-6 2021 Herein, we demonstrate a highly active and adsorbing filter tip for cigarettes, fabricated by decorating polydopamine (PDA) on the surface of a commercial filter tip in situ. polydopamine 105-117 TOR signaling pathway regulator Homo sapiens 162-165 34324292-6 2021 Herein, we demonstrate a highly active and adsorbing filter tip for cigarettes, fabricated by decorating polydopamine (PDA) on the surface of a commercial filter tip in situ. polydopamine 119-122 TOR signaling pathway regulator Homo sapiens 60-63 34324292-6 2021 Herein, we demonstrate a highly active and adsorbing filter tip for cigarettes, fabricated by decorating polydopamine (PDA) on the surface of a commercial filter tip in situ. polydopamine 119-122 TOR signaling pathway regulator Homo sapiens 162-165 34324292-7 2021 The PDA coating on the filter tip was obtained by the self-polymerization of dopamine (DA) within 16 h, which was quicker and easier than the preparation processes of other reported functionalized filter tips. polydopamine 4-7 TOR signaling pathway regulator Homo sapiens 30-33 34075916-0 2021 Thrombin immobilized polydopamine-diatom biosilica for effective hemorrhage control. polydopamine 21-33 coagulation factor II Mus musculus 0-8 34457350-0 2021 Integrin alphavbeta3-targeted polydopamine-coated gold nanostars for photothermal ablation therapy of hepatocellular carcinoma. polydopamine 30-42 integrin subunit alpha V Homo sapiens 0-20 34087438-2 2021 Herein, we reported a novel and simple approach to fabricate acorn-like poly(acrylic acid)-mesoporous calcium phosphate/polydopamine (PAA-mCaP/PDA) JNPs, which were selectively functionalized with methoxy-poly(ethylene glycol)thiol (PEG-SH) on PDA domains to obtain superior stability, while the other mCaP sides served as a storage space and passage for the anti-cancer drug of doxorubicin (DOX). polydopamine 120-132 bromodomain containing 4 Mus musculus 138-142 34443739-4 2021 This study demonstrates that the stronger hydrogen bonding interactions existed in PFD-BTO/PVDF composite film comparative to the PDA-BTO/PVDF composite film induced the higher beta-phase formation (90%), which was evidenced by the XRD, FTIR and DSC results, as well as led to a better dispersion of NPs and improved mechanical properties of composite films. polydopamine 130-133 desmocollin 3 Homo sapiens 246-249 34075916-1 2021 In this study, an efficient composite hemostatic material (DA-diatom-T) was prepared, using a polydopamine layer as a linker to immobilize thrombin on the surface of diatom biosilica. polydopamine 94-106 coagulation factor II Mus musculus 139-147 34169349-2 2021 In this study, a smart polydopamine nanodots-based cost-effective fluorescence turn-on nanoprobe (denoted as PDA-Ag-GOx) for intracellular glucose detection is established. polydopamine 23-35 hydroxyacid oxidase 1 Homo sapiens 116-119 34218050-4 2021 To this end, an injectable hydrogel with photo-responsive property was prepared by using polydopamine crosslinked collagen/silk fibroin composite to deliver thrombin for blocking blood vessels and angiogenesis. polydopamine 89-101 coagulation factor II, thrombin Homo sapiens 157-165 34298943-11 2021 Blocking activation of the integrin alpha5/beta1, MAPK, or SMAD signaling pathways downregulated the PDA/GO-induced osteogenic differentiation of ESCs. polydopamine 101-104 integrin alpha 5 (fibronectin receptor alpha) Mus musculus 27-48 34373741-3 2021 Inspired by cell membrane that separates and protects cell organelles and components from outside environment while selectively ingesting nutrition sources, we designed polydopamine (PDA)-structured nano-shell to allow free transportation of glucose for catalytic reaction, while impede the penetration of GOx, proteinase, and other GOx-deactivating macromolecules across the shell membrane. polydopamine 169-181 hydroxyacid oxidase 1 Homo sapiens 306-309 34373741-3 2021 Inspired by cell membrane that separates and protects cell organelles and components from outside environment while selectively ingesting nutrition sources, we designed polydopamine (PDA)-structured nano-shell to allow free transportation of glucose for catalytic reaction, while impede the penetration of GOx, proteinase, and other GOx-deactivating macromolecules across the shell membrane. polydopamine 169-181 endogenous retrovirus group K member 25 Homo sapiens 311-321 34298943-11 2021 Blocking activation of the integrin alpha5/beta1, MAPK, or SMAD signaling pathways downregulated the PDA/GO-induced osteogenic differentiation of ESCs. polydopamine 101-104 SMAD family member 1 Mus musculus 59-63 34373741-3 2021 Inspired by cell membrane that separates and protects cell organelles and components from outside environment while selectively ingesting nutrition sources, we designed polydopamine (PDA)-structured nano-shell to allow free transportation of glucose for catalytic reaction, while impede the penetration of GOx, proteinase, and other GOx-deactivating macromolecules across the shell membrane. polydopamine 169-181 hydroxyacid oxidase 1 Homo sapiens 333-336 34373741-3 2021 Inspired by cell membrane that separates and protects cell organelles and components from outside environment while selectively ingesting nutrition sources, we designed polydopamine (PDA)-structured nano-shell to allow free transportation of glucose for catalytic reaction, while impede the penetration of GOx, proteinase, and other GOx-deactivating macromolecules across the shell membrane. polydopamine 183-186 hydroxyacid oxidase 1 Homo sapiens 306-309 34373741-3 2021 Inspired by cell membrane that separates and protects cell organelles and components from outside environment while selectively ingesting nutrition sources, we designed polydopamine (PDA)-structured nano-shell to allow free transportation of glucose for catalytic reaction, while impede the penetration of GOx, proteinase, and other GOx-deactivating macromolecules across the shell membrane. polydopamine 183-186 endogenous retrovirus group K member 25 Homo sapiens 311-321 34373741-3 2021 Inspired by cell membrane that separates and protects cell organelles and components from outside environment while selectively ingesting nutrition sources, we designed polydopamine (PDA)-structured nano-shell to allow free transportation of glucose for catalytic reaction, while impede the penetration of GOx, proteinase, and other GOx-deactivating macromolecules across the shell membrane. polydopamine 183-186 hydroxyacid oxidase 1 Homo sapiens 333-336 34298943-12 2021 These results suggest that the PDA/GO composite stimulates the osteogenic differentiation of ESCs via the integrin alpha5/beta1, MAPK, and BMPR/SMAD signaling pathways. polydopamine 31-34 integrin alpha 5 (fibronectin receptor alpha) Mus musculus 106-127 34298943-12 2021 These results suggest that the PDA/GO composite stimulates the osteogenic differentiation of ESCs via the integrin alpha5/beta1, MAPK, and BMPR/SMAD signaling pathways. polydopamine 31-34 bone morphogenetic protein receptor, type 1A Mus musculus 139-143 34298943-12 2021 These results suggest that the PDA/GO composite stimulates the osteogenic differentiation of ESCs via the integrin alpha5/beta1, MAPK, and BMPR/SMAD signaling pathways. polydopamine 31-34 SMAD family member 1 Mus musculus 144-148 35500311-7 2022 Ultimately, the quenching labels of streptavidin modified Pt nanoparticles functionalized polydopamine composites (SA-Pt@PDA) were introduced via biotin and streptavidin recognition, realizing ECL emission quenching of S2O82-/O2 system for "on-off" detection of BCR-ABL fusion gene. polydopamine 90-102 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 262-269 34073998-0 2021 Development of a Glucose Sensor Based on Glucose Dehydrogenase Using Polydopamine-Functionalized Nanotubes. polydopamine 69-81 hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase Homo sapiens 41-62 34073998-5 2021 Herein, we report the use of polydopamine-functionalized multi-walled carbon nanotubes (PDA-MWCNTs) to effectively attach Ru(dmo-bpy)2Cl2 and GDH onto screen-printed carbon electrodes (SPCEs) without requiring a cross-linker. polydopamine 29-41 hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase Homo sapiens 142-145 34137582-0 2021 Imaging-Guided Chemo-Photothermal Polydopamine Carbon Dots for EpCAM-Targeted Delivery toward Liver Tumor. polydopamine 34-46 epithelial cell adhesion molecule Homo sapiens 63-68 34064007-7 2021 Moreover, loaded polydopamine nanoparticles, which notably increased the number of apoptotic HER2-positive breast cancer cells after treatment, also maintained an efficient antineoplastic effect when validated in tumor spheroids. polydopamine 17-29 erb-b2 receptor tyrosine kinase 2 Homo sapiens 93-97 35483856-3 2022 Herein, the chitin-based NGC (ChT NGC) is firstly reported by facile dissolution, molding and regeneration process, performed excellent nerve regeneration and neuroma inhibition after deposited with anti-inflammatory polydopamine (ChT-PDA NGC). polydopamine 217-229 solute carrier family 5 member 7 Rattus norvegicus 30-33 35483856-3 2022 Herein, the chitin-based NGC (ChT NGC) is firstly reported by facile dissolution, molding and regeneration process, performed excellent nerve regeneration and neuroma inhibition after deposited with anti-inflammatory polydopamine (ChT-PDA NGC). polydopamine 217-229 solute carrier family 5 member 7 Rattus norvegicus 231-234 35152024-2 2022 The lysozyme specific aptamer was immobilized on poly (dopamine) coated magnetic chitosan beads and the chip via Schiff base reaction. polydopamine 49-64 lysozyme Homo sapiens 4-12 35567878-5 2022 In this study, an iron hydroxide@polydopamine@waste polyurethane foam (Fe(OH)3@PDA@WPU) was synthesized via a facile and mild "one-pot" reaction. polydopamine 33-45 general transcription factor IIE subunit 1 Homo sapiens 71-78 35578815-2 2022 Here, we synthesized epsilon-polylysine-grafted nanocellulose (NCF-EPL) and polydopamine (PDA) nanoparticles and embedded them in genipin-cross-linked gelatin to prepare a hydrogel (NCF-EPL/GTP/PDA). polydopamine 76-88 neutrophil cytosolic factor 4 Homo sapiens 182-185 35470077-2 2022 We developed a polydopamine-based nanoplatform constructed with ferric ion and sulfasalazine-loaded nanoparticles (Fe(III)PP@SAS NPs) for dual-functional ferrotherapy strategy of "sword and shield" through enhanced Fenton reaction and inactivation of glutathione peroxidase 4 (GPX4), respectively. polydopamine 15-27 glutathione peroxidase 4 Homo sapiens 251-275 35579224-3 2022 Herein, human serum albumin (HSA)-imprinted polymer coated Fe3O4 nanoparticles (Fe3O4@MIPs) are fabricated by oxidative polymerization of dopamine in the presence of HSA on the polydopamine pre-modified Fe3O4 nanoparticle surface, followed by the removal of HSA. polydopamine 177-189 albumin Homo sapiens 14-27 35470077-2 2022 We developed a polydopamine-based nanoplatform constructed with ferric ion and sulfasalazine-loaded nanoparticles (Fe(III)PP@SAS NPs) for dual-functional ferrotherapy strategy of "sword and shield" through enhanced Fenton reaction and inactivation of glutathione peroxidase 4 (GPX4), respectively. polydopamine 15-27 glutathione peroxidase 4 Homo sapiens 277-281 35063828-0 2022 Peptide nanotubes/self-assembled polydopamine molecularly imprinted biochip for the impedimetric detection of human Interleukin-6. polydopamine 33-45 interleukin 6 Homo sapiens 116-129 35063828-1 2022 In the study, an impedimetric biochip was designed with molecularly imprinted polydopamine (MIP(pDa)) on peptide nanotube (PNT) functionalized screen printed electrodes (SPEs) and adopted first time as a support matrix to construct the electrochemical sensor for the determination of interleukin 6 (IL-6). polydopamine 78-90 interleukin 6 Homo sapiens 284-297 35189559-0 2022 An antifouling electrochemical aptasensor based on hyaluronic acid functionalized polydopamine for thrombin detection in human serum. polydopamine 82-94 coagulation factor II, thrombin Homo sapiens 99-107 35063828-1 2022 In the study, an impedimetric biochip was designed with molecularly imprinted polydopamine (MIP(pDa)) on peptide nanotube (PNT) functionalized screen printed electrodes (SPEs) and adopted first time as a support matrix to construct the electrochemical sensor for the determination of interleukin 6 (IL-6). polydopamine 78-90 interleukin 6 Homo sapiens 299-303 35189559-2 2022 Herein, a universal strategy for sensitive and low-fouling detection of thrombin in human serum was developed based on hyaluronic acid functionalized polydopamine. polydopamine 150-162 coagulation factor II, thrombin Homo sapiens 72-80 35193120-3 2022 Utilizing the mussel-inspired polydopamine (PDA) surface modification, brain-derived neurotrophic factor (BDNF) was loaded onto PCL/CNTs fibrous scaffolds to obtain PCL/CNTs-PDA-BDNF fibrous scaffolds capable of the sustained release of BDNF over 28 days. polydopamine 30-42 brain-derived neurotrophic factor Rattus norvegicus 106-110 35189559-3 2022 The material hyaluronic acid with hydroxyl groups was grafted to the polydopamine modified electrode surface through the connection of 6-mercapto-1-hexanol to exert antifouling performance, and the hyaluronic acid also provided a good substrate for the immobilization of aptamers specific for thrombin. polydopamine 69-81 coagulation factor II, thrombin Homo sapiens 293-301 35562356-3 2022 Herein, through a facile surface coating process, mussel-inspired polydopamine (PDA) is adhered to the surface of a biocompatible porous scaffold followed by the immobilization of a small-molecule activator (LYN-1604 (LYN)) and the subsequent in situ coprecipitation of hydroxyapatite (HA) nanocrystals. polydopamine 66-78 LYN proto-oncogene, Src family tyrosine kinase Rattus norvegicus 208-216 35562356-3 2022 Herein, through a facile surface coating process, mussel-inspired polydopamine (PDA) is adhered to the surface of a biocompatible porous scaffold followed by the immobilization of a small-molecule activator (LYN-1604 (LYN)) and the subsequent in situ coprecipitation of hydroxyapatite (HA) nanocrystals. polydopamine 66-78 LYN proto-oncogene, Src family tyrosine kinase Rattus norvegicus 218-221 35562356-3 2022 Herein, through a facile surface coating process, mussel-inspired polydopamine (PDA) is adhered to the surface of a biocompatible porous scaffold followed by the immobilization of a small-molecule activator (LYN-1604 (LYN)) and the subsequent in situ coprecipitation of hydroxyapatite (HA) nanocrystals. polydopamine 80-83 LYN proto-oncogene, Src family tyrosine kinase Rattus norvegicus 208-216 35562356-3 2022 Herein, through a facile surface coating process, mussel-inspired polydopamine (PDA) is adhered to the surface of a biocompatible porous scaffold followed by the immobilization of a small-molecule activator (LYN-1604 (LYN)) and the subsequent in situ coprecipitation of hydroxyapatite (HA) nanocrystals. polydopamine 80-83 LYN proto-oncogene, Src family tyrosine kinase Rattus norvegicus 218-221 35388697-4 2022 In the present study, we combined photothermal and immunotherapy to design a novel nanoparticle delivery system by loading indoleamine 2,3-dioxygenase (IDO) inhibitors and toll-like receptor (TLR) agonists into polydopamine (PDA) nanoparticles coated with polyethylene imine (PEI). polydopamine 211-223 indoleamine 2,3-dioxygenase 1 Mus musculus 123-150 35388697-4 2022 In the present study, we combined photothermal and immunotherapy to design a novel nanoparticle delivery system by loading indoleamine 2,3-dioxygenase (IDO) inhibitors and toll-like receptor (TLR) agonists into polydopamine (PDA) nanoparticles coated with polyethylene imine (PEI). polydopamine 211-223 indoleamine 2,3-dioxygenase 1 Mus musculus 152-155 35388697-4 2022 In the present study, we combined photothermal and immunotherapy to design a novel nanoparticle delivery system by loading indoleamine 2,3-dioxygenase (IDO) inhibitors and toll-like receptor (TLR) agonists into polydopamine (PDA) nanoparticles coated with polyethylene imine (PEI). polydopamine 225-228 indoleamine 2,3-dioxygenase 1 Mus musculus 123-150 35388697-4 2022 In the present study, we combined photothermal and immunotherapy to design a novel nanoparticle delivery system by loading indoleamine 2,3-dioxygenase (IDO) inhibitors and toll-like receptor (TLR) agonists into polydopamine (PDA) nanoparticles coated with polyethylene imine (PEI). polydopamine 225-228 indoleamine 2,3-dioxygenase 1 Mus musculus 152-155 35074704-1 2022 Polydopamine/defective ultrathin mesoporous graphitic carbon nitride (PDA/DCN) Z-scheme organic assembly is fabricated through high-temperature surface hydrogenation and ultrasonic freeze-dried strategies. polydopamine 0-12 decorin Homo sapiens 74-77 35193120-0 2022 Polydopamine-coated polycaprolactone/carbon nanotubes fibrous scaffolds loaded with brain-derived neurotrophic factor for peripheral nerve regeneration. polydopamine 0-12 brain-derived neurotrophic factor Rattus norvegicus 84-117 35193120-3 2022 Utilizing the mussel-inspired polydopamine (PDA) surface modification, brain-derived neurotrophic factor (BDNF) was loaded onto PCL/CNTs fibrous scaffolds to obtain PCL/CNTs-PDA-BDNF fibrous scaffolds capable of the sustained release of BDNF over 28 days. polydopamine 30-42 brain-derived neurotrophic factor Rattus norvegicus 71-104 35339902-2 2022 Herein, a dual-catalytic redox system was constructed by using the inner dynamic redox-activity of PDA and free radical initiator ammonium persulfate (APS) to initiate the polymerization of acrylic acid (AA) monomer to obtain Fe-PDA hydrogels within 2 h at room temperature. polydopamine 229-232 general transcription factor IIE subunit 1 Homo sapiens 226-228 35596855-0 2022 Modification-Free Fluorescent Biosensor for CEA Based on Polydopamine-Coated Upconversion Nanoparticles. polydopamine 57-69 CEA cell adhesion molecule 3 Homo sapiens 44-47 35578899-6 2022 Here, we constructed PEG-modified mesoporous polydopamine nanoparticles with Cu2+ chelation and LOX encapsulation (denoted as mCuLP). polydopamine 45-57 lysyl oxidase Homo sapiens 96-99 35193120-3 2022 Utilizing the mussel-inspired polydopamine (PDA) surface modification, brain-derived neurotrophic factor (BDNF) was loaded onto PCL/CNTs fibrous scaffolds to obtain PCL/CNTs-PDA-BDNF fibrous scaffolds capable of the sustained release of BDNF over 28 days. polydopamine 44-47 brain-derived neurotrophic factor Rattus norvegicus 71-104 35193120-3 2022 Utilizing the mussel-inspired polydopamine (PDA) surface modification, brain-derived neurotrophic factor (BDNF) was loaded onto PCL/CNTs fibrous scaffolds to obtain PCL/CNTs-PDA-BDNF fibrous scaffolds capable of the sustained release of BDNF over 28 days. polydopamine 44-47 brain-derived neurotrophic factor Rattus norvegicus 106-110 35380840-2 2022 In this study, LL-37, a natural human antimicrobial peptide, was successfully modified on the PEKK surface with polydopamine as the intermediate layer and released continuously for more than 6 days. polydopamine 112-124 cathelicidin antimicrobial peptide Homo sapiens 15-20 35344350-3 2022 Second, the surface of CNF was modified using polydopamine (PDA) to obtain PDA@CNF (PCNF) composite aerogel. polydopamine 46-58 NPHS1 adhesion molecule, nephrin Homo sapiens 23-26 35344350-3 2022 Second, the surface of CNF was modified using polydopamine (PDA) to obtain PDA@CNF (PCNF) composite aerogel. polydopamine 46-58 NPHS1 adhesion molecule, nephrin Homo sapiens 75-82 35344350-3 2022 Second, the surface of CNF was modified using polydopamine (PDA) to obtain PDA@CNF (PCNF) composite aerogel. polydopamine 60-63 NPHS1 adhesion molecule, nephrin Homo sapiens 23-26 35344350-3 2022 Second, the surface of CNF was modified using polydopamine (PDA) to obtain PDA@CNF (PCNF) composite aerogel. polydopamine 60-63 NPHS1 adhesion molecule, nephrin Homo sapiens 75-82 35408497-1 2022 An ascorbic acid (AA) sensor was constructed based on the fluorescence resonance energy transfer (FRET) between CdS quantum dots (CdS QDs) and polydopamine (PDA) to detect trace AA sensitively. polydopamine 143-155 CDP-diacylglycerol synthase 1 Homo sapiens 112-115 35398972-4 2022 In this work, we attempted to shape the nano-topography of PEEK surface by nitrogen low-temperature plasma and polydopamine coating on the surface as a secondary reaction platform to bond the aminated poly (lactic-co-glycolic acid) (PLGA) microspheres encapsulating the BMP-2 gene for enhancing the biological activity. polydopamine 111-123 bone morphogenetic protein 2 Rattus norvegicus 270-275 35464724-4 2022 Furthermore, bone morphogenetic protein-2 (BMP-2) was facilely incorporated into this scaffold through a facile polydopamine (PDA) modification process. polydopamine 112-124 bone morphogenetic protein 2 Rattus norvegicus 13-41 35464724-4 2022 Furthermore, bone morphogenetic protein-2 (BMP-2) was facilely incorporated into this scaffold through a facile polydopamine (PDA) modification process. polydopamine 112-124 bone morphogenetic protein 2 Rattus norvegicus 43-48 35464724-4 2022 Furthermore, bone morphogenetic protein-2 (BMP-2) was facilely incorporated into this scaffold through a facile polydopamine (PDA) modification process. polydopamine 126-129 bone morphogenetic protein 2 Rattus norvegicus 13-41 35464724-4 2022 Furthermore, bone morphogenetic protein-2 (BMP-2) was facilely incorporated into this scaffold through a facile polydopamine (PDA) modification process. polydopamine 126-129 bone morphogenetic protein 2 Rattus norvegicus 43-48 35158079-4 2022 By using electrospun fiber fragments as the template, urokinase (uPA)-loaded polydopamine (PDA) microtubes with surface decorated fucoidan (FuPDAuPA) were prepared at the aspect ratio of around 2. polydopamine 77-89 proline rich acidic protein 1 Homo sapiens 65-68 35158079-4 2022 By using electrospun fiber fragments as the template, urokinase (uPA)-loaded polydopamine (PDA) microtubes with surface decorated fucoidan (FuPDAuPA) were prepared at the aspect ratio of around 2. polydopamine 91-94 proline rich acidic protein 1 Homo sapiens 65-68 35168125-1 2022 In this study, a novel polydopamine and C18 dual-functionalized magnetic core-shell mesoporous silica (Fe3O4@nSiO2@mSiO2@PDA-C18) nanocomposite was designed and synthesized, which was employed as an adsorbent to extract illegal drugs from urine samples by magnetic solid-phase extraction (MSPE) procedures. polydopamine 23-35 Bardet-Biedl syndrome 9 Homo sapiens 125-128 35408497-1 2022 An ascorbic acid (AA) sensor was constructed based on the fluorescence resonance energy transfer (FRET) between CdS quantum dots (CdS QDs) and polydopamine (PDA) to detect trace AA sensitively. polydopamine 157-160 CDP-diacylglycerol synthase 1 Homo sapiens 112-115 35088512-4 2022 To address this refractory concern, an antibacterial fibrous membrane consisting of electrospun poly (polycaprolactone) scaffolds and polydopamine (pDA) coated MXene/Ag3 PO4 bioheterojunctions (MX@AgP bio-HJs) is devised and developed. polydopamine 134-146 anterior gradient 3, protein disulphide isomerase family member Homo sapiens 166-169 35088512-4 2022 To address this refractory concern, an antibacterial fibrous membrane consisting of electrospun poly (polycaprolactone) scaffolds and polydopamine (pDA) coated MXene/Ag3 PO4 bioheterojunctions (MX@AgP bio-HJs) is devised and developed. polydopamine 148-151 anterior gradient 3, protein disulphide isomerase family member Homo sapiens 166-169 35133364-2 2022 Here, a fluorescence biosensor was established to detect HER2 based on the fluorescence resonance energy transfer (FRET) and photoinduced electron transfer (PET) occurring between the bimetal-polydopamine organic framework with core-shell structure Au@PDA@UiO-66 and the Cy5 fluorophore in HER2-Cy5-Apt. polydopamine 192-204 erb-b2 receptor tyrosine kinase 2 Homo sapiens 290-294 35197099-0 2022 Sensitive and selective detection of Mucin1 in pancreatic cancer using hybridization chain reaction with the assistance of Fe3O4@polydopamine nanocomposites. polydopamine 129-141 mucin 1, cell surface associated Homo sapiens 37-43 34505327-4 2022 RESULTS: The optimal conditions for the preparation of polydopamine-nucleopolyhedrovirus microcapsules were as follows: Spodoptera exigua nucleopolyhedrovirus (SeMNPV)concentration of 2 x 108 polyhedral inclusion body(PIB) mL-1 , reaction time of 6 h, and pH of 9.0. polydopamine 55-67 L1 cell adhesion molecule Mus musculus 225-229 35133364-0 2022 Preparation of bimetal-polydopamine organic frameworks with core-shell structure and their application in HER2 detection. polydopamine 23-35 erb-b2 receptor tyrosine kinase 2 Homo sapiens 106-110 35133364-2 2022 Here, a fluorescence biosensor was established to detect HER2 based on the fluorescence resonance energy transfer (FRET) and photoinduced electron transfer (PET) occurring between the bimetal-polydopamine organic framework with core-shell structure Au@PDA@UiO-66 and the Cy5 fluorophore in HER2-Cy5-Apt. polydopamine 192-204 erb-b2 receptor tyrosine kinase 2 Homo sapiens 57-61 35424626-2 2022 Herein, we designed the multilayer TC4-Ag-polydopamine coatings, to provide TC4 with slow-release antibacterial properties whilst maintaining cytocompatibility. polydopamine 42-54 RAN pseudogene 1 Homo sapiens 35-38 35424626-2 2022 Herein, we designed the multilayer TC4-Ag-polydopamine coatings, to provide TC4 with slow-release antibacterial properties whilst maintaining cytocompatibility. polydopamine 42-54 RAN pseudogene 1 Homo sapiens 76-79 35424626-5 2022 In addition, the prepared TC4-Ag-polydopamine samples with Ag thickness of 20 and 30 nm, showed high hydrophilic performance with the contact-angle less than 20 , low cytotoxicity and good cytocompatibility. polydopamine 33-45 RAN pseudogene 1 Homo sapiens 26-29 34950937-1 2022 In this paper, a smart enzyme reactor (SER) was synthesized using immobilized tyrosinase (Tyr) in a photo-responsive hydrogel via a polydopamine-assisted self-assembly strategy for purifying water from phenol contaminated water. polydopamine 132-144 tyrosinase Homo sapiens 78-88 34959229-1 2022 In this work, a novel antibacterial nanocomposite system was developed using mesoporous silica (MSN) as an effective nanocarrier, and the resultant nanocomposites demonstrated remarkable antibacterial performance due to the synergistic effect among nano zinc oxides, silver nanoparticles, and polydopamine (PDA). polydopamine 293-305 moesin Homo sapiens 96-99 34959229-1 2022 In this work, a novel antibacterial nanocomposite system was developed using mesoporous silica (MSN) as an effective nanocarrier, and the resultant nanocomposites demonstrated remarkable antibacterial performance due to the synergistic effect among nano zinc oxides, silver nanoparticles, and polydopamine (PDA). polydopamine 307-310 moesin Homo sapiens 96-99 34959229-2 2022 The successful synthesis of MSN/ZnO@PDA/Ag nanocomposites was confirmed. polydopamine 36-39 moesin Homo sapiens 28-31